<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Psychological interventions for co‐occurring depression and substance use disorders - Hides, L - 2019 | Cochrane Library</title> <meta content="Psychological interventions for co‐occurring depression and substance use disorders - Hides, L - 2019 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009501.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Psychological interventions for co‐occurring depression and substance use disorders - Hides, L - 2019 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009501.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD009501.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Psychological interventions for co‐occurring depression and substance use disorders" name="citation_title"/> <meta content="Leanne Hides" name="citation_author"/> <meta content="The University of Queensland" name="citation_author_institution"/> <meta content="l.hides@uq.edu.au" name="citation_author_email"/> <meta content="Catherine Quinn" name="citation_author"/> <meta content="Queensland University of Technology" name="citation_author_institution"/> <meta content="Stoyan Stoyanov" name="citation_author"/> <meta content="Queensland University of Technology" name="citation_author_institution"/> <meta content="David Kavanagh" name="citation_author"/> <meta content="Queensland University of Technology" name="citation_author_institution"/> <meta content="Amanda Baker" name="citation_author"/> <meta content="University of Newcastle, Callaghan" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="11" name="citation_issue"/> <meta content="10.1002/14651858.CD009501.pub2" name="citation_doi"/> <meta content="2019" name="citation_date"/> <meta content="2019/11/26" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009501.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009501.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009501.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Cognitive Behavioral Therapy; Depression [epidemiology, *therapy]; Psychotherapy [*methods]; Psychotherapy, Brief [methods]; Psychotherapy, Group; Randomized Controlled Trials as Topic; Substance‐Related Disorders [epidemiology, *therapy]; Treatment Outcome" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009501.pub2&amp;doi=10.1002/14651858.CD009501.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009501.pub2&amp;doi=10.1002/14651858.CD009501.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009501.pub2&amp;doi=10.1002/14651858.CD009501.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009501.pub2&amp;doi=10.1002/14651858.CD009501.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009501.pub2&amp;doi=10.1002/14651858.CD009501.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009501.pub2&amp;doi=10.1002/14651858.CD009501.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009501.pub2&amp;doi=10.1002/14651858.CD009501.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009501.pub2&amp;doi=10.1002/14651858.CD009501.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009501.pub2&amp;doi=10.1002/14651858.CD009501.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009501.pub2&amp;doi=10.1002/14651858.CD009501.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009501.pub2&amp;doi=10.1002/14651858.CD009501.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009501.pub2&amp;doi=10.1002/14651858.CD009501.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009501.pub2&amp;doi=10.1002/14651858.CD009501.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009501.pub2&amp;doi=10.1002/14651858.CD009501.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009501.pub2&amp;doi=10.1002/14651858.CD009501.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009501.pub2&amp;doi=10.1002/14651858.CD009501.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009501.pub2&amp;doi=10.1002/14651858.CD009501.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009501.pub2&amp;doi=10.1002/14651858.CD009501.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009501.pub2&amp;doi=10.1002/14651858.CD009501.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009501.pub2&amp;doi=10.1002/14651858.CD009501.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009501.pub2&amp;doi=10.1002/14651858.CD009501.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009501.pub2&amp;doi=10.1002/14651858.CD009501.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009501.pub2&amp;doi=10.1002/14651858.CD009501.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="77cjsSG8";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD009501\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD009501\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009501\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009501\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ms","fa","fr","zh_HANS","ko","pl","ja"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD009501.pub2",title:"Psychological interventions for co\\u2010occurring depression and substance use disorders",firstPublishedDate:"Nov 26, 2019 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Drugs and Alcohol Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=77cjsSG8&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009501.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009501.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD009501.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD009501.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009501.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD009501.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD009501.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD009501.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD009501.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD009501.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>8408 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD009501.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009501.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009501.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009501.pub2/full#CD009501-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009501.pub2/full#CD009501-sec-0098"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009501.pub2/full#CD009501-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009501.pub2/full#CD009501-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009501.pub2/full#CD009501-sec-0035"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009501.pub2/full#CD009501-sec-0036"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009501.pub2/full#CD009501-sec-0060"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009501.pub2/full#CD009501-sec-0092"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009501.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009501.pub2/appendices#CD009501-sec-0103"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009501.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009501.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/table_n/CD009501StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/table_n/CD009501StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009501.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009501.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009501.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009501.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009501.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD009501.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2019 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Psychological interventions for co‐occurring depression and substance use disorders</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009501.pub2/information#CD009501-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Leanne Hides</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009501.pub2/information#CD009501-cr-0003">Catherine Quinn</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009501.pub2/information#CD009501-cr-0004">Stoyan Stoyanov</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009501.pub2/information#CD009501-cr-0005">David Kavanagh</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009501.pub2/information#CD009501-cr-0006">Amanda Baker</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/information/en#CD009501-sec-0110">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 26 November 2019 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD009501.pub2">https://doi.org/10.1002/14651858.CD009501.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD009501-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009501-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009501-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009501-abs-0002">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD009501-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD009501-abs-0012">한국어</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD009501-abs-0010">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD009501-abs-0001" lang="en"> <section id="CD009501-sec-0001"> <h3 class="title" id="CD009501-sec-0001">Background</h3> <p>Comorbid depression and substance use disorders are common and have poorer outcomes than either disorder alone. While effective psychological treatments for depression or substance use disorders are available, relatively few randomised controlled trials (RCTs) have examined the efficacy of these treatments in people with these comorbid disorders. </p> </section> <section id="CD009501-sec-0002"> <h3 class="title" id="CD009501-sec-0002">Objectives</h3> <p>To assess the efficacy of psychological interventions delivered alone or in combination with pharmacotherapy for people diagnosed with comorbid depression and substance use disorders. </p> </section> <section id="CD009501-sec-0003"> <h3 class="title" id="CD009501-sec-0003">Search methods</h3> <p>We searched the following databases up to February 2019: Cochrane Central Register of Controlled Trials, PubMed, Embase, CINAHL, Google Scholar and clinical trials registers. All systematic reviews identified, were handsearched for relevant articles. </p> </section> <section id="CD009501-sec-0004"> <h3 class="title" id="CD009501-sec-0004">Selection criteria</h3> <p>The review includes data from RCTs of psychological treatments for people diagnosed with comorbid depression and substance use disorders, using structured clinical interviews. Studies were included if some of the sample were experiencing another mental health disorder (e.g. anxiety); however, studies which required a third disorder as part of their inclusion criteria were not included. Studies were included if psychological interventions (with or without pharmacotherapy) were compared with no treatment, delayed treatment, treatment as usual or other psychological treatments. </p> </section> <section id="CD009501-sec-0005"> <h3 class="title" id="CD009501-sec-0005">Data collection and analysis</h3> <p>We used standard methodological procedures expected by Cochrane.</p> </section> <section id="CD009501-sec-0006"> <h3 class="title" id="CD009501-sec-0006">Main results</h3> <p>Seven RCTs of psychological treatments with a total of 608 participants met inclusion criteria. All studies were published in the USA and predominately consisted of Caucasian samples. All studies compared different types of psychological treatments. Two studies compared Integrated Cognitive Behavioural Therapy (ICBT) with Twelve Step Facilitation (TSF), another two studies compared Interpersonal Psychotherapy for Depression (IPT‐D) with other treatment (Brief Supportive Therapy (BST) or Psychoeducation). The other three studies compared different types or combinations of psychological treatments. No studies compared psychological interventions with no treatment or treatment as usual control conditions. The studies included a diverse range of participants (e.g. veterans, prisoners, community adults and adolescents). </p> <p>All studies were at high risk of performance bias, other main sources were selection, outcome detection and attrition bias. Due to heterogeneity between studies only two meta‐analyses were conducted. The first meta‐analysis focused on two studies (296 participants) comparing ICBT to TSF. Very low‐quality evidence revealed that while the TSF group had lower depression scores than the ICBT group at post‐treatment (mean difference (MD) 4.05, 95% confidence interval (CI) 1.43 to 6.66; 212 participants), there was no difference between groups in depression symptoms (MD 1.53, 95% CI ‐1.73 to 4.79; 181 participants) at six‐ to 12‐month follow‐up. At post‐treatment there was no difference between groups in proportion of days abstinent (MD ‐2.84, 95% CI ‐8.04 to 2.35; 220 participants), however, the ICBT group had a greater proportion of days abstinent than the TSF group at the six‐ to 12‐month follow‐up (MD 10.76, 95% CI 3.10 to 18.42; 189 participants). There were no differences between the groups in treatment attendance (MD ‐1.27, 95% CI ‐6.10 to 3.56; 270 participants) or treatment retention (RR 0.95, 95% CI 0.72 to 1.25; 296 participants). </p> <p>The second meta‐analysis was conducted with two studies (64 participants) comparing IPT‐D with other treatment (Brief Supportive Psychotherapy/Psychoeducation). Very low‐quality evidence indicated IPT‐D resulted in significantly lower depressive symptoms at post‐treatment (MD ‐0.54, 95% CI ‐1.04 to ‐0.04; 64 participants), but this effect was not maintained at three‐month follow‐up (MD 3.80, 95% CI ‐3.83 to 11.43) in the one study reporting follow‐up outcomes (38 participants; IPT‐D versus Psychoeducation). Substance use was examined separately in each study, due to heterogeneity in outcomes. Both studies found very low‐quality evidence of no significant differences in substance use outcomes at post‐treatment (percentage of days abstinent, IPD versus Brief Supportive Psychotherapy; MD ‐2.70, 95% CI ‐28.74 to 23.34; 26 participants) or at three‐month follow‐up (relative risk of relapse, IPT‐D versus Psychoeducation; RR 0.67, 95% CI 0.30 to 1.50; 38 participants). There was also very low‐quality evidence for no significant differences between groups in treatment retention (RR 1.00, 95% CI 0.81 to 1.23; 64 participants). No adverse events were reported in any study. </p> </section> <section id="CD009501-sec-0007"> <h3 class="title" id="CD009501-sec-0007">Authors' conclusions</h3> <p>The conclusions of this review are limited due to the low number and very poor quality of included studies. No conclusions can be made about the efficacy of psychological interventions (delivered alone or in combination with pharmacotherapy) for the treatment of comorbid depression and substance use disorders, as they are yet to be compared with no treatment or treatment as usual in this population. In terms of differences between psychotherapies, although some significant effects were found, the effects were too inconsistent and small, and the evidence of too poor quality, to be of relevance to practice. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD009501-abs-0005" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009501-abs-0005">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009501-abs-0009">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009501-abs-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD009501-abs-0008">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD009501-abs-0015">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD009501-abs-0013">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD009501-abs-0006">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD009501-abs-0014">Polski</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD009501-abs-0011">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD009501-abs-0005" lang="en"> <h3>Do psychological interventions work for people with both depression and substance use disorders? </h3> <p><b>What is the aim of this review?</b> </p> <p>The aim of this Cochrane Review was to find out if psychological interventions (delivered with or without pharmacotherapy) are effective for the treatment of comorbid depression and substance use disorders. Cochrane researchers collected and analysed all relevant studies to answer this question. </p> <p><b>Key messages</b> </p> <p>No conclusions about the effectiveness of psychological interventions for the treatment of comorbid depression and substance use disorders can be made, due to the low number of studies found and very low quality of the evidence. More high‐quality studies comparing psychological interventions versus no treatment, delayed treatment, treatment as usual and other psychological interventions are needed. </p> <p><b>What was studied in the review?</b> </p> <p>Comorbidity occurs for people experiencing mental disorders when the same person has two or more mental disorders. People diagnosed with depression are more likely to have substance use disorders, and vice versa. Comorbid disorders are associated with poorer clinical, social and vocational outcomes than either disorder alone. Psychological treatments for comorbid depression and substance use disorders are available, but relatively few have been tested. These treatments target psychological (thoughts, feelings, behaviours), social (family and personal relationships), and environmental risk factors (access to drugs) for depression and substance use. </p> <p><b>What are the main results of the review?</b> </p> <p>The review authors searched for studies and found seven randomised controlled trials involving 608 people with comorbid depression and substance use disorders published between 2003 and 2014. All seven studies were published in the USA and predominately consisted of individuals from Caucasian backgrounds. No conclusions about the effectiveness of psychological interventions delivered with or without pharmacotherapy could be made, as no studies comparing these interventions with no treatment, delayed treatment or treatment as usual were found. All seven studies compared different types or combinations of psychological treatments. Few consistent differences in depression or substance use treatment outcomes were found. No conclusions about which type of psychological intervention was most effective could be made, due to the low number of studies found and very low quality of the evidence . None of the studies reported any harms related to receiving psychological treatment for depression and substance use disorders. All studies were funded by university and government research grants in the USA. </p> <p><b>How up‐to‐date is this review?</b> </p> <p>The review authors searched for studies that had been published up to February 2019.</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD009501-sec-0098" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD009501-sec-0098"></div> <h3 class="title" id="CD009501-sec-0099">Implications for practice</h3> <section id="CD009501-sec-0099"> <p>The conclusions of this review are limited due to the low number and poor quality of included studies. No conclusions can be made about the efficacy of psychological interventions (delivered alone or in combination with pharmacotherapy) for the treatment of comorbid depression and substance use disorders, as they are yet to be compared with no treatment, treatment as usual or delayed interventions in this population. All seven studies included in this review compared psychological interventions. However, no conclusions can be made about which psychological treatment is most effective, as although some significant effects were found, the effects were too small and inconsistent, and the evidence too poor quality to be of relevance to practice. </p> </section> <h3 class="title" id="CD009501-sec-0100">Implications for research</h3> <section id="CD009501-sec-0100"> <p>More research on the psychological treatment of comorbid depression and substance use disorders using well‐designed randomised controlled trials (RCTs) based on accepted guidelines (CONSORT (Consolidated Standards of Reporting Trials), Cochrane, SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials)) are required (<a href="./references#CD009501-bbs2-0146" title="BoutronI , MoherD , AltmanD , SchulzK , RavaudP . Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Annals of Internal Medicine2008;148(4):295‐309. [PUBMED: 18283207] ">Boutron 2008</a>; <a href="./references#CD009501-bbs2-0148" title="ChanAW , TetzlaffJM , AltmanDG , LaupacisA , GøtzschePC , Krleža‐JerićK , et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Annals of Internal Medicine2013;158(3):200‐7. [PUBMED: 23295957] ">Chan 2013</a>). This should include RCTs comparing the efficacy of psychological interventions delivered alone or in combination with pharmacotherapy, and comparing them with delayed or no treatment control conditions. A number of studies were excluded from this review because they did not use diagnostic criteria for depression and substance use disorder. Consensus definitions and measures of depression and substance use outcome variables, as well as consistent scale cut‐offs to accurately identify individuals with comorbid depression and substance use problems are needed to improve the quality of evidence. Future research needs to clearly specify the qualifications, training and supervision of therapists and ensure fidelity checks are conducted regularly by independent raters to ensure high‐quality psychological treatments are delivered in RCTs. However, acknowledgement is also required that this need for qualification, training and supervision, and the higher rigor required for RCTs is expensive, and may preclude the conduct of these high‐quality trials, particularly in countries beyond the USA. Hence, consideration of how to adequately fund these trials is also needed. It is imperative that information on the number and length of sessions and the delivered treatment components is recorded and compared with other active and non‐active treatments to avoid contamination effects. The treatment dose within and across intervention arms and the impact of this on depression and substance use outcomes also needs to be examined. Larger sample sizes and more ethnically diverse samples would enable subgroup analyses to control for heterogeneity in the inclusion/exclusion criteria used, as well as the length, intensity, target (depression, substance use, depression and substance use), content and modality of treatment provided. The impact of assessments, treatment as usual and regression to the mean among treatment‐seeking populations also requires consideration when comparing psychological treatments. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD009501-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD009501-sec-0029"></div> <div class="table" id="CD009501-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Integrated CBT compared with Twelve Step Facilitation for co‐occurring depression and substance use disorders</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p><b>Integrated CBT compared with Twelve Step Facilitation for co‐occurring depression and substance use disorders</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p><b>Patient or population:</b> co‐occurring depression and substance use disorders<br/> <b>Setting:</b> <br/> <b>Intervention:</b> Integrated CBT<br/> <b>Comparison:</b> Twelve Step Facilitation </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Twelve Step Facilitation</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Integrated CBT</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Depression score<br/> Assessed with: Hamilton Depression Rating Scale (HDRS) ‐ Structured clinical interview (21 items)<br/> Scale from: 0 to 54 (higher score worse)<br/> Follow‐up: end of treatment </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean depression score ranged from 21.0 to 23.2</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 4.05 higher<br/> (1.43 higher to 6.66 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>212<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Depression score<br/> Assessed with: Hamilton Depression Rating Scale (HDRS) ‐ Structured clinical interview (21 items)<br/> Scale from: 0 to 54 (higher score worse)<br/> Follow‐up: 6 months to 12 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean depression score ranged from 21.0 to 27.9</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 1.53 higher<br/> (1.73 lower to 4.79 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>181<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Percent of days abstinent<br/> Assessed with: The calendar‐assisted structured interview ‐ Time‐Line Follow‐Back (TLFB) for past 3‐month substance use<br/> Scale from: 0 to 100 (lower score better)<br/> Follow‐up: end of treatment </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean proportion of days abstinent ranged from 93 to 90</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 2.84 lower<br/> (8.04 lower to 2.35 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>220<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Percent of days abstinent<br/> Assessed with: TLFB for past 3‐month substance use<br/> Scale from: 0 to 100 (lower score better)<br/> Follow‐up: 6 months to 12 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean proportion of days abstinent ranged from 72 to 75</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 10.76 higher<br/> (3.10 higher to 18.42 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>189<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>2 3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Treatment retention<br/> Assessed with: dropped out of treatment after attending an average of 1.2 sessions </p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.95<br/> (0.72 to 1.25) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>296<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>785 per 1,000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>745 per 1,000<br/> (565 to 981) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of treatment sessions attended<br/> Scale from: 0 to 36 </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of Treatment Sessions Attended ranged from 19.4‐22.1</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 1.27 lower<br/> (6.10 lower to 3.56 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>270<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>2 3 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>MD:</b> mean difference; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate. The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited. The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate. The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p><sup>1</sup> Downgraded two levels due to very serious risk of bias: high levels of performance bias, attrition bias and uneven medication use between groups. One study also had high risk of selection bias and unclear risk for selective reporting. </p> <p><sup>2</sup> Downgraded one level due to Imprecision: small number of trials/participants </p> <p><sup>3</sup> Downgraded one level due to indirectness: population of predominately Caucasian male veterans </p> <p><sup>4</sup> Downgraded two levels due to very serious risk of bias: high levels of selection bias, performance bias, attrition bias, unclear risk for selective reporting and uneven attendance between groups at 12‐step Community Meetings </p> <p><sup>5</sup> Downgraded two levels due to very serious risk of bias: mean attendance was based on a reduced sample, not those originally randomised into the study. Also high risk of selection bias, performance bias and attrition bias </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD009501-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Interpersonal Psychotherapy for Depression (IPT‐D) compared with Other Psychological Interventions for co‐occurring depression and substance use disorders</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Interpersonal Psychotherapy for Depression (IPT‐D) compared with Other Psychological Interventions for co‐occurring depression and substance use disorders</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> Individuals experiencing co‐occurring depression and substance use disorders<br/> <b>Setting:</b> any setting<br/> <b>Intervention:</b> Interpersonal Psychotherapy for Depression (IPT‐D)<br/> <b>Comparison:</b> Other Psychological Interventions </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Other Theraputic Interventions</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Interpersonal Psychotherapy for Depression (IPT‐D)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Depression score<br/> Assessed with: Hamilton Depression Rating Scale (HDRS) ‐ Structured clinical interview (17 and 24 items)<br/> Scale from: 0 to 54 (higher score worse)<br/> Follow‐up: end of treatment </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>SMD 0.54 SD lower<br/> (1.04 lower to 0.04 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>64<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Depression score<br/> Assessed with: Hamilton Depression Rating Scale (HDRS) ‐ Structured clinical interview (17 items)<br/> Scale from: 0 to 54 (higher score worse)<br/> Follow‐up: 3 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean depression score was 15.8</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 3.80 higher<br/> (3.83 lower to 11.43 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>3 4 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Percentage of days abstinent<br/> Assessed with: the calendar‐assisted structured interview ‐ Time‐Line Follow‐Back (TLFB) for past month of alcohol use<br/> Scale from: 0 to 100 (better)<br/> Follow‐up: end of treatment </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean percentage of days abstinent was 49.7</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 2.70 lower<br/> (28.74 lower to 23.34 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>3 6 7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Substance use ‐ relapse<br/> Assessed with: self‐reported heavy drinking (4+ drinks) or drug use on at least 10% of non‐incarcerated days or positive urine test<br/> Follow‐up: 3‐months </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.67<br/> (0.30 to 1.50) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>38<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>3 4 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>316 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>212 per 1,000<br/> (95 to 474) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Treatment retention</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.00<br/> (0.81 to 1.23) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>64<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>774 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>744 per 1,000<br/> (627 to 952) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>MD:</b> mean difference; <b>RR:</b> Risk ratio; <b>SMD:</b> standardised mean difference </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate. The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited. The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate. The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded two levels due to serious risk of bias: high levels of performance bias due to difficulties with blinding participants and personnel, one of the studies also had high attrition bias and reported group differences in use of antidepressants and adjunctive mental health counselling </p> <p><sup>2</sup> Downgraded one level due to indirectness: one of the study was based on a female prison population, the other were recruited through a medical college, neither sample is likely to be representative of broader population of individuals experience comorbid substance use and depressive disorders </p> <p><sup>3</sup> Downgraded two levels due to very small sample size </p> <p><sup>4</sup> Downgraded two levels due to serious risk of bias: high levels of performance bias due to difficulties with blinding participants and personnel and reported group differences in use of antidepressants and adjunctive mental health counselling </p> <p><sup>5</sup> Downgraded one level due to indirectness: Female prison population unlikely to be representative of broader population of individuals experience comorbid substance use and depressive disorders </p> <p><sup>6</sup> Downgraded two levels due to serious risk of bias: high levels of performance bias due to difficulties with blinding participants and personnel </p> <p><sup>7</sup> Downgraded one level due to indirectness: sample recruited through a medical college, predominately White male, unlikely to be representative of broader population of individuals experience comorbid substance use and depressive disorders </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD009501-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD009501-sec-0030"></div> <section id="CD009501-sec-0031"> <h3 class="title" id="CD009501-sec-0031">Description of the condition</h3> <p>Comorbidity occurs for people experiencing mental disorders when the same person is diagnosed with two or more mental disorders using Diagnostic and Statistical Manual (DSM)/International Statistical Classification of Diseases and Related Health Problems (ICD) criteria (<a href="./references#CD009501-bbs2-0134" title="American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders IV Text Revision (DSM‐IV‐TR). IV‐TR. Washington: American Psychiatric Association, 2000. ">American Psychiatric Association 2000</a>; <a href="./references#CD009501-bbs2-0205" title="World Health Organization. The ICD‐10 Classification of Mental and Behavioural Disorders : Clinical Descriptions and Diagnostic Guidelines. 10. Geneva: World Health Organiztion, 1992. ">World Health Organization 1992</a>). People diagnosed with substance use disorders are more likely to have a depression disorder, and vice versa. High rates of comorbid substance use and depression disorders have consistently been reported in epidemiological surveys (<a href="./references#CD009501-bbs2-0135" title="Australian Bureau of Statistics. National Survey of Mental Health and Wellbeing: Summary of Results. Canberra: Australian Bureau of Statistics, 2007. ">Australian Bureau of Statistics 2007</a>; <a href="./references#CD009501-bbs2-0154" title="DegenhardtL , HallW , LynskeyM . Alcohol, cannabis and tobacco use among Australians: a comparison of their associations with other drug use and use disorders, affective and anxiety disorders, and psychosis. Addiction2001;96(11):1603‐14. [PUBMED: 11784457] ">Degenhardt 2001</a>; <a href="./references#CD009501-bbs2-0155" title="European Monitoring Centre for Drugs and Drug Addiction. Co‐morbid substance use and mental disorders in Europe: A review of the data. EMCDDA Papers. Lisbon: The European Monitoring Centre for Drugs and Drug Addiction, 2013:1‐12. ">EMCDDA 2013</a>; <a href="./references#CD009501-bbs2-0156" title="FarrellM , HowesS , BebbingtonP , BrughaT , JenkinsR , LewisG , et al. Nicotine, alcohol and drug dependence and psychiatric comorbidity: results of a national household survey. British Journal of Psychiatry2001;179(5):432‐7. [PUBMED: 11689401] ">Farrell 2001</a>; <a href="./references#CD009501-bbs2-0159" title="GrantBF , StinsonFS , DawsonDA , ChouP , DufourMC , ComptonW , et al. Prevalence and co‐occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry2004;61:807‐16. [DOI: 15289279] ">Grant 2004</a>; <a href="./references#CD009501-bbs2-0173" title="Jane‐LlopisE , MatytsinaI . Mental health and alcohol, drugs and tobacco: a review of the comorbidity between mental disorders and the use of alcohol, tobacco and illicit drugs. Drug and Alcohol Review2006;25(6):515‐36. [PUBMED: 17132571] ">Jane‐Llopis 2006</a>; <a href="./references#CD009501-bbs2-0175" title="KesslerRC , BerglundP , DemlerOV , JinR , KoretzD , MerikangasKE , et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS‐R). JAMA2003;289:3095‐3105. [PUBMED: 12813115] ">Kessler 2003</a>). The United States National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) found that individuals with alcohol or drug dependence were four and nine times more likely to experience major depression, respectively than individuals with no substance dependence (<a href="./references#CD009501-bbs2-0159" title="GrantBF , StinsonFS , DawsonDA , ChouP , DufourMC , ComptonW , et al. Prevalence and co‐occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry2004;61:807‐16. [DOI: 15289279] ">Grant 2004</a>). Similarly in Australia, the National Survey of Mental Health and Wellbeing found that individuals with an alcohol or drug use disorder were 3 to 4 times more likely to have experienced depression, or another affective disorder, in the past 12 months compared with the general population (<a href="./references#CD009501-bbs2-0199" title="TeessonM , SladeT , MillsK . Comorbidity in Australia: findings of the 2007 National Survey of Mental Health and Wellbeing. Australian and New Zealand Journal of Psychiatry2009;43(7):606‐14. [PUBMED: 19530017] ">Teesson 2009</a>; <a href="./references#CD009501-bbs2-0200" title="TeessonM , HallW , SladeT , MillsK , GroveR , MewtonL , et al. Prevalence and correlates of DSM‐IV alcohol abuse and dependence in Australia: findings of the 2007 National Survey of Mental Health and Wellbeing. Addiction (Abingdon, England)2010;105(12):2085‐94. [PUBMED: 20707771] ">Teesson 2010</a>). Within treatment settings, rates of comorbid substance use and affective disorders are even higher, with 30% to 50% of patients meeting criteria for concurrent major depression (<a href="./references#CD009501-bbs2-0137" title="BakerA , LubemanDI , CosgraveEM , KillackeyE , YuenH , HidesL , et al. The impact of co‐occurring substance use on six‐month outcomes for young people seeking mental health treatment. Australian &amp; New Zealand Journal of Psychiatry2007;41:896‐902. [PUBMED: 17924242] ">Baker 2007a</a>; <a href="./references#CD009501-bbs2-0147" title="BuksteinOG , GlancyLG , KaminerY . Patterns of affective comorbidity in a clinical population of dually diagnosed adolescent substance users. Journal of the American Academy of Child &amp; Adolescent Psychiatry1992;31:1041‐5. [PUBMED: 1429402] ">Bulkstein 1992</a>; <a href="./references#CD009501-bbs2-0160" title="GrellaCE , HserYI , JoshiV , Rounds‐BryantJ . Drug treatment outcomes for adolescents with comorbid mental and substance use disorders. Journal of Nervous and Mental Disease2001;189:384‐92. [PUBMED: 11434639] ">Grella 2001</a>; <a href="./references#CD009501-bbs2-0163" title='HallW , DegenhardtL , TeessonM . Reprint of "Understanding comorbidity between substance use, anxiety and affective disorders: broadening the research base". Addictive Behaviors2009;34(10):795‐9. [PUBMED: 19604645] '>Hall 2009</a>; <a href="./references#CD009501-bbs2-0176" title="LejoyeuxM , LehertP . Alcohol‐use disorders and depression: results from individual patient data meta‐analysis of the acamprosate‐controlled studies. Alcohol and Alcoholism2011;46(1):61‐7. [PUBMED: 21118900] ">Lejoyeux 2011</a>; <a href="./references#CD009501-bbs2-0178" title="LubmanDI , AllenNB , RogersN , CementonE , BonomoY . The impact of co‐occurring mood and anxiety disorders among substance‐abusing youth. Journal of Affective Disorders2007;103:105‐12. [PUBMED: 17291589] ">Lubman 2007</a>; <a href="./references#CD009501-bbs2-0198" title="TeessonM , HavardA , FairbairnS , RossJ , LynskeyM , DarkeS . Depression among entrants to treatment for heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence, correlates and treatment seeking. Drug and Alcohol Dependence2005;78:309‐15. [PUBMED: 15893162] ">Teesson 2005</a>). Such high rates of comorbid disorders are problematic, as they have been linked to treatment non‐compliance, a more severe and chronic illness course, and an increased risk of relapse in both substance use and co‐occurring mental disorders, as well as greater social and vocational impairment, poor physical health, higher risk of suicidal behaviour and greater use of health services (<a href="./references#CD009501-bbs2-0135" title="Australian Bureau of Statistics. National Survey of Mental Health and Wellbeing: Summary of Results. Canberra: Australian Bureau of Statistics, 2007. ">Australian Bureau of Statistics 2007</a>; <a href="./references#CD009501-bbs2-0152" title="DavisL , UezatoA , NewellJM , FrazierE . Major depression and comorbid substance use disorders. Current Opinion in Psychiatry2008;21(1):14‐8. [PUBMED: 18281835] ">Davis 2008</a>; <a href="./references#CD009501-bbs2-0166" title="HasinDS , LiuX , NunesE , McCloudS , SametS , EndicottJ . Effects of major depression on remission and relapse of substance dependence. Archives of General Psychiatry2002;59:375‐80. [DOI: 10.1001/archpsyc.59.4.375] ">Hasin 2002</a>; <a href="./references#CD009501-bbs2-0197" title="SullivanLE , FiellinDA , O'ConnorP . The prevalence and impact of alcohol problem in major depression: a systematic review. American Journal of Medicine2005;118:330‐41. [DOI: 10.1016/j.amjmed.2005.01.007] ">Sullivan 2005</a>; <a href="./references#CD009501-bbs2-0207" title="ŠprahL , DernovšekMZ , WahlbeckK , HaaramoP . Psychiatric readmissions and their association with physical comorbidity: a systematic literature review. BMC Psychiatry2017;17(1):1172‐3. [DOI: 10.1186/s12888‐016‐1172‐3; PUBMED: 28049441] ">Šprah 2017</a>). </p> </section> <section id="CD009501-sec-0032"> <h3 class="title" id="CD009501-sec-0032">Description of the intervention</h3> <p>Psychological interventions are theory‐based, manualised approaches to the treatment of depression, substance use and other mental disorders. Common approaches include the following. </p> <p> <ul id="CD009501-list-0001"> <li> <p>Cognitive behavior therapy (CBT), a family of interventions targeting cognitions, behaviours, emotions and environmental factors ,which may predispose, precipitate or perpetuate comorbid depression and substance use disorders (<a href="./references#CD009501-bbs2-0144" title="BeckJS . Cognitive Behavior Therapy: Basics and Beyond. New York City: Guilford Press, 2011. ">Beck 2011</a>). CBT approaches include cognitive therapy (CT), behaviour therapy (BT), traditional CBT approaches and ‘third wave’ approaches including acceptance and commitment therapy, dialectical behaviour therapy and mindfulness‐based interventions (<a href="./references#CD009501-bbs2-0171" title="Hofman , SG . An Introduction to Modern CBT: Psychological Solutions to Mental Health Problems. West Sussex: Wiley‐Blackwell, 2012. ">Hofmann 2012b</a>; <a href="./references#CD009501-bbs2-0202" title="WellsA , FisherP . Treating Depression: MCT, CBT and Third Wave Therapies. West Sussex: John Wiley &amp; Sons Inc, 2016. ">Wells 2016</a>). </p> </li> </ul> <ul id="CD009501-list-0002"> <li> <p>Motivational interviewing is a psychotherapeutic approach that aims to elicit behaviour change by first exploring and resolving ambivalence about making a change (<a href="./references#CD009501-bbs2-0182" title="MillerWR , RollnickS . Motivational Interviewing: Helping People Change. New York City: Guilford Press, 2013. ">Miller 2013</a>). A number of strategies are then utilised to enhance commitment to making the change. Motivational interviewing is commonly delivered in combination with other psychotherapies including CBT. Only studies combining motivational interviewing with CBT were included in this review. </p> </li> </ul> <ul id="CD009501-list-0003"> <li> <p>Interpersonal psychotherapy (IPT) is most commonly used to treat depression (<a href="./references#CD009501-bbs2-0158" title="FrankE , LevensonJC . Interpersonal Psychotherapy. Washington DC: American Psychological Association, 2011. ">Frank 2011</a>). It focuses on the role of difficulties in everyday interactions with others on depressive symptoms by targeting the individual's emotional responses to life stressors, role disputes and role transitions (<a href="./references#CD009501-bbs2-0158" title="FrankE , LevensonJC . Interpersonal Psychotherapy. Washington DC: American Psychological Association, 2011. ">Frank 2011</a>; <a href="./references#CD009501-bbs2-0196" title="StuartS , RobertsonMD . Interpersonal Psychotherapy: a Clinician's Guide. London: Hodder Arnold, 2012. ">Stuart 2012</a>). </p> </li> </ul> <ul id="CD009501-list-0004"> <li> <p>Contingency management is most‐widely used in the treatment of substance use disorders. Based on the principles of operant conditioning, it provides incentives or rewards to encourage behaviour change (<a href="./references#CD009501-bbs2-0188" title="PetryNM . Contingency Management for Substance Abuse Treatment: a Guide to Implementing this Evidence‐Based Practice. New York City: Routledge, 2012. ">Petry 2012</a>). Typical reward systems include the use of abstinence‐based voucher programs, which increase in value with each consecutive negative drug test (<a href="./references#CD009501-bbs2-0188" title="PetryNM . Contingency Management for Substance Abuse Treatment: a Guide to Implementing this Evidence‐Based Practice. New York City: Routledge, 2012. ">Petry 2012</a>). </p> </li> </ul> </p> </section> <section id="CD009501-sec-0033"> <h3 class="title" id="CD009501-sec-0033">How the intervention might work</h3> <p>Psychological interventions aim to modify individual, family, social and environmental factors that may increase risk of depression and substance use disorders (<a href="./references#CD009501-bbs2-0138" title="BakerA , VellemanR . Clinical Handbook of Co‐existing Mental Health and Drug and Alcohol Problems. Clinical Handbook of Co‐existing Mental Health and Drug and Alcohol Problems. East Sussex: Routledge, 2007. ">Baker 2007b</a>). Psychological approaches vary depending on the theoretical models underpinning them, but typically target thoughts, feelings, behaviours, interpersonal relationships, social and environmental variables that may predispose, precipitate or perpetuate depression and substance use (<a href="./references#CD009501-bbs2-0138" title="BakerA , VellemanR . Clinical Handbook of Co‐existing Mental Health and Drug and Alcohol Problems. Clinical Handbook of Co‐existing Mental Health and Drug and Alcohol Problems. East Sussex: Routledge, 2007. ">Baker 2007b</a>; <a href="./references#CD009501-bbs2-0184" title="National Collaborating Centre for Mental Health. Depression: The Treatment and Management of Depression in Adults. NICE Clinical Guideline 90. London: National Institute for Health and Clinical Excellence, 2009. ">NCCMH 2009</a>). They can be delivered face‐to‐face, online, via telephone or bibliotherapy (e.g. self‐help books; <a href="./references#CD009501-bbs2-0184" title="National Collaborating Centre for Mental Health. Depression: The Treatment and Management of Depression in Adults. NICE Clinical Guideline 90. London: National Institute for Health and Clinical Excellence, 2009. ">NCCMH 2009</a>). </p> </section> <section id="CD009501-sec-0034"> <h3 class="title" id="CD009501-sec-0034">Why it is important to do this review</h3> <p>There have been numerous studies investigating the efficacy of psychological interventions for people experiencing depression or substance use disorders. Manualised psychological interventions, including CBT (<a href="./references#CD009501-bbs2-0151" title="CuijpersP , BerkingM , AnderssonG , QuigleyL , KleiboerA , DobsonKS . A meta‐analysis of cognitive‐behavioural therapy for adult depression, alone and in comparison with other treatments. Canadian Journal of Psychiatry: Revue Canadienne de Psychiatrie2013;58(7):376‐85. [PUBMED: 23870719] ">Cuijpers 2013</a>; <a href="./references#CD009501-bbs2-0170" title="HofmannSG , AsnaaniA , VonkIJ , SawyerAT , FangA . The efficacy of Cognitive Behavioral Therapy: a review of meta‐analyses. Cognitive Therapy and Research2012a;36(5):427‐40. [PUBMED: 23459093] ">Hofmann 2012a</a>), motivational interviewing (<a href="./references#CD009501-bbs2-0193" title="SmedslundG , BergRC , HammerstromKT , SteiroA , LeiknesKA , DahlHM , et al. Motivational interviewing for substance abuse. Cochrane Database of Systematic Reviews2011, Issue 5. [DOI: 10.1002/14651858.CD008063.pub2; PUBMED: 21563163] ">Smedslund 2011</a>), IPT (<a href="./references#CD009501-bbs2-0150" title="CuijpersP , GeraedtsAS , vanOppenP , AnderssonG , MarkowitzJC , vanStratenA . Interpersonal psychotherapy for depression: a meta‐analysis. American Journal of Psychiatry2011;168(6):581‐92. [PUBMED: 21362740] ">Cuijpers 2011</a>) and contingency management (<a href="./references#CD009501-bbs2-0145" title="BenishekLA , DugoshKL , KirbyKC , MatejkowskiJ , ClementsNT , SeymourBL , et al. Prize‐based contingency management for the treatment of substance abusers: a meta‐analysis. Addiction (Abingdon, England)2014;109(9):1426‐36. [PUBMED: 24750232] ">Benishek 2014</a>; <a href="./references#CD009501-bbs2-0190" title="PrendergastM , PodusD , FinneyJ , GreenwellL , RollJ . Contingency management for treatment of substance use disorders: a meta‐analysis. Addiction (Abingdon, England)2006;101(11):1546‐60. [PUBMED: 17034434] ">Prendergast 2006</a>), have shown some promise in individually reducing symptoms related to each of these disorders. However, many of the trials excluded comorbid disorders making it difficult to ascertain the efficacy of these interventions for those experiencing both disorders. While there have been some trials examining the efficacy of these treatments within comorbid populations, the few existing meta‐analyses or systematic reviews on comorbid substance use and depression have either mainly focused on pharmacological interventions (e.g. <a href="./references#CD009501-bbs2-0132" title="AgabioR , TroguE , PaniPP . Antidepressants for the treatment of people with co‐occurring depression and alcohol dependence. Cochrane Database of Systematic Reviews2018, Issue 4. [DOI: 10.1002/14651858.CD008581.pub2] ">Agabio 2018</a>; <a href="./references#CD009501-bbs2-0157" title="FouldsJA , AdamsonSJ , BodenJM , WillimanJA , MulderRT . Depression in patients with alcohol use disorders: systematic review and meta‐analysis of outcomes for independent and substance‐induced disorders. Journal of Affective Disorders2015;185:47‐59. [PUBMED: 26143404] ">Foulds 2015</a>; <a href="./references#CD009501-bbs2-0187" title="PaniPP , VaccaR , TroguE , AmatoL , DavoliM . Pharmacological treatment for depression during opioid agonist treatment for opioid dependence. Cochrane Database of Systematic Reviews2010, Issue 9. [DOI: 10.1002/14651858.CD008373] ">Pani 2010</a>; <a href="./references#CD009501-bbs2-0206" title="ZhouX , QinB , DelGiovaneC , PanJ , GentileS , LiuY , et al. Efficacy and tolerability of antidepressants in the treatment of adolescents and young adults with depression and substance use disorders: a systematic review and meta‐analysis. Addiction (Abingdon, England)2015;110(1):38‐48. [PUBMED: 25098732] ">Zhou 2015</a>), have included subclinical populations for either depression and/or substance use (<a href="./references#CD009501-bbs2-0136" title="BabowitchJD , AntshelKM . Adolescent treatment outcomes for comorbid depression and substance misuse: a systematic review and synthesis of the literature. Journal of Affective Disorders2016;201:25‐33. [PUBMED: 27156096] ">Babowitch 2016</a>; <a href="./references#CD009501-bbs2-0139" title="BakerAL , ThorntonLK , HilesS , HidesL , LubmanDI . Psychological interventions for alcohol misuse among people with co‐occurring depression or anxiety disorders: a systematic review. Journal of Affective Disorders2012;139(3):217‐29. [DOI: 10.1016/j.jad.2011.08.004] ">Baker 2012</a>; <a href="./references#CD009501-bbs2-0167" title="HesseM . Integrated psychological treatment for substance use and co‐morbid anxiety or depression vs. treatment for substance use alone. A systematic review of the published literature. BMC Psychiatry2009;9:6. [PUBMED: 19232121] ">Hesse 2009</a>), or did not exclusively examine randomised controlled trials (<a href="./references#CD009501-bbs2-0191" title="RiperH , AnderssonG , HunterSB , deWitJ , BerkingM , CuijpersP . Treatment of comorbid alcohol use disorders and depression with cognitive‐behavioural therapy and motivational interviewing: a meta‐analysis. Addiction (Abingdon, England)2014;109(3):394‐406. [PUBMED: 24304463] ">Riper 2014</a>). There have been no systematic reviews conducted to determine which psychological intervention is most efficacious among individuals with comorbid depression and substance use disorders. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD009501-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD009501-sec-0035"></div> <p>To assess the efficacy of psychological interventions delivered alone or in combination with pharmacotherapy for people diagnosed with comorbid depression and any substance use disorder (excluding nicotine). </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD009501-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD009501-sec-0036"></div> <section id="CD009501-sec-0037"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD009501-sec-0038"> <h4 class="title">Types of studies</h4> <p>Randomised controlled trials (RCTs)</p> </section> <section id="CD009501-sec-0039"> <h4 class="title">Types of participants</h4> <p>Individuals (adults and adolescents) with co‐occurring Diagnostic and Statistical Manual (DSM) or International Classification of Diseases (ICD) depression and substance use disorder (excluding nicotine) derived using a structured clinical interview were included. Where possible, those with psychosis, bipolar disorder and intellectual disability were excluded as these individuals form distinct clinical groups with specific needs. Studies were included if some of the sample were experiencing another mental health disorder (e.g. anxiety); however, studies which required a third disorder as part of their inclusion criteria were not included in the review. </p> </section> <section id="CD009501-sec-0040"> <h4 class="title">Types of interventions</h4> <p>Experimental conditions (+/‐ pharmacotherapy)</p> <p> <ul id="CD009501-list-0005"> <li> <p>CBT with and without motivational interviewing</p> </li> <li> <p>Cognitive therapy</p> </li> <li> <p>Behaviour therapy</p> </li> <li> <p>Contingency management</p> </li> <li> <p>Acceptance and commitment therapy</p> </li> <li> <p>Dialectical behaviour therapy</p> </li> <li> <p>Interpersonal psychotherapy (IPT)</p> </li> </ul> </p> <p>Control conditions (+/‐ pharmacotherapy)</p> <p> <ul id="CD009501-list-0006"> <li> <p>No, minimal or delayed treatment</p> </li> <li> <p>Other psychological interventions (including studies comparing those listed above)</p> </li> <li> <p>Treatment as usual (defined according to study setting but typically consists of case management) </p> </li> </ul> </p> </section> <section id="CD009501-sec-0041"> <h4 class="title">Types of outcome measures</h4> <section id="CD009501-sec-0042"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD009501-list-0007"> <li> <p>Depression: changes in symptom severity on a standardised questionnaire (e.g. Beck Depression Inventory (BDI) or Hamilton Depression Rating Scale (HDRS)) or presence of DSM/ICD disorder on a structured clinical interview (e.g. the Structured Clinical Interview for DSM‐IV (SCID‐IV)). </p> </li> <li> <p>Substance use: changes in the frequency (including abstinence), quantity, severity of use measured by calendar‐based methods such as Timeline Follow Back (TLFB) and self‐report instruments such as the Alcohol Use Disorders Identification Test (AUDIT) or presence of DSM/ICD substance use disorders. </p> </li> <li> <p>Treatment retention as measured by the number of participants still in treatment at the end of the study, and treatment attendance as assessed by the average number of sessions attended. </p> </li> </ul> </p> </section> <section id="CD009501-sec-0043"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD009501-list-0008"> <li> <p>Functioning: changes in social, occupational/educational functioning as measured by changes on standardised measures of quality of life (e.g., World Health Organization‐Quality of Life Scale) or daily functioning (e.g. Global Assessment of Functioning (GAF) scale. </p> </li> <li> <p>Anxiety: changes in symptom severity on a standardised questionnaire (e.g. Beck Anxiety Inventory (BAI)) or presence of DSM/ICD disorder on a structured clinical interviews (e.g. SCID‐IV). </p> </li> <li> <p>Global clinical severity of mental health disorders: as measured by changes on standardised instruments such as the Clinical Global Impression Scale (CGI) scale. </p> </li> <li> <p>Adverse effects linked to treatments delivered.</p> </li> </ul> </p> </section> </section> </section> <section id="CD009501-sec-0044"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD009501-sec-0045"> <h4 class="title">Electronic searches</h4> <p>We aimed to identify all relevant RCTs regardless of language or publication status (published, unpublished, in press, or in progress). </p> <p>We searched the following databases up to 04 February 2019:</p> <p> <ul id="CD009501-list-0009"> <li> <p>the Cochrane Central Register of Controlled Trials (CENTRAL; (2019, Issue 1), in the Cochrane Library using the strategy in <a href="./appendices#CD009501-sec-0104">Appendix 1</a>; </p> </li> <li> <p>PubMed (from 1966 to 04 February 2019) using the strategy in <a href="./appendices#CD009501-sec-0105">Appendix 2</a>; </p> </li> <li> <p>Embase (from 1980 to 04 February 2019) using the strategy in <a href="./appendices#CD009501-sec-0106">Appendix 3</a>; </p> </li> <li> <p>CINAHL (from 1982 to 04 February 2019) using the strategy in <a href="./appendices#CD009501-sec-0107">Appendix 4</a>; </p> </li> <li> <p>Google Scholar, scholar.google.com (searched on 04 February 2019).</p> </li> </ul> </p> <p>We searched the following trials registries on 25 February 2019:</p> <p> <ul id="CD009501-list-0010"> <li> <p>the ISRCTN registry (www.isrctn.com);</p> </li> <li> <p>ClinicalTrials.gov (clinicaltrials.gov).</p> </li> </ul> </p> </section> <section id="CD009501-sec-0046"> <h4 class="title">Searching other resources</h4> <p>We handsearched relevant articles, systematic or meta‐analytic reviews. We also searched grey literature including internal reports and conference proceedings to identify unpublished studies and we contacted the authors of these studies to obtain relevant information. </p> </section> </section> <section id="CD009501-sec-0047"> <h3 class="title" id="CD009501-sec-0047">Data collection and analysis</h3> <section id="CD009501-sec-0048"> <h4 class="title">Selection of studies</h4> <p> <ul id="CD009501-list-0011"> <li> <p>We merged all search results (including records identified from electronic searches and other resources) into Endnote and deleted duplicate records. </p> </li> <li> <p>Two review authors independently examined titles and abstracts and deleted obviously irrelevant records </p> </li> <li> <p>Two review authors independently assessed full‐text articles of the potentially relevant records identified for inclusion in the review and linked multiple reports of the same study. </p> </li> </ul> </p> <p>In the event of a disagreement by the independent review authors, resolution followed a step‐wise process. Initially the review authors discussed the disagreement to establish whether there had been an error by one of the extractors that could easily be resolved. If the disagreement remained unresolved, the next step was to contact the study authors directly and any issues that persisted would be reported explicitly in the review. At all stages of this process the presence and resolution of disagreements were recorded and coding techniques were used to differentiate consensus data from extracted data across both review authors. </p> </section> <section id="CD009501-sec-0049"> <h4 class="title">Data extraction and management</h4> <p>Two review authors independently extracted data using a standardised data collection checklist. We resolved any disagreements via consultation with a third review author. </p> <p>The following data were extracted.</p> <p>Address for correspondence.</p> <p>Methods: study design, study length/number of follow‐up points, setting, country of origin. </p> <p>Participants: major depressive disorder/substance use disorder inclusion criteria/measure, other defining characteristics (sample size, age mean (standard deviation (SD)), sex (% male), ethnicity, other inclusion and exclusion criteria), study dates/duration (months). </p> <p>Interventions: number of treatment groups, intervention type and details (content, duration in sessions/weeks), format, intervention target (depression, substance use, both), allocation (number randomised/group), number of sessions attended, fidelity, adjunctive therapy or pharmacotherapy. </p> <p>Methods for: sequence generation, allocation sequence concealment and blinding.</p> <p>Outcomes: depression and substance use primary outcomes (definition/measure/unit of measurement, scale (range, interpretation); treatment retention (number of participants still in treatment at the end of the study), treatment attendance (average number of sessions attended). </p> </section> <section id="CD009501-sec-0050"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors independently assessed risk of bias using the criteria recommended by the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD009501-bbs2-0168" title="HigginsJP , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). We resolved any disagreement by discussion. The recommended approach for assessing risk of bias in studies included in Cochrane Reviews is a two‐part tool, addressing seven specific domains, including sequence generation and allocation concealment (selection bias), blinding of participants and providers (performance bias), blinding of outcome assessor (detection bias), incomplete outcome data (attrition bias), selective outcome reporting (reporting bias), and other source of bias. The first part of the tool involves describing what was reported to have happened in the study. The second part of the tool involves assigning a judgement relating to the risk of bias for that entry, in terms of low, high or unclear risk. To make these judgments, we used the criteria indicated by the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> adapted to the addiction field. </p> <p>The domains of sequence generation and allocation concealment (avoidance of selection bias) was addressed in the tool by a single entry for each study. </p> <p>We considered blinding of participants, personnel and outcome assessor (avoidance of performance bias and detection bias) separately for objective outcomes (e.g. treatment retention, attrition, participants engaged in further treatments) and self‐report and interviewer‐rated subjective outcomes (e.g. depression, substance use) separately. Given that participants and personnel cannot be blinded to the type of psychological intervention being delivered, subjective outcomes were always judged at high risk of performance bias. </p> <p>We assessed treatment fidelity and contamination under the 'Other bias' category, given their importance in ensuring the delivery of high‐quality psychological interventions in RCT's, as well as the potential influence of concurrent out‐of‐study psychotherapy and pharmacotherapy treatment on study outcomes (<a href="./references#CD009501-bbs2-0153" title="deBruinM , McCambridgeJ , PrinsJM . Reducing the risk of bias in health behaviour change trials: Improving trial design, reporting or bias assessment criteria? A review and case study. Psychology &amp; Health2015;30(1):8‐34. ">de Bruin 2015</a>). </p> <p>See <a href="./appendices#CD009501-sec-0108">Appendix 5</a> for details. </p> </section> <section id="CD009501-sec-0051"> <h4 class="title">Measures of treatment effect</h4> <p>We analysed dichotomous outcomes by calculating the risk ratio (RR) for each trial with the uncertainty in each result being expressed with 95% confidence interval (CI). We analysed continuous outcomes by calculating the mean difference (MD) with 95% CI and standard deviation (SD) when the studies used the same instrument for assessing the outcome. We used the standardised mean difference (SMD) and SD when the studies used different instruments. If the number and range of studies allowed it, we planned to calculate the numbers needed to treat for an additional beneficial outcome (NNTH) or number needed to treat for an additional harmful outcome (NNTH), where data were homogeneous. </p> </section> <section id="CD009501-sec-0052"> <h4 class="title">Unit of analysis issues</h4> <p>For multi‐arm studies included in the meta‐analyses, when one arm was considered more than once in same comparisons (e.g. two different experimental treatments compared with the same control group), we planned to combine all the relevant experimental groups into a single group and compare it with the control to avoid double‐counting participants in the control groups. </p> <p>If any cluster‐RCTs were identified, we intended to include them in the analyses along with individual RCTs, planning to synthesise the results unless there was non‐negligible heterogeneity between the trial designs. For cluster‐RCTs that did not adjust for clustering, we intended to adjust the sample sizes using reported or estimated intraclass correlations (ICCs) in line with the recommendations by <a href="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011315.pub2/references#CD011315-bbs2-0049" target="_blank">Higgins 2011</a>. </p> </section> <section id="CD009501-sec-0053"> <h4 class="title">Dealing with missing data</h4> <p>Whenever possible, we contacted the original investigators to request missing data. We made the assumptions of any methods used to cope with missing data explicit when possible, including whether the data were assumed to be missing at random, or missing values were assumed to have a particular value. The potential impact of missing data on the findings of the review are addressed in the <a href="#CD009501-sec-0092">Discussion</a> section. </p> </section> <section id="CD009501-sec-0054"> <h4 class="title">Assessment of heterogeneity</h4> <p>The presence of clinical, methodological and statistical heterogeneity between the included studies was assessed including: the country of origin, sample characteristics (inclusion and exclusion criteria), settings, types of treatment comparisons (including sample size, content, length of treatment), outcomes reported, measures used and length of follow‐up. We analysed heterogeneity by means of the I<sup>2</sup> statistic and the Chi<sup>2</sup> test. We regarded heterogeneity as substantial if the I² was greater than 50% or a P value was lower than &lt; 0.10 for the Chi² test for heterogeneity. Following the guidance in the <i>Cochrane Handbook for Systematic Reviews of Intervention</i> (<a href="./references#CD009501-bbs2-0168" title="HigginsJP , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>), we distinguished the following values to denote no important, moderate, substantial, and considerable heterogeneity, respectively: 0% to 40%, 30% to 60%, 50% to 90%, and 75% to 100%. </p> </section> <section id="CD009501-sec-0055"> <h4 class="title">Assessment of reporting biases</h4> <p>If meta‐analyses were conducted and number of studies allowed, we planned to use funnel plots (plots of the effect estimate from each study against the standard error (SE)) to assess the potential for bias related to the size of the trials, which could indicate possible publication bias. </p> </section> <section id="CD009501-sec-0056"> <h4 class="title">Data synthesis</h4> <p>We combined the outcomes from the individual trials through meta‐analysis where possible (comparability of intervention and outcomes between trials), using a random‐effects model, because we expected a certain degree of heterogeneity between trials. If the clinical or statistical heterogeneity between trials was too high (i.e. 75% to 100%), we considered not pooling the data </p> </section> <section id="CD009501-sec-0057"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>If the number and range of studies allowed it, we planned to conduct subgroup analyses for type of CBT, adults, young people, sex and type of substance used. </p> </section> <section id="CD009501-sec-0058"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to perform sensitivity analyses to assess how sensitive results were to reasonable changes in the assumptions about missing data (<a href="./references#CD009501-bbs2-0168" title="HigginsJP , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> <section id="CD009501-sec-0059"> <h5 class="title">'Summary of findings' tables</h5> <p>We assessed the overall quality of the evidence for the primary outcome variables using the Grading of Recommendation, Assessment, Development and Evaluation (GRADE) system. The GRADE Working Group developed a system for grading the quality of evidence (<a href="./references#CD009501-bbs2-0161" title="GuyattGH , OxmanAD , VistGE , KunzR , Falck‐YtterY , Alonso‐CoelloP , et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.. BMJ2008;336(7560):924‐6. ">Guyatt 2008</a>; <a href="./references#CD009501-bbs2-0162" title="GuyattG , OxmanAD , AklEA , KunzR , VistG , BrozekJ , et al. GRADE guidelines 1. Introduction‐GRADE evidence profiles and summary of findings tables.. Journal of Clinical Epidemiology2011;64:383‐394. ">Guyatt 2011</a>; <a href="./references#CD009501-bbs2-0186" title="OxmanAD , GRADE Working Group. Grading quality of evidence and strength of recommendations.. BMJ2004;328(19):1490‐4. ">Oxman 2004</a>), which takes into account issues not only related to internal validity, but also to external validity, such as directness of results. The <a href="./full#CD009501-tbl-0001">summary of findings Table for the main comparison</a> presents the main findings of the review in a transparent and simple tabular format. In particular, it provides key information concerning the quality of evidence, the magnitude of effect of the interventions examined and the sum of available data on the main outcomes. </p> <p>The GRADE system uses the following criteria for assigning grades of evidence.</p> <p> <ul id="CD009501-list-0012"> <li> <p>High: we are very confident that the true effect lies close to that of the estimate of the effect. </p> </li> <li> <p>Moderate: we are moderately confident in the effect estimate. The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. </p> </li> <li> <p>Low: our confidence in the effect estimate is limited. The true effect may be substantially different from the estimate of the effect. </p> </li> <li> <p>Very low: we have very little confidence in the effect estimate. The true effect is likely to be substantially different from the estimate of effect. </p> </li> </ul> </p> <p>Grading is decreased for the following reasons.</p> <p> <ul id="CD009501-list-0013"> <li> <p>Serious (−1) or very serious (−2) study limitation for risk of bias.</p> </li> <li> <p>Serious (−1) or very serious (−2) inconsistency between study results.</p> </li> <li> <p>Some (−1) or major (−2) uncertainty about directness (the correspondence between the population, the intervention, or the outcomes measured in the studies actually found and those under consideration in our systematic review). </p> </li> <li> <p>Serious (−1) or very serious (−2) Imprecision of the pooled estimate.</p> </li> <li> <p>Strong suspicion of publication bias (−1).</p> </li> </ul> </p> <p>We used <a href="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004148.pub4/references#CD004148-bbs2-0145" target="_blank">GRADEpro GDT 2015</a> to import data from <a href="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004148.pub4/references#CD004148-bbs2-0173" target="_blank">Review Manager 2014</a> for the main outcomes of depression score, substance use (percentage of days abstinent, proportion of days abstinent, relapse, percentage of daily use) and treatment retention. Due to the wide variation of treatments compared, we produced one summary table per treatment comparison (<a href="./full#CD009501-tbl-0001">summary of findings Table for the main comparison</a>; <a href="./full#CD009501-tbl-0002">summary of findings Table 2</a>). </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD009501-sec-0060" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD009501-sec-0060"></div> <section id="CD009501-sec-0061"> <h3 class="title">Description of studies</h3> <section id="CD009501-sec-0062"> <h4 class="title">Results of the search</h4> <p>We identified 23,901 records through database searching and 36 from other sources. After removing duplicates, we were left with 19,087 unique references for analysis. We excluded 18,951 on the basis of title and abstract. We retrieved 136 articles in full text for more detailed evaluation, 127 of which were excluded for not meeting the inclusion criteria. </p> <p>We included seven studies (from nine articles) that satisfied all criteria required for inclusion in the review. See <a href="#CD009501-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD009501-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD009501-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> <p>For substantive descriptions of studies see the <a href="./references#CD009501-sec-0116" title="">Characteristics of included studies</a> and <a href="./references#CD009501-sec-0117" title="">Characteristics of excluded studies</a> tables </p> </section> <section id="CD009501-sec-0063"> <h4 class="title">Included studies</h4> <p>Seven studies enrolling a total of 608 participants were included (<a href="./references#CD009501-bbs2-0001" title="BeutlerLE , MoleiroC , MarlikM , HarwoodTM , RomanelliR , Gallagher‐ThompsonD , et al. A comparison of the dodo, EST, and ATI factors among comorbid stimulant‐dependent, depressed patients. Clinical Psychology &amp; Psychotherapy2003;10(2):69‐85. [DOI: 10.1002/cpp.354] ">Beutler 2003</a>; <a href="./references#CD009501-bbs2-0002" title="BrownSA , Glasner‐EdwardsSV , TateSR , McQuaidJR , ChalekianJ , GranholmE . Integrated cognitive behavioral therapy versus twelve‐step facilitation therapy for substance‐dependent adults with depressive disorders. Journal of Psychoactive Drugs2006;38(4):449‐60. [PUBMED: 17373561] ">Brown 2006</a>; <a href="./references#CD009501-bbs2-0003" title="CarpenterKM , SmithJL , AharonovichE , NunesEV . Developing therapies for depression in drug dependence: results of a stage 1 therapy study. American Journal of Drug and Alcohol Abuse2008;34(5):642‐52. [PUBMED: 18821458] ">Carpenter 2008</a>; <a href="./references#CD009501-bbs2-0004" title="JohnsonJE , ZlotnickC . Pilot study of treatment for major depression among women prisoners with substance use disorder. Journal of Psychiatric Research2012;46(9):1174‐83. [PUBMED: 22694906] ">Johnson 2012</a>; <a href="./references#CD009501-bbs2-0005" title="LydeckerKP , TateSR , CumminsKM , McQuaidJ , GranholmE , BrownSA . Clinical outcomes of an integrated treatment for depression and substance use disorders. Psychology of Addictive Behaviors2010;24(3):453‐65. [PUBMED: 20853931] WorleyMJ , TateSR , McQuaidJR , GranholmEL , BrownSA . 12‐step affiliation and attendance following treatment for comorbid substance dependence and depression: a latent growth curve mediation model. Substance Abuse2013;34(1):43‐50. [PUBMED: 23327503] WorleyMJ , TrimRS , RoeschSC , Mrnak‐MeyerJ , TateSR , BrownSA . Comorbid depression and substance use disorder: longitudinal associations between symptoms in a controlled trial. Journal of Substance Abuse Treatment2012;43(3):291‐302. [PUBMED: 22406052] ">Lydecker 2010</a>; <a href="./references#CD009501-bbs2-0006" title="MarkowitzJC , KocsusJH , ChristosP , BleibergK , CarlinA . Pilot study of interpersonal psychotherapy versus supportive psychotherapy for dysthymic patients with secondary alcohol abuse or dependence. Journal of Nervous and Mental Disease2008;196(6):468‐74. [PUBMED: 18552624] ">Markowitz 2008</a>; <a href="./references#CD009501-bbs2-0007" title="RohdeP , WaldronHB , TurnerCW , BrodyJ , JorgensenJ . Sequenced versus coordinated treatment for adolescents with comorbid depressive and substance use disorders. Journal of Consulting and Clinical Psychology2014;82(2):342‐8. [PUBMED: 24491069] ">Rohde 2014</a>). </p> <p><b>Country:</b> all included studies were conducted in the USA. </p> <p><b>Participant characteristics:</b> the studies were conducted with a variety of patient groups including veterans (<a href="./references#CD009501-bbs2-0002" title="BrownSA , Glasner‐EdwardsSV , TateSR , McQuaidJR , ChalekianJ , GranholmE . Integrated cognitive behavioral therapy versus twelve‐step facilitation therapy for substance‐dependent adults with depressive disorders. Journal of Psychoactive Drugs2006;38(4):449‐60. [PUBMED: 17373561] ">Brown 2006</a>; <a href="./references#CD009501-bbs2-0005" title="LydeckerKP , TateSR , CumminsKM , McQuaidJ , GranholmE , BrownSA . Clinical outcomes of an integrated treatment for depression and substance use disorders. Psychology of Addictive Behaviors2010;24(3):453‐65. [PUBMED: 20853931] WorleyMJ , TateSR , McQuaidJR , GranholmEL , BrownSA . 12‐step affiliation and attendance following treatment for comorbid substance dependence and depression: a latent growth curve mediation model. Substance Abuse2013;34(1):43‐50. [PUBMED: 23327503] WorleyMJ , TrimRS , RoeschSC , Mrnak‐MeyerJ , TateSR , BrownSA . Comorbid depression and substance use disorder: longitudinal associations between symptoms in a controlled trial. Journal of Substance Abuse Treatment2012;43(3):291‐302. [PUBMED: 22406052] ">Lydecker 2010</a>); adults (<a href="./references#CD009501-bbs2-0001" title="BeutlerLE , MoleiroC , MarlikM , HarwoodTM , RomanelliR , Gallagher‐ThompsonD , et al. A comparison of the dodo, EST, and ATI factors among comorbid stimulant‐dependent, depressed patients. Clinical Psychology &amp; Psychotherapy2003;10(2):69‐85. [DOI: 10.1002/cpp.354] ">Beutler 2003</a>; <a href="./references#CD009501-bbs2-0003" title="CarpenterKM , SmithJL , AharonovichE , NunesEV . Developing therapies for depression in drug dependence: results of a stage 1 therapy study. American Journal of Drug and Alcohol Abuse2008;34(5):642‐52. [PUBMED: 18821458] ">Carpenter 2008;</a><a href="./references#CD009501-bbs2-0006" title="MarkowitzJC , KocsusJH , ChristosP , BleibergK , CarlinA . Pilot study of interpersonal psychotherapy versus supportive psychotherapy for dysthymic patients with secondary alcohol abuse or dependence. Journal of Nervous and Mental Disease2008;196(6):468‐74. [PUBMED: 18552624] ">Markowitz 2008</a>); adolescents (<a href="./references#CD009501-bbs2-0007" title="RohdeP , WaldronHB , TurnerCW , BrodyJ , JorgensenJ . Sequenced versus coordinated treatment for adolescents with comorbid depressive and substance use disorders. Journal of Consulting and Clinical Psychology2014;82(2):342‐8. [PUBMED: 24491069] ">Rohde 2014</a>); and incarcerated females (<a href="./references#CD009501-bbs2-0004" title="JohnsonJE , ZlotnickC . Pilot study of treatment for major depression among women prisoners with substance use disorder. Journal of Psychiatric Research2012;46(9):1174‐83. [PUBMED: 22694906] ">Johnson 2012</a>). The average age ranged from 16.4 to 48.8 years. All studies had samples with a majority of Caucasians (61% to 81%). The proportion of males ranged from 57% to 92%. One study enrolled females only (<a href="./references#CD009501-bbs2-0004" title="JohnsonJE , ZlotnickC . Pilot study of treatment for major depression among women prisoners with substance use disorder. Journal of Psychiatric Research2012;46(9):1174‐83. [PUBMED: 22694906] ">Johnson 2012</a>). </p> <p>While all study participants had comorbid DSM‐IV depression and substance use disorders there was considerable variability in the disorder types included. Several studies included participants with major depression disorders only (<a href="./references#CD009501-bbs2-0002" title="BrownSA , Glasner‐EdwardsSV , TateSR , McQuaidJR , ChalekianJ , GranholmE . Integrated cognitive behavioral therapy versus twelve‐step facilitation therapy for substance‐dependent adults with depressive disorders. Journal of Psychoactive Drugs2006;38(4):449‐60. [PUBMED: 17373561] ">Brown 2006</a>; <a href="./references#CD009501-bbs2-0004" title="JohnsonJE , ZlotnickC . Pilot study of treatment for major depression among women prisoners with substance use disorder. Journal of Psychiatric Research2012;46(9):1174‐83. [PUBMED: 22694906] ">Johnson 2012</a>), two included participants with major depressive disorder/dysthymia only (<a href="./references#CD009501-bbs2-0003" title="CarpenterKM , SmithJL , AharonovichE , NunesEV . Developing therapies for depression in drug dependence: results of a stage 1 therapy study. American Journal of Drug and Alcohol Abuse2008;34(5):642‐52. [PUBMED: 18821458] ">Carpenter 2008</a>; <a href="./references#CD009501-bbs2-0005" title="LydeckerKP , TateSR , CumminsKM , McQuaidJ , GranholmE , BrownSA . Clinical outcomes of an integrated treatment for depression and substance use disorders. Psychology of Addictive Behaviors2010;24(3):453‐65. [PUBMED: 20853931] WorleyMJ , TateSR , McQuaidJR , GranholmEL , BrownSA . 12‐step affiliation and attendance following treatment for comorbid substance dependence and depression: a latent growth curve mediation model. Substance Abuse2013;34(1):43‐50. [PUBMED: 23327503] WorleyMJ , TrimRS , RoeschSC , Mrnak‐MeyerJ , TateSR , BrownSA . Comorbid depression and substance use disorder: longitudinal associations between symptoms in a controlled trial. Journal of Substance Abuse Treatment2012;43(3):291‐302. [PUBMED: 22406052] ">Lydecker 2010</a>), one included dysthymia only (<a href="./references#CD009501-bbs2-0006" title="MarkowitzJC , KocsusJH , ChristosP , BleibergK , CarlinA . Pilot study of interpersonal psychotherapy versus supportive psychotherapy for dysthymic patients with secondary alcohol abuse or dependence. Journal of Nervous and Mental Disease2008;196(6):468‐74. [PUBMED: 18552624] ">Markowitz 2008</a>), and the others included any depression disorder (<a href="./references#CD009501-bbs2-0001" title="BeutlerLE , MoleiroC , MarlikM , HarwoodTM , RomanelliR , Gallagher‐ThompsonD , et al. A comparison of the dodo, EST, and ATI factors among comorbid stimulant‐dependent, depressed patients. Clinical Psychology &amp; Psychotherapy2003;10(2):69‐85. [DOI: 10.1002/cpp.354] ">Beutler 2003</a>; <a href="./references#CD009501-bbs2-0007" title="RohdeP , WaldronHB , TurnerCW , BrodyJ , JorgensenJ . Sequenced versus coordinated treatment for adolescents with comorbid depressive and substance use disorders. Journal of Consulting and Clinical Psychology2014;82(2):342‐8. [PUBMED: 24491069] ">Rohde 2014</a>). </p> <p>Two studies included participants with any substance abuse or dependence (<a href="./references#CD009501-bbs2-0004" title="JohnsonJE , ZlotnickC . Pilot study of treatment for major depression among women prisoners with substance use disorder. Journal of Psychiatric Research2012;46(9):1174‐83. [PUBMED: 22694906] ">Johnson 2012</a>; <a href="./references#CD009501-bbs2-0007" title="RohdeP , WaldronHB , TurnerCW , BrodyJ , JorgensenJ . Sequenced versus coordinated treatment for adolescents with comorbid depressive and substance use disorders. Journal of Consulting and Clinical Psychology2014;82(2):342‐8. [PUBMED: 24491069] ">Rohde 2014</a>), the two veterans studies included individuals with alcohol, cannabis and/or stimulant dependence (<a href="./references#CD009501-bbs2-0002" title="BrownSA , Glasner‐EdwardsSV , TateSR , McQuaidJR , ChalekianJ , GranholmE . Integrated cognitive behavioral therapy versus twelve‐step facilitation therapy for substance‐dependent adults with depressive disorders. Journal of Psychoactive Drugs2006;38(4):449‐60. [PUBMED: 17373561] ">Brown 2006</a>; <a href="./references#CD009501-bbs2-0005" title="LydeckerKP , TateSR , CumminsKM , McQuaidJ , GranholmE , BrownSA . Clinical outcomes of an integrated treatment for depression and substance use disorders. Psychology of Addictive Behaviors2010;24(3):453‐65. [PUBMED: 20853931] WorleyMJ , TateSR , McQuaidJR , GranholmEL , BrownSA . 12‐step affiliation and attendance following treatment for comorbid substance dependence and depression: a latent growth curve mediation model. Substance Abuse2013;34(1):43‐50. [PUBMED: 23327503] WorleyMJ , TrimRS , RoeschSC , Mrnak‐MeyerJ , TateSR , BrownSA . Comorbid depression and substance use disorder: longitudinal associations between symptoms in a controlled trial. Journal of Substance Abuse Treatment2012;43(3):291‐302. [PUBMED: 22406052] ">Lydecker 2010</a>), and the three remaining studies included alcohol abuse or dependence only (<a href="./references#CD009501-bbs2-0006" title="MarkowitzJC , KocsusJH , ChristosP , BleibergK , CarlinA . Pilot study of interpersonal psychotherapy versus supportive psychotherapy for dysthymic patients with secondary alcohol abuse or dependence. Journal of Nervous and Mental Disease2008;196(6):468‐74. [PUBMED: 18552624] ">Markowitz 2008</a>), stimulant (cocaine or methamphetamine) dependence only (<a href="./references#CD009501-bbs2-0001" title="BeutlerLE , MoleiroC , MarlikM , HarwoodTM , RomanelliR , Gallagher‐ThompsonD , et al. A comparison of the dodo, EST, and ATI factors among comorbid stimulant‐dependent, depressed patients. Clinical Psychology &amp; Psychotherapy2003;10(2):69‐85. [DOI: 10.1002/cpp.354] ">Beutler 2003</a>), or opiate dependence only (<a href="./references#CD009501-bbs2-0003" title="CarpenterKM , SmithJL , AharonovichE , NunesEV . Developing therapies for depression in drug dependence: results of a stage 1 therapy study. American Journal of Drug and Alcohol Abuse2008;34(5):642‐52. [PUBMED: 18821458] ">Carpenter 2008</a>). </p> <p><b>Settings:</b> six studies were conducted in outpatient settings, including two in dual diagnosis treatment services for veterans (<a href="./references#CD009501-bbs2-0002" title="BrownSA , Glasner‐EdwardsSV , TateSR , McQuaidJR , ChalekianJ , GranholmE . Integrated cognitive behavioral therapy versus twelve‐step facilitation therapy for substance‐dependent adults with depressive disorders. Journal of Psychoactive Drugs2006;38(4):449‐60. [PUBMED: 17373561] ">Brown 2006</a>; <a href="./references#CD009501-bbs2-0005" title="LydeckerKP , TateSR , CumminsKM , McQuaidJ , GranholmE , BrownSA . Clinical outcomes of an integrated treatment for depression and substance use disorders. Psychology of Addictive Behaviors2010;24(3):453‐65. [PUBMED: 20853931] WorleyMJ , TateSR , McQuaidJR , GranholmEL , BrownSA . 12‐step affiliation and attendance following treatment for comorbid substance dependence and depression: a latent growth curve mediation model. Substance Abuse2013;34(1):43‐50. [PUBMED: 23327503] WorleyMJ , TrimRS , RoeschSC , Mrnak‐MeyerJ , TateSR , BrownSA . Comorbid depression and substance use disorder: longitudinal associations between symptoms in a controlled trial. Journal of Substance Abuse Treatment2012;43(3):291‐302. [PUBMED: 22406052] ">Lydecker 2010</a>). One study was conducted among incarcerated females (<a href="./references#CD009501-bbs2-0004" title="JohnsonJE , ZlotnickC . Pilot study of treatment for major depression among women prisoners with substance use disorder. Journal of Psychiatric Research2012;46(9):1174‐83. [PUBMED: 22694906] ">Johnson 2012</a>). </p> <p><b>Types of comparisons:</b> no studies that compared psychological interventions (alone or combined with pharmacotherapy) with delayed treatment, treatment as usual or no treatment control conditions met inclusion criteria; nor did any studies comparing combined psychological and pharmacological interventions with other psychological interventions. All seven studies included for review compared different types of psychological treatments. </p> <p>Four studies provided group therapy (<a href="./references#CD009501-bbs2-0002" title="BrownSA , Glasner‐EdwardsSV , TateSR , McQuaidJR , ChalekianJ , GranholmE . Integrated cognitive behavioral therapy versus twelve‐step facilitation therapy for substance‐dependent adults with depressive disorders. Journal of Psychoactive Drugs2006;38(4):449‐60. [PUBMED: 17373561] ">Brown 2006</a>; <a href="./references#CD009501-bbs2-0003" title="CarpenterKM , SmithJL , AharonovichE , NunesEV . Developing therapies for depression in drug dependence: results of a stage 1 therapy study. American Journal of Drug and Alcohol Abuse2008;34(5):642‐52. [PUBMED: 18821458] ">Carpenter 2008</a>; <a href="./references#CD009501-bbs2-0005" title="LydeckerKP , TateSR , CumminsKM , McQuaidJ , GranholmE , BrownSA . Clinical outcomes of an integrated treatment for depression and substance use disorders. Psychology of Addictive Behaviors2010;24(3):453‐65. [PUBMED: 20853931] WorleyMJ , TateSR , McQuaidJR , GranholmEL , BrownSA . 12‐step affiliation and attendance following treatment for comorbid substance dependence and depression: a latent growth curve mediation model. Substance Abuse2013;34(1):43‐50. [PUBMED: 23327503] WorleyMJ , TrimRS , RoeschSC , Mrnak‐MeyerJ , TateSR , BrownSA . Comorbid depression and substance use disorder: longitudinal associations between symptoms in a controlled trial. Journal of Substance Abuse Treatment2012;43(3):291‐302. [PUBMED: 22406052] ">Lydecker 2010</a>;<a href="./references#CD009501-bbs2-0007" title="RohdeP , WaldronHB , TurnerCW , BrodyJ , JorgensenJ . Sequenced versus coordinated treatment for adolescents with comorbid depressive and substance use disorders. Journal of Consulting and Clinical Psychology2014;82(2):342‐8. [PUBMED: 24491069] ">Rohde 2014</a>), two individual therapy (<a href="./references#CD009501-bbs2-0001" title="BeutlerLE , MoleiroC , MarlikM , HarwoodTM , RomanelliR , Gallagher‐ThompsonD , et al. A comparison of the dodo, EST, and ATI factors among comorbid stimulant‐dependent, depressed patients. Clinical Psychology &amp; Psychotherapy2003;10(2):69‐85. [DOI: 10.1002/cpp.354] ">Beutler 2003</a>; <a href="./references#CD009501-bbs2-0006" title="MarkowitzJC , KocsusJH , ChristosP , BleibergK , CarlinA . Pilot study of interpersonal psychotherapy versus supportive psychotherapy for dysthymic patients with secondary alcohol abuse or dependence. Journal of Nervous and Mental Disease2008;196(6):468‐74. [PUBMED: 18552624] ">Markowitz 2008</a>), and one study provided group therapy followed by individual therapy (<a href="./references#CD009501-bbs2-0004" title="JohnsonJE , ZlotnickC . Pilot study of treatment for major depression among women prisoners with substance use disorder. Journal of Psychiatric Research2012;46(9):1174‐83. [PUBMED: 22694906] ">Johnson 2012</a>). </p> <p>Five studies compared CBT with other psychological interventions for comorbid depression and substance use disorders. </p> <p> <ul id="CD009501-list-0014"> <li> <p>Two studies compared 24 weeks (36 sessions) of group‐based integrated CBT (ICBT) versus Twelve Step Facilitation (TSF) in veterans accessing a dual diagnosis outpatient clinic with a DSM‐IV major depressive disorder and co‐occurring alcohol, cannabis and/or stimulant dependence (n = 90 <a href="./references#CD009501-bbs2-0002" title="BrownSA , Glasner‐EdwardsSV , TateSR , McQuaidJR , ChalekianJ , GranholmE . Integrated cognitive behavioral therapy versus twelve‐step facilitation therapy for substance‐dependent adults with depressive disorders. Journal of Psychoactive Drugs2006;38(4):449‐60. [PUBMED: 17373561] ">Brown 2006</a>; n = 206 <a href="./references#CD009501-bbs2-0005" title="LydeckerKP , TateSR , CumminsKM , McQuaidJ , GranholmE , BrownSA . Clinical outcomes of an integrated treatment for depression and substance use disorders. Psychology of Addictive Behaviors2010;24(3):453‐65. [PUBMED: 20853931] WorleyMJ , TateSR , McQuaidJR , GranholmEL , BrownSA . 12‐step affiliation and attendance following treatment for comorbid substance dependence and depression: a latent growth curve mediation model. Substance Abuse2013;34(1):43‐50. [PUBMED: 23327503] WorleyMJ , TrimRS , RoeschSC , Mrnak‐MeyerJ , TateSR , BrownSA . Comorbid depression and substance use disorder: longitudinal associations between symptoms in a controlled trial. Journal of Substance Abuse Treatment2012;43(3):291‐302. [PUBMED: 22406052] ">Lydecker 2010</a>). </p> </li> <li> <p>One study compared 24 weeks (24 sessions) of group‐based Behavioral Therapy for Depression in Drug Dependence (BTDD) versus 24 weeks of a group‐based structured Relaxation Intervention (REL) among 38 treatment‐seeking outpatients with DSM‐IV opiate dependence and major depressive disorder/dysthymia (<a href="./references#CD009501-bbs2-0003" title="CarpenterKM , SmithJL , AharonovichE , NunesEV . Developing therapies for depression in drug dependence: results of a stage 1 therapy study. American Journal of Drug and Alcohol Abuse2008;34(5):642‐52. [PUBMED: 18821458] ">Carpenter 2008</a>). </p> </li> <li> <p>One study compared 1418 weeks (16‐20 sessions) of Cognitive Therapy (CT) with Narrative Therapy (NT) and Prescriptive Therapy (PT) among 40 patients seeking outpatient care with a DSM‐IV depression disorder and stimulant dependence (<a href="./references#CD009501-bbs2-0001" title="BeutlerLE , MoleiroC , MarlikM , HarwoodTM , RomanelliR , Gallagher‐ThompsonD , et al. A comparison of the dodo, EST, and ATI factors among comorbid stimulant‐dependent, depressed patients. Clinical Psychology &amp; Psychotherapy2003;10(2):69‐85. [DOI: 10.1002/cpp.354] ">Beutler 2003</a>). </p> </li> <li> <p>One study compared three methods for integrating CBT and Functional Family Therapy (FFT) in 170 adolescents with a comorbid DSM‐IV depression and substance use disorder seeking substance use treatment (<a href="./references#CD009501-bbs2-0007" title="RohdeP , WaldronHB , TurnerCW , BrodyJ , JorgensenJ . Sequenced versus coordinated treatment for adolescents with comorbid depressive and substance use disorders. Journal of Consulting and Clinical Psychology2014;82(2):342‐8. [PUBMED: 24491069] ">Rohde 2014</a>). Participants received 24 weeks (24 sessions) of either the adolescent Coping With Depression (CWD) followed by FFT (CWD/FFT), FFT followed by CWD (FFT/WD) or integrated CWD and FFT care (CWD+FFT). </p> </li> </ul> </p> <p>Two studies compared IPT for depression (IPT‐D) with other psychological interventions.</p> <p> <ul id="CD009501-list-0015"> <li> <p>A pilot study compared 16 weeks (16‐18 sessions) of individual IPT‐D versus Brief Supportive Therapy (BST) in 26 adults seeking outpatient care with DSM‐IV dysthymia and secondary alcohol use disorder (<a href="./references#CD009501-bbs2-0006" title="MarkowitzJC , KocsusJH , ChristosP , BleibergK , CarlinA . Pilot study of interpersonal psychotherapy versus supportive psychotherapy for dysthymic patients with secondary alcohol abuse or dependence. Journal of Nervous and Mental Disease2008;196(6):468‐74. [PUBMED: 18552624] ">Markowitz 2008</a>). </p> </li> <li> <p>A second study compared eight weeks (24 sessions) of group IPT‐D with a psychoeducation group for co‐occurring mental health and substance use disorders (PSYCHOED) among 40 incarcerated females with DSM major depressive disorder and substance abuse or dependence. Both treatment groups also received three individual sessions at pre, mid and post the group intervention, as well as treatment as usual for substance use and mental health problems (<a href="./references#CD009501-bbs2-0004" title="JohnsonJE , ZlotnickC . Pilot study of treatment for major depression among women prisoners with substance use disorder. Journal of Psychiatric Research2012;46(9):1174‐83. [PUBMED: 22694906] ">Johnson 2012</a>). </p> </li> </ul> </p> <p><b>Outcomes</b> </p> <p>The depression and substance use outcomes reported differed across studies, as detailed in the <a href="./references#CD009501-sec-0116" title="">Characteristics of included studies</a> table. All but one study used a version of the Hamilton Depression Rating Scale (HDRS, <a href="./references#CD009501-bbs2-0164" title="HamiltonM . A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry1960;23:56‐62. [PUBMED: 14399272] ">Hamilton 1960</a>), a clinician‐rated measure of the frequency of depression symptoms in the past week. The original version (<a href="./references#CD009501-bbs2-0164" title="HamiltonM . A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry1960;23:56‐62. [PUBMED: 14399272] ">Hamilton 1960</a>) contained 17 items, but current versions range from 17 to 29 items (<a href="./references#CD009501-bbs2-0165" title="Hamilton , M . Rating depressive patients. Journal of Clinical Psychiatry1980;41:21‐4. ">Hamilton 1980</a>; <a href="./references#CD009501-bbs2-0204" title="WilliamsJB , LinkMJ , RosenthalNE , TermanM . Structured Interview Guide for the Hamilton Depression Rating Scale, Seasonal Affective Disorders Version (SIGHSAD). New York: New York Psychiatric Institute, 1988. ">Williams 1988</a>). Items are scored on a 3‐or 5‐point scale. Total scores for depression are usually derived from the original 17 items on a 3‐point scale and range from zero to 51 points, with scores from 7 to 17 indicating mild depression, from 18 to 24 indicating moderate depression, and above 24 indicating severe depression. </p> <p>Three studies also included the Beck Depression Inventory (BDI) (<a href="./references#CD009501-bbs2-0140" title="BeckAT , WardCH , MendelsonM , MockJ , ErbaughJ . An inventory for measuring depression. Archives of General Psychiatry1961;4:561‐9. [PUBMED: 13688369] ">Beck 1961</a>; <a href="./references#CD009501-bbs2-0141" title="BeckAT . Depression Inventory. Philadelphia: Center for CognitiveTherapy, 1978. ">Beck 1978</a>; <a href="./references#CD009501-bbs2-0143" title="BeckAT , SteerRA , BrownGK . Beck Depression Inventory‐Second Edition Manual. San Antonio: The Psychological Corporation, 1996. ">Beck 1996</a>), a self‐report measure of the frequency of depression symptoms in the previous two weeks. <a href="./references#CD009501-bbs2-0007" title="RohdeP , WaldronHB , TurnerCW , BrodyJ , JorgensenJ . Sequenced versus coordinated treatment for adolescents with comorbid depressive and substance use disorders. Journal of Consulting and Clinical Psychology2014;82(2):342‐8. [PUBMED: 24491069] ">Rohde 2014</a> used the Child Depression Rating Scale‐Revised (CDRS‐R, <a href="./references#CD009501-bbs2-0189" title="PoznanskiEO , HartmutBM . Children's Depression Rating Scale, Revised (CDRS‐R). Los Angeles: Western Psychological Services, 1995. ">Poznanski 1995</a>), a 17‐item clinician‐rated measure of depressive symptomatology in six‐ to 12‐year olds, which is also widely used in adolescents. </p> <p>All studies used the Timeline Followback method (TLFB; <a href="./references#CD009501-bbs2-0181" title="MillerWR , DelBocaFK . Measurement of drinking behavior using the Form 90 family of instruments. Journal of Studies on Alcohol. Supplement1994;12:112‐8. [PUBMED: 7722987] ">Miller 1994</a>; <a href="./references#CD009501-bbs2-0194" title="SobellMB , MaistoSA , SobellLC , CooperAM , CooperT , SandersB . Developing a prototype for evaluating alcohol treatment effectiveness. In: SobellLC , SobellMB , WardE editor(s). Evaluating Alcohol and Drug Abuse Treatment Effectiveness: Recent Advances. New York: Pergamon Press, 1980:129‐50. ">Sobell 1980</a>; <a href="./references#CD009501-bbs2-0195" title="SobellLC , SobellMB . Timeline followback: a technique for assessing self‐reported ethanol consumption. In: JAllen , RZLitten editor(s). Measuring Alcohol Consumption: Psychosocial and Biological Methods. Totowa (NJ): Humana Press, 1992:41‐72. ">Sobell 1992</a>) to assess substance use outcomes. This calendar‐based method assesses the frequency and quantity of substance use, including the number of days abstinent over a specified timeframe. Both the timeframe (30 to 90 days) and definition of substance use outcome measures (mean percentage days abstinent, proportion of days abstinent, square root of percentage of daily substance use) varied across studies. One study used the alcohol and drug index score of the Addiction Severity Index (ASI; <a href="./references#CD009501-bbs2-0001" title="BeutlerLE , MoleiroC , MarlikM , HarwoodTM , RomanelliR , Gallagher‐ThompsonD , et al. A comparison of the dodo, EST, and ATI factors among comorbid stimulant‐dependent, depressed patients. Clinical Psychology &amp; Psychotherapy2003;10(2):69‐85. [DOI: 10.1002/cpp.354] ">Beutler 2003</a>). </p> <p>Definitions of treatment retention varied across studies. Four studies reported the mean number of treatment sessions attended (<a href="./references#CD009501-bbs2-0002" title="BrownSA , Glasner‐EdwardsSV , TateSR , McQuaidJR , ChalekianJ , GranholmE . Integrated cognitive behavioral therapy versus twelve‐step facilitation therapy for substance‐dependent adults with depressive disorders. Journal of Psychoactive Drugs2006;38(4):449‐60. [PUBMED: 17373561] ">Brown 2006</a>; <a href="./references#CD009501-bbs2-0003" title="CarpenterKM , SmithJL , AharonovichE , NunesEV . Developing therapies for depression in drug dependence: results of a stage 1 therapy study. American Journal of Drug and Alcohol Abuse2008;34(5):642‐52. [PUBMED: 18821458] ">Carpenter 2008</a>; <a href="./references#CD009501-bbs2-0005" title="LydeckerKP , TateSR , CumminsKM , McQuaidJ , GranholmE , BrownSA . Clinical outcomes of an integrated treatment for depression and substance use disorders. Psychology of Addictive Behaviors2010;24(3):453‐65. [PUBMED: 20853931] WorleyMJ , TateSR , McQuaidJR , GranholmEL , BrownSA . 12‐step affiliation and attendance following treatment for comorbid substance dependence and depression: a latent growth curve mediation model. Substance Abuse2013;34(1):43‐50. [PUBMED: 23327503] WorleyMJ , TrimRS , RoeschSC , Mrnak‐MeyerJ , TateSR , BrownSA . Comorbid depression and substance use disorder: longitudinal associations between symptoms in a controlled trial. Journal of Substance Abuse Treatment2012;43(3):291‐302. [PUBMED: 22406052] ">Lydecker 2010</a>; <a href="./references#CD009501-bbs2-0007" title="RohdeP , WaldronHB , TurnerCW , BrodyJ , JorgensenJ . Sequenced versus coordinated treatment for adolescents with comorbid depressive and substance use disorders. Journal of Consulting and Clinical Psychology2014;82(2):342‐8. [PUBMED: 24491069] ">Rohde 2014</a>). Three studies reported the percentage of participants who dropped out of treatment but the definitions of dropout varied. <a href="./references#CD009501-bbs2-0001" title="BeutlerLE , MoleiroC , MarlikM , HarwoodTM , RomanelliR , Gallagher‐ThompsonD , et al. A comparison of the dodo, EST, and ATI factors among comorbid stimulant‐dependent, depressed patients. Clinical Psychology &amp; Psychotherapy2003;10(2):69‐85. [DOI: 10.1002/cpp.354] ">Beutler 2003</a> defined treatment as missing three or more consecutive sessions out of the 20 sessions. <a href="./references#CD009501-bbs2-0006" title="MarkowitzJC , KocsusJH , ChristosP , BleibergK , CarlinA . Pilot study of interpersonal psychotherapy versus supportive psychotherapy for dysthymic patients with secondary alcohol abuse or dependence. Journal of Nervous and Mental Disease2008;196(6):468‐74. [PUBMED: 18552624] ">Markowitz 2008</a> reported the percentage of participants who failed to complete treatment, but it is unclear how this was defined. <a href="./references#CD009501-bbs2-0004" title="JohnsonJE , ZlotnickC . Pilot study of treatment for major depression among women prisoners with substance use disorder. Journal of Psychiatric Research2012;46(9):1174‐83. [PUBMED: 22694906] ">Johnson 2012</a> defined treatment dropout as missing more than two out of 24 sessions by choice. </p> <p>No studies reported information on any of the secondary outcome variables specified in the original Cochrane Review research protocol, including functioning, quality of life, anxiety symptoms or disorders or the global clinical severity of mental health disorders. No adverse effects linked to treatments delivered were reported. </p> <p><b>Follow‐up</b> </p> <p>All studies reported post‐treatment outcomes. Three studies conducted three‐month follow‐ups (<a href="./references#CD009501-bbs2-0002" title="BrownSA , Glasner‐EdwardsSV , TateSR , McQuaidJR , ChalekianJ , GranholmE . Integrated cognitive behavioral therapy versus twelve‐step facilitation therapy for substance‐dependent adults with depressive disorders. Journal of Psychoactive Drugs2006;38(4):449‐60. [PUBMED: 17373561] ">Brown 2006</a>; <a href="./references#CD009501-bbs2-0004" title="JohnsonJE , ZlotnickC . Pilot study of treatment for major depression among women prisoners with substance use disorder. Journal of Psychiatric Research2012;46(9):1174‐83. [PUBMED: 22694906] ">Johnson 2012</a>; <a href="./references#CD009501-bbs2-0005" title="LydeckerKP , TateSR , CumminsKM , McQuaidJ , GranholmE , BrownSA . Clinical outcomes of an integrated treatment for depression and substance use disorders. Psychology of Addictive Behaviors2010;24(3):453‐65. [PUBMED: 20853931] WorleyMJ , TateSR , McQuaidJR , GranholmEL , BrownSA . 12‐step affiliation and attendance following treatment for comorbid substance dependence and depression: a latent growth curve mediation model. Substance Abuse2013;34(1):43‐50. [PUBMED: 23327503] WorleyMJ , TrimRS , RoeschSC , Mrnak‐MeyerJ , TateSR , BrownSA . Comorbid depression and substance use disorder: longitudinal associations between symptoms in a controlled trial. Journal of Substance Abuse Treatment2012;43(3):291‐302. [PUBMED: 22406052] ">Lydecker 2010</a>), three conducted six‐month follow‐ups (<a href="./references#CD009501-bbs2-0001" title="BeutlerLE , MoleiroC , MarlikM , HarwoodTM , RomanelliR , Gallagher‐ThompsonD , et al. A comparison of the dodo, EST, and ATI factors among comorbid stimulant‐dependent, depressed patients. Clinical Psychology &amp; Psychotherapy2003;10(2):69‐85. [DOI: 10.1002/cpp.354] ">Beutler 2003</a>; <a href="./references#CD009501-bbs2-0002" title="BrownSA , Glasner‐EdwardsSV , TateSR , McQuaidJR , ChalekianJ , GranholmE . Integrated cognitive behavioral therapy versus twelve‐step facilitation therapy for substance‐dependent adults with depressive disorders. Journal of Psychoactive Drugs2006;38(4):449‐60. [PUBMED: 17373561] ">Brown 2006</a>; <a href="./references#CD009501-bbs2-0005" title="LydeckerKP , TateSR , CumminsKM , McQuaidJ , GranholmE , BrownSA . Clinical outcomes of an integrated treatment for depression and substance use disorders. Psychology of Addictive Behaviors2010;24(3):453‐65. [PUBMED: 20853931] WorleyMJ , TateSR , McQuaidJR , GranholmEL , BrownSA . 12‐step affiliation and attendance following treatment for comorbid substance dependence and depression: a latent growth curve mediation model. Substance Abuse2013;34(1):43‐50. [PUBMED: 23327503] WorleyMJ , TrimRS , RoeschSC , Mrnak‐MeyerJ , TateSR , BrownSA . Comorbid depression and substance use disorder: longitudinal associations between symptoms in a controlled trial. Journal of Substance Abuse Treatment2012;43(3):291‐302. [PUBMED: 22406052] ">Lydecker 2010</a>; <a href="./references#CD009501-bbs2-0007" title="RohdeP , WaldronHB , TurnerCW , BrodyJ , JorgensenJ . Sequenced versus coordinated treatment for adolescents with comorbid depressive and substance use disorders. Journal of Consulting and Clinical Psychology2014;82(2):342‐8. [PUBMED: 24491069] ">Rohde 2014</a>), and two conducted 12‐month follow‐ups (<a href="./references#CD009501-bbs2-0005" title="LydeckerKP , TateSR , CumminsKM , McQuaidJ , GranholmE , BrownSA . Clinical outcomes of an integrated treatment for depression and substance use disorders. Psychology of Addictive Behaviors2010;24(3):453‐65. [PUBMED: 20853931] WorleyMJ , TateSR , McQuaidJR , GranholmEL , BrownSA . 12‐step affiliation and attendance following treatment for comorbid substance dependence and depression: a latent growth curve mediation model. Substance Abuse2013;34(1):43‐50. [PUBMED: 23327503] WorleyMJ , TrimRS , RoeschSC , Mrnak‐MeyerJ , TateSR , BrownSA . Comorbid depression and substance use disorder: longitudinal associations between symptoms in a controlled trial. Journal of Substance Abuse Treatment2012;43(3):291‐302. [PUBMED: 22406052] ">Lydecker 2010</a>, <a href="./references#CD009501-bbs2-0007" title="RohdeP , WaldronHB , TurnerCW , BrodyJ , JorgensenJ . Sequenced versus coordinated treatment for adolescents with comorbid depressive and substance use disorders. Journal of Consulting and Clinical Psychology2014;82(2):342‐8. [PUBMED: 24491069] ">Rohde 2014</a>). </p> </section> <section id="CD009501-sec-0064"> <h4 class="title">Excluded studies</h4> <p>We excluded 127 articles from 124 studies for not meeting the inclusion criteria. Overall 76 articles (from 75 studies) were excluded because they did not meet the depression criteria, 20 articles (from 19 studies) were excluded because they did not meet the substance use criteria, 23 articles (from 22 studies) were excluded because they did not meet both the depression and substance use criteria, two studies were excluded because they were not RCTs, one study was excluded because it focused depression and substance use in the context of Posttraumatic Stress Disorder and Trauma, and five studies were excluded because they did not meet psychotherapy criteria (three of these studies focused on the use of technology as an adjunct to therapy, not actual differences between therapies; and the remaining two studies randomised pharmacological treatments, without randomising psychological therapies) See <a href="#CD009501-fig-0001">Figure 1</a> for further details. </p> </section> </section> <section id="CD009501-sec-0065"> <h3 class="title">Risk of bias in included studies</h3> <p>The seven included studies were evaluated by the review author's using Cochrane's 'Risk of bias' tool (see <a href="./appendices#CD009501-sec-0108">Appendix 5</a>). The results are summarised in <a href="#CD009501-fig-0002">Figure 2</a> and <a href="#CD009501-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD009501-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD009501-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD009501-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD009501-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD009501-sec-0066"> <h4 class="title">Allocation</h4> <p>Random sequence generation: all of the included studies were described as RCTs. Five studies were judged at low risk of selection bias: one study used concealed random draws (<a href="./references#CD009501-bbs2-0001" title="BeutlerLE , MoleiroC , MarlikM , HarwoodTM , RomanelliR , Gallagher‐ThompsonD , et al. A comparison of the dodo, EST, and ATI factors among comorbid stimulant‐dependent, depressed patients. Clinical Psychology &amp; Psychotherapy2003;10(2):69‐85. [DOI: 10.1002/cpp.354] ">Beutler 2003</a>) and four used independent computer‐based randomisation to generate the sequence allocation (<a href="./references#CD009501-bbs2-0003" title="CarpenterKM , SmithJL , AharonovichE , NunesEV . Developing therapies for depression in drug dependence: results of a stage 1 therapy study. American Journal of Drug and Alcohol Abuse2008;34(5):642‐52. [PUBMED: 18821458] ">Carpenter 2008</a>; <a href="./references#CD009501-bbs2-0004" title="JohnsonJE , ZlotnickC . Pilot study of treatment for major depression among women prisoners with substance use disorder. Journal of Psychiatric Research2012;46(9):1174‐83. [PUBMED: 22694906] ">Johnson 2012</a>; <a href="./references#CD009501-bbs2-0006" title="MarkowitzJC , KocsusJH , ChristosP , BleibergK , CarlinA . Pilot study of interpersonal psychotherapy versus supportive psychotherapy for dysthymic patients with secondary alcohol abuse or dependence. Journal of Nervous and Mental Disease2008;196(6):468‐74. [PUBMED: 18552624] ">Markowitz 2008</a>; <a href="./references#CD009501-bbs2-0007" title="RohdeP , WaldronHB , TurnerCW , BrodyJ , JorgensenJ . Sequenced versus coordinated treatment for adolescents with comorbid depressive and substance use disorders. Journal of Consulting and Clinical Psychology2014;82(2):342‐8. [PUBMED: 24491069] ">Rohde 2014</a>). Two studies used sequential allocation of consecutively‐admitted patients (<a href="./references#CD009501-bbs2-0002" title="BrownSA , Glasner‐EdwardsSV , TateSR , McQuaidJR , ChalekianJ , GranholmE . Integrated cognitive behavioral therapy versus twelve‐step facilitation therapy for substance‐dependent adults with depressive disorders. Journal of Psychoactive Drugs2006;38(4):449‐60. [PUBMED: 17373561] ">Brown 2006</a>; <a href="./references#CD009501-bbs2-0005" title="LydeckerKP , TateSR , CumminsKM , McQuaidJ , GranholmE , BrownSA . Clinical outcomes of an integrated treatment for depression and substance use disorders. Psychology of Addictive Behaviors2010;24(3):453‐65. [PUBMED: 20853931] WorleyMJ , TateSR , McQuaidJR , GranholmEL , BrownSA . 12‐step affiliation and attendance following treatment for comorbid substance dependence and depression: a latent growth curve mediation model. Substance Abuse2013;34(1):43‐50. [PUBMED: 23327503] WorleyMJ , TrimRS , RoeschSC , Mrnak‐MeyerJ , TateSR , BrownSA . Comorbid depression and substance use disorder: longitudinal associations between symptoms in a controlled trial. Journal of Substance Abuse Treatment2012;43(3):291‐302. [PUBMED: 22406052] ">Lydecker 2010</a>) and were judged to be at high risk of selection bias due to the use of a non‐random sequence generation process. All but one study (<a href="./references#CD009501-bbs2-0001" title="BeutlerLE , MoleiroC , MarlikM , HarwoodTM , RomanelliR , Gallagher‐ThompsonD , et al. A comparison of the dodo, EST, and ATI factors among comorbid stimulant‐dependent, depressed patients. Clinical Psychology &amp; Psychotherapy2003;10(2):69‐85. [DOI: 10.1002/cpp.354] ">Beutler 2003</a>), checked the success of randomisation by comparing the group allocations on baseline variables. </p> <p>Allocation concealment: five studies were judged at low risk of bias ( <a href="./references#CD009501-bbs2-0001" title="BeutlerLE , MoleiroC , MarlikM , HarwoodTM , RomanelliR , Gallagher‐ThompsonD , et al. A comparison of the dodo, EST, and ATI factors among comorbid stimulant‐dependent, depressed patients. Clinical Psychology &amp; Psychotherapy2003;10(2):69‐85. [DOI: 10.1002/cpp.354] ">Beutler 2003</a>;<a href="./references#CD009501-bbs2-0003" title="CarpenterKM , SmithJL , AharonovichE , NunesEV . Developing therapies for depression in drug dependence: results of a stage 1 therapy study. American Journal of Drug and Alcohol Abuse2008;34(5):642‐52. [PUBMED: 18821458] ">Carpenter 2008</a>; ,<a href="./references#CD009501-bbs2-0004" title="JohnsonJE , ZlotnickC . Pilot study of treatment for major depression among women prisoners with substance use disorder. Journal of Psychiatric Research2012;46(9):1174‐83. [PUBMED: 22694906] ">Johnson 2012</a>; <a href="./references#CD009501-bbs2-0006" title="MarkowitzJC , KocsusJH , ChristosP , BleibergK , CarlinA . Pilot study of interpersonal psychotherapy versus supportive psychotherapy for dysthymic patients with secondary alcohol abuse or dependence. Journal of Nervous and Mental Disease2008;196(6):468‐74. [PUBMED: 18552624] ">Markowitz 2008</a>; <a href="./references#CD009501-bbs2-0007" title="RohdeP , WaldronHB , TurnerCW , BrodyJ , JorgensenJ . Sequenced versus coordinated treatment for adolescents with comorbid depressive and substance use disorders. Journal of Consulting and Clinical Psychology2014;82(2):342‐8. [PUBMED: 24491069] ">Rohde 2014</a>). Two studies were judged at high risk of bias (<a href="./references#CD009501-bbs2-0002" title="BrownSA , Glasner‐EdwardsSV , TateSR , McQuaidJR , ChalekianJ , GranholmE . Integrated cognitive behavioral therapy versus twelve‐step facilitation therapy for substance‐dependent adults with depressive disorders. Journal of Psychoactive Drugs2006;38(4):449‐60. [PUBMED: 17373561] ">Brown 2006</a>, <a href="./references#CD009501-bbs2-0005" title="LydeckerKP , TateSR , CumminsKM , McQuaidJ , GranholmE , BrownSA . Clinical outcomes of an integrated treatment for depression and substance use disorders. Psychology of Addictive Behaviors2010;24(3):453‐65. [PUBMED: 20853931] WorleyMJ , TateSR , McQuaidJR , GranholmEL , BrownSA . 12‐step affiliation and attendance following treatment for comorbid substance dependence and depression: a latent growth curve mediation model. Substance Abuse2013;34(1):43‐50. [PUBMED: 23327503] WorleyMJ , TrimRS , RoeschSC , Mrnak‐MeyerJ , TateSR , BrownSA . Comorbid depression and substance use disorder: longitudinal associations between symptoms in a controlled trial. Journal of Substance Abuse Treatment2012;43(3):291‐302. [PUBMED: 22406052] ">Lydecker 2010</a>) because a consecutive allocation was used. </p> </section> <section id="CD009501-sec-0067"> <h4 class="title">Blinding</h4> <p>Performance bias: no study blinded therapists to the treatment allocation, as this is not possible in psychological trials. Only one study attempted to blind participants to their group allocation, and checked but did not report the success of this blinding process (<a href="./references#CD009501-bbs2-0001" title="BeutlerLE , MoleiroC , MarlikM , HarwoodTM , RomanelliR , Gallagher‐ThompsonD , et al. A comparison of the dodo, EST, and ATI factors among comorbid stimulant‐dependent, depressed patients. Clinical Psychology &amp; Psychotherapy2003;10(2):69‐85. [DOI: 10.1002/cpp.354] ">Beutler 2003</a>). Thus, all studies were rated at high risk of performance bias, due to the subjective nature of the depression and substance use outcomes. These studies were also rated at high risk for performance bias for the treatment retention/attendance variable, as despite the objective nature of this outcome, knowledge of the treatment allocation may influence participant's treatment engagement, participation and attendance. </p> <p>Detection bias: five of the seven studies were at low risk of detection bias for interviewer‐rated outcomes, due to the use of outcome assessors blind to treatment allocation. Two studies which did not blind the outcome assessors were judged to be at high risk of detection bias (<a href="./references#CD009501-bbs2-0003" title="CarpenterKM , SmithJL , AharonovichE , NunesEV . Developing therapies for depression in drug dependence: results of a stage 1 therapy study. American Journal of Drug and Alcohol Abuse2008;34(5):642‐52. [PUBMED: 18821458] ">Carpenter 2008</a>; <a href="./references#CD009501-bbs2-0005" title="LydeckerKP , TateSR , CumminsKM , McQuaidJ , GranholmE , BrownSA . Clinical outcomes of an integrated treatment for depression and substance use disorders. Psychology of Addictive Behaviors2010;24(3):453‐65. [PUBMED: 20853931] WorleyMJ , TateSR , McQuaidJR , GranholmEL , BrownSA . 12‐step affiliation and attendance following treatment for comorbid substance dependence and depression: a latent growth curve mediation model. Substance Abuse2013;34(1):43‐50. [PUBMED: 23327503] WorleyMJ , TrimRS , RoeschSC , Mrnak‐MeyerJ , TateSR , BrownSA . Comorbid depression and substance use disorder: longitudinal associations between symptoms in a controlled trial. Journal of Substance Abuse Treatment2012;43(3):291‐302. [PUBMED: 22406052] ">Lydecker 2010</a>). All four studies that reported self‐report outcomes were rated at unclear risk of detection bias (<a href="./references#CD009501-bbs2-0001" title="BeutlerLE , MoleiroC , MarlikM , HarwoodTM , RomanelliR , Gallagher‐ThompsonD , et al. A comparison of the dodo, EST, and ATI factors among comorbid stimulant‐dependent, depressed patients. Clinical Psychology &amp; Psychotherapy2003;10(2):69‐85. [DOI: 10.1002/cpp.354] ">Beutler 2003</a>; <a href="./references#CD009501-bbs2-0003" title="CarpenterKM , SmithJL , AharonovichE , NunesEV . Developing therapies for depression in drug dependence: results of a stage 1 therapy study. American Journal of Drug and Alcohol Abuse2008;34(5):642‐52. [PUBMED: 18821458] ">Carpenter 2008</a>; <a href="./references#CD009501-bbs2-0006" title="MarkowitzJC , KocsusJH , ChristosP , BleibergK , CarlinA . Pilot study of interpersonal psychotherapy versus supportive psychotherapy for dysthymic patients with secondary alcohol abuse or dependence. Journal of Nervous and Mental Disease2008;196(6):468‐74. [PUBMED: 18552624] ">Markowitz 2008</a>; <a href="./references#CD009501-bbs2-0007" title="RohdeP , WaldronHB , TurnerCW , BrodyJ , JorgensenJ . Sequenced versus coordinated treatment for adolescents with comorbid depressive and substance use disorders. Journal of Consulting and Clinical Psychology2014;82(2):342‐8. [PUBMED: 24491069] ">Rohde 2014</a>). While participants were not blind to treatment allocation and self‐report measures may be impacted by self‐presentation bias or client insight, it is unlikely that any such risk of bias will vary by treatment condition. There was insufficient information to determine whether the individuals who collected information on treatment attendance/completion were blind to treatment allocation in all studies. However, this objective outcome measure is unlikely to be influenced by lack of blinding, and all seven studies were judged to be at low risk of detection bias on this outcome variable. </p> </section> <section id="CD009501-sec-0068"> <h4 class="title">Incomplete outcome data</h4> <p>Treatment retention/attendance: less than 50% of participants completed treatment or attended half of the allocated treatment sessions (in at least one group) in four studies (<a href="./references#CD009501-bbs2-0001" title="BeutlerLE , MoleiroC , MarlikM , HarwoodTM , RomanelliR , Gallagher‐ThompsonD , et al. A comparison of the dodo, EST, and ATI factors among comorbid stimulant‐dependent, depressed patients. Clinical Psychology &amp; Psychotherapy2003;10(2):69‐85. [DOI: 10.1002/cpp.354] ">Beutler 2003</a>; <a href="./references#CD009501-bbs2-0002" title="BrownSA , Glasner‐EdwardsSV , TateSR , McQuaidJR , ChalekianJ , GranholmE . Integrated cognitive behavioral therapy versus twelve‐step facilitation therapy for substance‐dependent adults with depressive disorders. Journal of Psychoactive Drugs2006;38(4):449‐60. [PUBMED: 17373561] ">Brown 2006</a>; <a href="./references#CD009501-bbs2-0003" title="CarpenterKM , SmithJL , AharonovichE , NunesEV . Developing therapies for depression in drug dependence: results of a stage 1 therapy study. American Journal of Drug and Alcohol Abuse2008;34(5):642‐52. [PUBMED: 18821458] ">Carpenter 2008</a>; <a href="./references#CD009501-bbs2-0005" title="LydeckerKP , TateSR , CumminsKM , McQuaidJ , GranholmE , BrownSA . Clinical outcomes of an integrated treatment for depression and substance use disorders. Psychology of Addictive Behaviors2010;24(3):453‐65. [PUBMED: 20853931] WorleyMJ , TateSR , McQuaidJR , GranholmEL , BrownSA . 12‐step affiliation and attendance following treatment for comorbid substance dependence and depression: a latent growth curve mediation model. Substance Abuse2013;34(1):43‐50. [PUBMED: 23327503] WorleyMJ , TrimRS , RoeschSC , Mrnak‐MeyerJ , TateSR , BrownSA . Comorbid depression and substance use disorder: longitudinal associations between symptoms in a controlled trial. Journal of Substance Abuse Treatment2012;43(3):291‐302. [PUBMED: 22406052] ">Lydecker 2010</a>). Between‐group differences in the number of sessions participants completed were reported in two studies (<a href="./references#CD009501-bbs2-0001" title="BeutlerLE , MoleiroC , MarlikM , HarwoodTM , RomanelliR , Gallagher‐ThompsonD , et al. A comparison of the dodo, EST, and ATI factors among comorbid stimulant‐dependent, depressed patients. Clinical Psychology &amp; Psychotherapy2003;10(2):69‐85. [DOI: 10.1002/cpp.354] ">Beutler 2003</a>; <a href="./references#CD009501-bbs2-0007" title="RohdeP , WaldronHB , TurnerCW , BrodyJ , JorgensenJ . Sequenced versus coordinated treatment for adolescents with comorbid depressive and substance use disorders. Journal of Consulting and Clinical Psychology2014;82(2):342‐8. [PUBMED: 24491069] ">Rohde 2014</a>). </p> <p>Outcome assessments: high risk of attrition bias (defined as ≥50% in at least one group) was found in three studies at post‐treatment (<a href="./references#CD009501-bbs2-0001" title="BeutlerLE , MoleiroC , MarlikM , HarwoodTM , RomanelliR , Gallagher‐ThompsonD , et al. A comparison of the dodo, EST, and ATI factors among comorbid stimulant‐dependent, depressed patients. Clinical Psychology &amp; Psychotherapy2003;10(2):69‐85. [DOI: 10.1002/cpp.354] ">Beutler 2003</a>; <a href="./references#CD009501-bbs2-0002" title="BrownSA , Glasner‐EdwardsSV , TateSR , McQuaidJR , ChalekianJ , GranholmE . Integrated cognitive behavioral therapy versus twelve‐step facilitation therapy for substance‐dependent adults with depressive disorders. Journal of Psychoactive Drugs2006;38(4):449‐60. [PUBMED: 17373561] ">Brown 2006</a>; <a href="./references#CD009501-bbs2-0003" title="CarpenterKM , SmithJL , AharonovichE , NunesEV . Developing therapies for depression in drug dependence: results of a stage 1 therapy study. American Journal of Drug and Alcohol Abuse2008;34(5):642‐52. [PUBMED: 18821458] ">Carpenter 2008</a>) and two studies at follow‐up (<a href="./references#CD009501-bbs2-0001" title="BeutlerLE , MoleiroC , MarlikM , HarwoodTM , RomanelliR , Gallagher‐ThompsonD , et al. A comparison of the dodo, EST, and ATI factors among comorbid stimulant‐dependent, depressed patients. Clinical Psychology &amp; Psychotherapy2003;10(2):69‐85. [DOI: 10.1002/cpp.354] ">Beutler 2003</a>; <a href="./references#CD009501-bbs2-0002" title="BrownSA , Glasner‐EdwardsSV , TateSR , McQuaidJR , ChalekianJ , GranholmE . Integrated cognitive behavioral therapy versus twelve‐step facilitation therapy for substance‐dependent adults with depressive disorders. Journal of Psychoactive Drugs2006;38(4):449‐60. [PUBMED: 17373561] ">Brown 2006</a>). One study in which one of the treatment groups had double the attrition rate at post‐treatment was considered high‐risk (<a href="./references#CD009501-bbs2-0006" title="MarkowitzJC , KocsusJH , ChristosP , BleibergK , CarlinA . Pilot study of interpersonal psychotherapy versus supportive psychotherapy for dysthymic patients with secondary alcohol abuse or dependence. Journal of Nervous and Mental Disease2008;196(6):468‐74. [PUBMED: 18552624] ">Markowitz 2008</a>). Attrition rates were typically between 20% and 30% in two other studies (<a href="./references#CD009501-bbs2-0005" title="LydeckerKP , TateSR , CumminsKM , McQuaidJ , GranholmE , BrownSA . Clinical outcomes of an integrated treatment for depression and substance use disorders. Psychology of Addictive Behaviors2010;24(3):453‐65. [PUBMED: 20853931] WorleyMJ , TateSR , McQuaidJR , GranholmEL , BrownSA . 12‐step affiliation and attendance following treatment for comorbid substance dependence and depression: a latent growth curve mediation model. Substance Abuse2013;34(1):43‐50. [PUBMED: 23327503] WorleyMJ , TrimRS , RoeschSC , Mrnak‐MeyerJ , TateSR , BrownSA . Comorbid depression and substance use disorder: longitudinal associations between symptoms in a controlled trial. Journal of Substance Abuse Treatment2012;43(3):291‐302. [PUBMED: 22406052] ">Lydecker 2010</a>; <a href="./references#CD009501-bbs2-0007" title="RohdeP , WaldronHB , TurnerCW , BrodyJ , JorgensenJ . Sequenced versus coordinated treatment for adolescents with comorbid depressive and substance use disorders. Journal of Consulting and Clinical Psychology2014;82(2):342‐8. [PUBMED: 24491069] ">Rohde 2014</a>) and one study among incarcerated females reported zero attrition (<a href="./references#CD009501-bbs2-0004" title="JohnsonJE , ZlotnickC . Pilot study of treatment for major depression among women prisoners with substance use disorder. Journal of Psychiatric Research2012;46(9):1174‐83. [PUBMED: 22694906] ">Johnson 2012</a>). </p> <p>Missing data/Intent‐to‐treat (ITT) analysis: three studies used the last observation carried forward (LOCF) method to manage missing data (<a href="./references#CD009501-bbs2-0001" title="BeutlerLE , MoleiroC , MarlikM , HarwoodTM , RomanelliR , Gallagher‐ThompsonD , et al. A comparison of the dodo, EST, and ATI factors among comorbid stimulant‐dependent, depressed patients. Clinical Psychology &amp; Psychotherapy2003;10(2):69‐85. [DOI: 10.1002/cpp.354] ">Beutler 2003</a>; <a href="./references#CD009501-bbs2-0003" title="CarpenterKM , SmithJL , AharonovichE , NunesEV . Developing therapies for depression in drug dependence: results of a stage 1 therapy study. American Journal of Drug and Alcohol Abuse2008;34(5):642‐52. [PUBMED: 18821458] ">Carpenter 2008</a>; <a href="./references#CD009501-bbs2-0006" title="MarkowitzJC , KocsusJH , ChristosP , BleibergK , CarlinA . Pilot study of interpersonal psychotherapy versus supportive psychotherapy for dysthymic patients with secondary alcohol abuse or dependence. Journal of Nervous and Mental Disease2008;196(6):468‐74. [PUBMED: 18552624] ">Markowitz 2008</a>) and one imputed missing data, using Markov Chain Monte Carlo multiple imputation (<a href="./references#CD009501-bbs2-0007" title="RohdeP , WaldronHB , TurnerCW , BrodyJ , JorgensenJ . Sequenced versus coordinated treatment for adolescents with comorbid depressive and substance use disorders. Journal of Consulting and Clinical Psychology2014;82(2):342‐8. [PUBMED: 24491069] ">Rohde 2014</a>). All but one study usedITT analyses (<a href="./references#CD009501-bbs2-0002" title="BrownSA , Glasner‐EdwardsSV , TateSR , McQuaidJR , ChalekianJ , GranholmE . Integrated cognitive behavioral therapy versus twelve‐step facilitation therapy for substance‐dependent adults with depressive disorders. Journal of Psychoactive Drugs2006;38(4):449‐60. [PUBMED: 17373561] ">Brown 2006</a>). This study also excluded treatment dropouts (attended &lt; 8 treatment sessions) and participants who missed two or more follow‐up assessments from the analyses and was judged to be at very high risk of attrition bias. </p> </section> <section id="CD009501-sec-0069"> <h4 class="title">Selective reporting</h4> <p>Risk of selective reporting was unclear in all seven studies, as none of them had a published study protocol available. However, the results of all planned analyses using the outcome listed in the methods section are reported in the manuscripts. Two studies did not conduct or report the results of endpoint analyses at all follow‐up points. Trajectory, but not endpoint analyses were conducted (three‐month follow‐up (<a href="./references#CD009501-bbs2-0002" title="BrownSA , Glasner‐EdwardsSV , TateSR , McQuaidJR , ChalekianJ , GranholmE . Integrated cognitive behavioral therapy versus twelve‐step facilitation therapy for substance‐dependent adults with depressive disorders. Journal of Psychoactive Drugs2006;38(4):449‐60. [PUBMED: 17373561] ">Brown 2006</a>; <a href="./references#CD009501-bbs2-0005" title="LydeckerKP , TateSR , CumminsKM , McQuaidJ , GranholmE , BrownSA . Clinical outcomes of an integrated treatment for depression and substance use disorders. Psychology of Addictive Behaviors2010;24(3):453‐65. [PUBMED: 20853931] WorleyMJ , TateSR , McQuaidJR , GranholmEL , BrownSA . 12‐step affiliation and attendance following treatment for comorbid substance dependence and depression: a latent growth curve mediation model. Substance Abuse2013;34(1):43‐50. [PUBMED: 23327503] WorleyMJ , TrimRS , RoeschSC , Mrnak‐MeyerJ , TateSR , BrownSA . Comorbid depression and substance use disorder: longitudinal associations between symptoms in a controlled trial. Journal of Substance Abuse Treatment2012;43(3):291‐302. [PUBMED: 22406052] ">Lydecker 2010</a>) or nine‐month follow‐up (<a href="./references#CD009501-bbs2-0005" title="LydeckerKP , TateSR , CumminsKM , McQuaidJ , GranholmE , BrownSA . Clinical outcomes of an integrated treatment for depression and substance use disorders. Psychology of Addictive Behaviors2010;24(3):453‐65. [PUBMED: 20853931] WorleyMJ , TateSR , McQuaidJR , GranholmEL , BrownSA . 12‐step affiliation and attendance following treatment for comorbid substance dependence and depression: a latent growth curve mediation model. Substance Abuse2013;34(1):43‐50. [PUBMED: 23327503] WorleyMJ , TrimRS , RoeschSC , Mrnak‐MeyerJ , TateSR , BrownSA . Comorbid depression and substance use disorder: longitudinal associations between symptoms in a controlled trial. Journal of Substance Abuse Treatment2012;43(3):291‐302. [PUBMED: 22406052] ">Lydecker 2010</a>). </p> </section> <section id="CD009501-sec-0070"> <h4 class="title">Other potential sources of bias</h4> <p><b>Fidelity ratings</b> </p> <p>All seven trials conducted fidelity ratings of the interventions, but only two were performed by independent raters (<a href="./references#CD009501-bbs2-0004" title="JohnsonJE , ZlotnickC . Pilot study of treatment for major depression among women prisoners with substance use disorder. Journal of Psychiatric Research2012;46(9):1174‐83. [PUBMED: 22694906] ">Johnson 2012</a>; <a href="./references#CD009501-bbs2-0006" title="MarkowitzJC , KocsusJH , ChristosP , BleibergK , CarlinA . Pilot study of interpersonal psychotherapy versus supportive psychotherapy for dysthymic patients with secondary alcohol abuse or dependence. Journal of Nervous and Mental Disease2008;196(6):468‐74. [PUBMED: 18552624] ">Markowitz 2008</a>). Two studies controlled for therapist allegiance and contamination effects by using separate teams of therapists to deliver the different interventions (<a href="./references#CD009501-bbs2-0001" title="BeutlerLE , MoleiroC , MarlikM , HarwoodTM , RomanelliR , Gallagher‐ThompsonD , et al. A comparison of the dodo, EST, and ATI factors among comorbid stimulant‐dependent, depressed patients. Clinical Psychology &amp; Psychotherapy2003;10(2):69‐85. [DOI: 10.1002/cpp.354] ">Beutler 2003</a>; <a href="./references#CD009501-bbs2-0006" title="MarkowitzJC , KocsusJH , ChristosP , BleibergK , CarlinA . Pilot study of interpersonal psychotherapy versus supportive psychotherapy for dysthymic patients with secondary alcohol abuse or dependence. Journal of Nervous and Mental Disease2008;196(6):468‐74. [PUBMED: 18552624] ">Markowitz 2008</a>), but it was unclear if either study tested for contamination effects. One study routinely monitored therapist belief in and satisfaction with the treatment model selected and found this was comparable across the treatment groups (<a href="./references#CD009501-bbs2-0001" title="BeutlerLE , MoleiroC , MarlikM , HarwoodTM , RomanelliR , Gallagher‐ThompsonD , et al. A comparison of the dodo, EST, and ATI factors among comorbid stimulant‐dependent, depressed patients. Clinical Psychology &amp; Psychotherapy2003;10(2):69‐85. [DOI: 10.1002/cpp.354] ">Beutler 2003</a>). Risk of bias due to poor treatment fidelity was unclear in the other four studies, although <a href="./references#CD009501-bbs2-0002" title="BrownSA , Glasner‐EdwardsSV , TateSR , McQuaidJR , ChalekianJ , GranholmE . Integrated cognitive behavioral therapy versus twelve‐step facilitation therapy for substance‐dependent adults with depressive disorders. Journal of Psychoactive Drugs2006;38(4):449‐60. [PUBMED: 17373561] ">Brown 2006</a> tested for therapist effects between and within treatment groups and reported it had no impact on the primary depression and substance use outcome variables. While all studies reported information on the number of treatment dropouts or treatment sessions attended, only one controlled for this variable in the analyses (<a href="./references#CD009501-bbs2-0005" title="LydeckerKP , TateSR , CumminsKM , McQuaidJ , GranholmE , BrownSA . Clinical outcomes of an integrated treatment for depression and substance use disorders. Psychology of Addictive Behaviors2010;24(3):453‐65. [PUBMED: 20853931] WorleyMJ , TateSR , McQuaidJR , GranholmEL , BrownSA . 12‐step affiliation and attendance following treatment for comorbid substance dependence and depression: a latent growth curve mediation model. Substance Abuse2013;34(1):43‐50. [PUBMED: 23327503] WorleyMJ , TrimRS , RoeschSC , Mrnak‐MeyerJ , TateSR , BrownSA . Comorbid depression and substance use disorder: longitudinal associations between symptoms in a controlled trial. Journal of Substance Abuse Treatment2012;43(3):291‐302. [PUBMED: 22406052] ">Lydecker 2010</a>). </p> <p><b>Concurrent treatment</b> </p> <p>Only one study (<a href="./references#CD009501-bbs2-0006" title="MarkowitzJC , KocsusJH , ChristosP , BleibergK , CarlinA . Pilot study of interpersonal psychotherapy versus supportive psychotherapy for dysthymic patients with secondary alcohol abuse or dependence. Journal of Nervous and Mental Disease2008;196(6):468‐74. [PUBMED: 18552624] ">Markowitz 2008</a>) had concurrent pharmacotherapy as an exclusion criterion. None of the remaining studies reported on medication dose or adherence. For those that reported on pharmacotherapy, the main medication prescribed was antidepressants, with 22% to 98% of participants being prescribed an antidepressant during treatment (<a href="./references#CD009501-bbs2-0002" title="BrownSA , Glasner‐EdwardsSV , TateSR , McQuaidJR , ChalekianJ , GranholmE . Integrated cognitive behavioral therapy versus twelve‐step facilitation therapy for substance‐dependent adults with depressive disorders. Journal of Psychoactive Drugs2006;38(4):449‐60. [PUBMED: 17373561] ">Brown 2006</a>; <a href="./references#CD009501-bbs2-0004" title="JohnsonJE , ZlotnickC . Pilot study of treatment for major depression among women prisoners with substance use disorder. Journal of Psychiatric Research2012;46(9):1174‐83. [PUBMED: 22694906] ">Johnson 2012</a>; <a href="./references#CD009501-bbs2-0005" title="LydeckerKP , TateSR , CumminsKM , McQuaidJ , GranholmE , BrownSA . Clinical outcomes of an integrated treatment for depression and substance use disorders. Psychology of Addictive Behaviors2010;24(3):453‐65. [PUBMED: 20853931] WorleyMJ , TateSR , McQuaidJR , GranholmEL , BrownSA . 12‐step affiliation and attendance following treatment for comorbid substance dependence and depression: a latent growth curve mediation model. Substance Abuse2013;34(1):43‐50. [PUBMED: 23327503] WorleyMJ , TrimRS , RoeschSC , Mrnak‐MeyerJ , TateSR , BrownSA . Comorbid depression and substance use disorder: longitudinal associations between symptoms in a controlled trial. Journal of Substance Abuse Treatment2012;43(3):291‐302. [PUBMED: 22406052] ">Lydecker 2010</a>; <a href="./references#CD009501-bbs2-0007" title="RohdeP , WaldronHB , TurnerCW , BrodyJ , JorgensenJ . Sequenced versus coordinated treatment for adolescents with comorbid depressive and substance use disorders. Journal of Consulting and Clinical Psychology2014;82(2):342‐8. [PUBMED: 24491069] ">Rohde 2014</a>), compared with only 1.1% to 2.7% of participants using medication to treat substance use (<a href="./references#CD009501-bbs2-0004" title="JohnsonJE , ZlotnickC . Pilot study of treatment for major depression among women prisoners with substance use disorder. Journal of Psychiatric Research2012;46(9):1174‐83. [PUBMED: 22694906] ">Johnson 2012</a>; <a href="./references#CD009501-bbs2-0005" title="LydeckerKP , TateSR , CumminsKM , McQuaidJ , GranholmE , BrownSA . Clinical outcomes of an integrated treatment for depression and substance use disorders. Psychology of Addictive Behaviors2010;24(3):453‐65. [PUBMED: 20853931] WorleyMJ , TateSR , McQuaidJR , GranholmEL , BrownSA . 12‐step affiliation and attendance following treatment for comorbid substance dependence and depression: a latent growth curve mediation model. Substance Abuse2013;34(1):43‐50. [PUBMED: 23327503] WorleyMJ , TrimRS , RoeschSC , Mrnak‐MeyerJ , TateSR , BrownSA . Comorbid depression and substance use disorder: longitudinal associations between symptoms in a controlled trial. Journal of Substance Abuse Treatment2012;43(3):291‐302. [PUBMED: 22406052] ">Lydecker 2010</a>). The exception to this is the one study that included people with methadone‐maintained opiate dependence (<a href="./references#CD009501-bbs2-0003" title="CarpenterKM , SmithJL , AharonovichE , NunesEV . Developing therapies for depression in drug dependence: results of a stage 1 therapy study. American Journal of Drug and Alcohol Abuse2008;34(5):642‐52. [PUBMED: 18821458] ">Carpenter 2008</a>). Few studies reported on the type or number of antidepressants prescribed, though when these were listed selective serotonin reuptake inhibitors (SSRls) or atypical antidepressants (<a href="./references#CD009501-bbs2-0002" title="BrownSA , Glasner‐EdwardsSV , TateSR , McQuaidJR , ChalekianJ , GranholmE . Integrated cognitive behavioral therapy versus twelve‐step facilitation therapy for substance‐dependent adults with depressive disorders. Journal of Psychoactive Drugs2006;38(4):449‐60. [PUBMED: 17373561] ">Brown 2006</a>) and lithium, aripiprazole, or quetiapine (<a href="./references#CD009501-bbs2-0004" title="JohnsonJE , ZlotnickC . Pilot study of treatment for major depression among women prisoners with substance use disorder. Journal of Psychiatric Research2012;46(9):1174‐83. [PUBMED: 22694906] ">Johnson 2012</a>) were described as the most commonly used antidepressants. Only one study stratified the randomisation based on antidepressant use (<a href="./references#CD009501-bbs2-0003" title="CarpenterKM , SmithJL , AharonovichE , NunesEV . Developing therapies for depression in drug dependence: results of a stage 1 therapy study. American Journal of Drug and Alcohol Abuse2008;34(5):642‐52. [PUBMED: 18821458] ">Carpenter 2008</a>). Five studies compared differences in antidepressant use between the treatment groups or controlled for antidepressant use in their analyses (<a href="./references#CD009501-bbs2-0002" title="BrownSA , Glasner‐EdwardsSV , TateSR , McQuaidJR , ChalekianJ , GranholmE . Integrated cognitive behavioral therapy versus twelve‐step facilitation therapy for substance‐dependent adults with depressive disorders. Journal of Psychoactive Drugs2006;38(4):449‐60. [PUBMED: 17373561] ">Brown 2006</a>; <a href="./references#CD009501-bbs2-0003" title="CarpenterKM , SmithJL , AharonovichE , NunesEV . Developing therapies for depression in drug dependence: results of a stage 1 therapy study. American Journal of Drug and Alcohol Abuse2008;34(5):642‐52. [PUBMED: 18821458] ">Carpenter 2008</a>; <a href="./references#CD009501-bbs2-0004" title="JohnsonJE , ZlotnickC . Pilot study of treatment for major depression among women prisoners with substance use disorder. Journal of Psychiatric Research2012;46(9):1174‐83. [PUBMED: 22694906] ">Johnson 2012</a>; <a href="./references#CD009501-bbs2-0005" title="LydeckerKP , TateSR , CumminsKM , McQuaidJ , GranholmE , BrownSA . Clinical outcomes of an integrated treatment for depression and substance use disorders. Psychology of Addictive Behaviors2010;24(3):453‐65. [PUBMED: 20853931] WorleyMJ , TateSR , McQuaidJR , GranholmEL , BrownSA . 12‐step affiliation and attendance following treatment for comorbid substance dependence and depression: a latent growth curve mediation model. Substance Abuse2013;34(1):43‐50. [PUBMED: 23327503] WorleyMJ , TrimRS , RoeschSC , Mrnak‐MeyerJ , TateSR , BrownSA . Comorbid depression and substance use disorder: longitudinal associations between symptoms in a controlled trial. Journal of Substance Abuse Treatment2012;43(3):291‐302. [PUBMED: 22406052] ">Lydecker 2010</a>; <a href="./references#CD009501-bbs2-0007" title="RohdeP , WaldronHB , TurnerCW , BrodyJ , JorgensenJ . Sequenced versus coordinated treatment for adolescents with comorbid depressive and substance use disorders. Journal of Consulting and Clinical Psychology2014;82(2):342‐8. [PUBMED: 24491069] ">Rohde 2014</a>), with two studies reporting significant differences between groups in use of antidepressants (<a href="./references#CD009501-bbs2-0004" title="JohnsonJE , ZlotnickC . Pilot study of treatment for major depression among women prisoners with substance use disorder. Journal of Psychiatric Research2012;46(9):1174‐83. [PUBMED: 22694906] ">Johnson 2012</a>; <a href="./references#CD009501-bbs2-0005" title="LydeckerKP , TateSR , CumminsKM , McQuaidJ , GranholmE , BrownSA . Clinical outcomes of an integrated treatment for depression and substance use disorders. Psychology of Addictive Behaviors2010;24(3):453‐65. [PUBMED: 20853931] WorleyMJ , TateSR , McQuaidJR , GranholmEL , BrownSA . 12‐step affiliation and attendance following treatment for comorbid substance dependence and depression: a latent growth curve mediation model. Substance Abuse2013;34(1):43‐50. [PUBMED: 23327503] WorleyMJ , TrimRS , RoeschSC , Mrnak‐MeyerJ , TateSR , BrownSA . Comorbid depression and substance use disorder: longitudinal associations between symptoms in a controlled trial. Journal of Substance Abuse Treatment2012;43(3):291‐302. [PUBMED: 22406052] ">Lydecker 2010</a>). </p> <p>One study had concurrent non‐study psychotherapy as an exclusion criterion (<a href="./references#CD009501-bbs2-0006" title="MarkowitzJC , KocsusJH , ChristosP , BleibergK , CarlinA . Pilot study of interpersonal psychotherapy versus supportive psychotherapy for dysthymic patients with secondary alcohol abuse or dependence. Journal of Nervous and Mental Disease2008;196(6):468‐74. [PUBMED: 18552624] ">Markowitz 2008</a>). A further two studies excluded people attending other psychotherapy beyond 12‐Step Community Addiction Meetings (<a href="./references#CD009501-bbs2-0002" title="BrownSA , Glasner‐EdwardsSV , TateSR , McQuaidJR , ChalekianJ , GranholmE . Integrated cognitive behavioral therapy versus twelve‐step facilitation therapy for substance‐dependent adults with depressive disorders. Journal of Psychoactive Drugs2006;38(4):449‐60. [PUBMED: 17373561] ">Brown 2006</a>; <a href="./references#CD009501-bbs2-0005" title="LydeckerKP , TateSR , CumminsKM , McQuaidJ , GranholmE , BrownSA . Clinical outcomes of an integrated treatment for depression and substance use disorders. Psychology of Addictive Behaviors2010;24(3):453‐65. [PUBMED: 20853931] WorleyMJ , TateSR , McQuaidJR , GranholmEL , BrownSA . 12‐step affiliation and attendance following treatment for comorbid substance dependence and depression: a latent growth curve mediation model. Substance Abuse2013;34(1):43‐50. [PUBMED: 23327503] WorleyMJ , TrimRS , RoeschSC , Mrnak‐MeyerJ , TateSR , BrownSA . Comorbid depression and substance use disorder: longitudinal associations between symptoms in a controlled trial. Journal of Substance Abuse Treatment2012;43(3):291‐302. [PUBMED: 22406052] ">Lydecker 2010</a>). It was unclear whether participants were permitted to attend adjunctive psychotherapy in two studies (<a href="./references#CD009501-bbs2-0001" title="BeutlerLE , MoleiroC , MarlikM , HarwoodTM , RomanelliR , Gallagher‐ThompsonD , et al. A comparison of the dodo, EST, and ATI factors among comorbid stimulant‐dependent, depressed patients. Clinical Psychology &amp; Psychotherapy2003;10(2):69‐85. [DOI: 10.1002/cpp.354] ">Beutler 2003</a>; <a href="./references#CD009501-bbs2-0003" title="CarpenterKM , SmithJL , AharonovichE , NunesEV . Developing therapies for depression in drug dependence: results of a stage 1 therapy study. American Journal of Drug and Alcohol Abuse2008;34(5):642‐52. [PUBMED: 18821458] ">Carpenter 2008</a>), and the risk of other bias was high in the remaining two studies, as participants attended adjunctive therapy and attendance at this therapy was not consistent between the treatment arms (<a href="./references#CD009501-bbs2-0004" title="JohnsonJE , ZlotnickC . Pilot study of treatment for major depression among women prisoners with substance use disorder. Journal of Psychiatric Research2012;46(9):1174‐83. [PUBMED: 22694906] ">Johnson 2012</a>; <a href="./references#CD009501-bbs2-0007" title="RohdeP , WaldronHB , TurnerCW , BrodyJ , JorgensenJ . Sequenced versus coordinated treatment for adolescents with comorbid depressive and substance use disorders. Journal of Consulting and Clinical Psychology2014;82(2):342‐8. [PUBMED: 24491069] ">Rohde 2014</a>). </p> </section> </section> <section id="CD009501-sec-0071"> <h3 class="title" id="CD009501-sec-0071">Effects of interventions</h3> <p>See: <a href="./full#CD009501-tbl-0001"><b>Summary of findings for the main comparison</b> Integrated CBT compared with Twelve Step Facilitation for co‐occurring depression and substance use disorders</a>; <a href="./full#CD009501-tbl-0002"><b>Summary of findings 2</b> Interpersonal Psychotherapy for Depression (IPT‐D) compared with Other Psychological Interventions for co‐occurring depression and substance use disorders</a> </p> <p>Due to the heterogeneity of outcomes, only two small meta‐analyses could be conducted, followed by a narrative review of the remaining studies. See <a href="./full#CD009501-tbl-0001">summary of findings Table for the main comparison</a> for Integrated Cognitive Behavioural Therapy (ICBT) versus Twelve Step Facilitation (TSF); <a href="./full#CD009501-tbl-0002">summary of findings Table 2</a> for Interpersonal Psychotherapy for Depression (IPT‐D) versus other psychological treatments. </p> <p>Primary outcomes reported include depression score, substance use and treatment retention/adherence. No studies reported information on any of the secondary outcome variables specified in the original Cochrane Review research protocol (<a href="./references#CD009501-bbs2-0208" title="HidesL , BakerA , KavanaghD , ProctorD . Psychological interventions for co‐occurring depression and substance misuse. Cochrane Database of Systematic Reviews2011, Issue 12. [DOI: 10.1002/14651858.CD009501] ">Hides 2011</a>), including functioning, quality of life, anxiety symptoms or disorders or the global clinical severity of mental health disorders. No adverse effects linked to treatments delivered were reported. </p> <section id="CD009501-sec-0072"> <h4 class="title"><i>1.</i> Integrated Cognitive Behavioural Therapy (<i>ICBT) versus Twelve Step Facilitation (TSF)</i> </h4> <p>Two studies with 296 participants compared ICBT to TSF (<a href="./references#CD009501-bbs2-0002" title="BrownSA , Glasner‐EdwardsSV , TateSR , McQuaidJR , ChalekianJ , GranholmE . Integrated cognitive behavioral therapy versus twelve‐step facilitation therapy for substance‐dependent adults with depressive disorders. Journal of Psychoactive Drugs2006;38(4):449‐60. [PUBMED: 17373561] ">Brown 2006</a>; <a href="./references#CD009501-bbs2-0005" title="LydeckerKP , TateSR , CumminsKM , McQuaidJ , GranholmE , BrownSA . Clinical outcomes of an integrated treatment for depression and substance use disorders. Psychology of Addictive Behaviors2010;24(3):453‐65. [PUBMED: 20853931] WorleyMJ , TateSR , McQuaidJR , GranholmEL , BrownSA . 12‐step affiliation and attendance following treatment for comorbid substance dependence and depression: a latent growth curve mediation model. Substance Abuse2013;34(1):43‐50. [PUBMED: 23327503] WorleyMJ , TrimRS , RoeschSC , Mrnak‐MeyerJ , TateSR , BrownSA . Comorbid depression and substance use disorder: longitudinal associations between symptoms in a controlled trial. Journal of Substance Abuse Treatment2012;43(3):291‐302. [PUBMED: 22406052] ">Lydecker 2010</a>). Both studies recruited veterans experiencing alcohol, cannabinol and/or stimulant dependence and a major depressive diagnosis. Participants were predominately white males with a mean age of 48.3 (standard deviation (SD) = 7.8). Assessments were completed at post‐treatment and at three months, and six months later. Only one of the two studies assessed outcomes at 12 months post‐treatment (<a href="./references#CD009501-bbs2-0005" title="LydeckerKP , TateSR , CumminsKM , McQuaidJ , GranholmE , BrownSA . Clinical outcomes of an integrated treatment for depression and substance use disorders. Psychology of Addictive Behaviors2010;24(3):453‐65. [PUBMED: 20853931] WorleyMJ , TateSR , McQuaidJR , GranholmEL , BrownSA . 12‐step affiliation and attendance following treatment for comorbid substance dependence and depression: a latent growth curve mediation model. Substance Abuse2013;34(1):43‐50. [PUBMED: 23327503] WorleyMJ , TrimRS , RoeschSC , Mrnak‐MeyerJ , TateSR , BrownSA . Comorbid depression and substance use disorder: longitudinal associations between symptoms in a controlled trial. Journal of Substance Abuse Treatment2012;43(3):291‐302. [PUBMED: 22406052] ">Lydecker 2010</a>). </p> <p>See: <a href="./full#CD009501-tbl-0001">summary of findings Table for the main comparison</a>. </p> <section id="CD009501-sec-0073"> <h5 class="title">Depression</h5> <p>See: <a href="./references#CD009501-fig-0007" title="">Analysis 1.1</a> ;<a href="./references#CD009501-fig-0008" title="">Analysis 1.2</a>. </p> <p>The meta‐analysis examining depression score at post‐treatment and at follow‐up consisted of 296 randomised participants.The meta‐analysis suggested that the ICBT group had higher depression scores, compared with the TSF group, at post‐treatment (mean difference (MD) 4.05, 95% confidence interval (CI) 1.43 to 6.66; 2 studies, 212 participants; <a href="./references#CD009501-fig-0007" title="">Analysis 1.1</a>), however, there did not appear to be any difference between the groups at six‐ to12‐month follow‐up (MD 1.53, 95% CI ‐1.73 to 4.79; 2 studies, 181 participants; <a href="./references#CD009501-fig-0008" title="">Analysis 1.2</a>; <a href="#CD009501-fig-0004">Figure 4</a>) follow‐up. Heterogeneity was of no importance (I² = 0%, P = 0.91; I² = 0%, P = 0.44), respectively. </p> <div class="figure" id="CD009501-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Comparison 1 Integrated CBT vs Twelve Step Facilitation, Outcome: Depression at 6‐12 months" data-id="CD009501-fig-0004" src="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 Integrated CBT vs Twelve Step Facilitation, Outcome: Depression at 6‐12 months </p> </div> </div> </div> </section> <section id="CD009501-sec-0074"> <h5 class="title">Substance use</h5> <p>See: <a href="./references#CD009501-fig-0009" title="">Analysis 1.3</a>; <a href="./references#CD009501-fig-0010" title="">Analysis 1.4</a>. </p> <p>The meta‐analysis consisting of two studies (296 participants) that compared ICBT to TSF, suggested no substantial difference between the groups in proportion of days abstinent in the past three months, as assessed by the Timeline Follow Back (TLFB), at immediately post‐treatment (MD ‐2.84, 95% CI ‐8.04 to 2.35; 2 studies, 220 participants; <a href="./references#CD009501-fig-0009" title="">Analysis 1.3</a>). At six‐to 12‐month follow‐up, the ICBT group experienced on average 10.76% more days abstinent (95% CI 3.10 to 18.42; 2 studies, 189 participants; <a href="./references#CD009501-fig-0010" title="">Analysis 1.4</a>) compared with the TSF group (<a href="#CD009501-fig-0005">Figure 5</a>). Heterogeneity was of no importance in either analysis (I² = 0%; P = 0.39; I² = 0%;P = .65), respectively. </p> <div class="figure" id="CD009501-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Comparison 1 Integrated CBT vs Twelve Step Facilitation, Outcome: Percentage of Days Abstinent at 6 to 12 months." data-id="CD009501-fig-0005" src="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 Integrated CBT vs Twelve Step Facilitation, Outcome: Percentage of Days Abstinent at 6 to 12 months. </p> </div> </div> </div> </section> <section id="CD009501-sec-0075"> <h5 class="title">Treatment attendance and retention</h5> <p>See: <a href="./references#CD009501-fig-0011" title="">Analysis 1.5</a>; <a href="./references#CD009501-fig-0012" title="">Analysis 1.6</a> </p> <p>The meta‐analysis consisting of two studies (296 participants) that compared ICBT to TSF, revealed no substantial difference between the groups in treatment retention (RR 0.95, 95% CI 0.72 to 1.25; 2 studies, 270 participants; <a href="./references#CD009501-fig-0011" title="">Analysis 1.5</a>) or attendance (MD ‐1.27, 95% CI ‐6.10 to 3.56; 2 studies, 296 participants; <a href="./references#CD009501-fig-0012" title="">Analysis 1.6</a>). Heterogeneity was substantial for both analyses (I² = 74%, P = 0.05; I2 = 67%, P = 0.08). </p> </section> </section> <section id="CD009501-sec-0076"> <h4 class="title"><i>2.</i> Interpersonal Psychotherapy for Depression (<i>IPT‐D) versus other psychological treatments</i> </h4> <p>Two studies with 64 participants compared IPT‐D with other psychological treatments, one examining Brief Supportive Psychotherapy, with a sample of patients experiencing major depression/dysthymia and secondary alcohol abuse/dependence drawn from a medical college (n = 26; <a href="./references#CD009501-bbs2-0006" title="MarkowitzJC , KocsusJH , ChristosP , BleibergK , CarlinA . Pilot study of interpersonal psychotherapy versus supportive psychotherapy for dysthymic patients with secondary alcohol abuse or dependence. Journal of Nervous and Mental Disease2008;196(6):468‐74. [PUBMED: 18552624] ">Markowitz 2008</a>); and the other examining psychoeducation, with a sample of participants experiencing major depression and a substance use disorder (including alcohol, cocaine, opiate, marijuana and sedatives/hypnotics) drawn from a female prison (n = 38; <a href="./references#CD009501-bbs2-0004" title="JohnsonJE , ZlotnickC . Pilot study of treatment for major depression among women prisoners with substance use disorder. Journal of Psychiatric Research2012;46(9):1174‐83. [PUBMED: 22694906] ">Johnson 2012</a>). Both samples were predominantly female (63%‐ to ‐100%), mostly white, with an average age of 36.4 (SD = 9.9). </p> <p>See: <a href="./full#CD009501-tbl-0002">summary of findings Table 2</a>. </p> <section id="CD009501-sec-0077"> <h5 class="title">Depression</h5> <p>See: <a href="./references#CD009501-fig-0013" title="">Analysis 2.1</a>; <a href="./references#CD009501-fig-0014" title="">Analysis 2.2</a>. </p> <p>Two studies contributed 64 participants to end‐of‐treatment analyses (eight weeks/16 weeks), and one study (<a href="./references#CD009501-bbs2-0004" title="JohnsonJE , ZlotnickC . Pilot study of treatment for major depression among women prisoners with substance use disorder. Journal of Psychiatric Research2012;46(9):1174‐83. [PUBMED: 22694906] ">Johnson 2012</a>) with 38 participants assessed three‐month post‐treatment effects. The common outcome measure used in both studies was the clinician‐rated Hamilton Rating Scale for Depression (HDRS) (17‐item and 24‐item scales were used). The end of treatment results, showed no important heterogeneity (I² = 0%; P = 0.54), and suggested participants receiving IPT‐D had lower depressive symptoms at post‐treatment than other treatment (Brief Supportive Psychotherapy/Psychoeducation; standardised mean difference (SMD) ‐0.54, 95% CI ‐1.04 to ‐0.04; I = 0%; 2 studies, 64 participants; <a href="#CD009501-fig-0006">Figure 6</a>); however, there was no evidence that this effect was maintained at follow‐up (IPT‐D versus Psychoeducation; MD 3.80, 95% CI ‐3.83 to 11.43; 1 study, 38 participants). </p> <div class="figure" id="CD009501-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Comparison 2 Interpersonal Psychotherapy for Depression (IPT‐D) vs Other Theraputic Interventions, Outcome: Depression at end of treatment." data-id="CD009501-fig-0006" src="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 2 Interpersonal Psychotherapy for Depression (IPT‐D) vs Other Theraputic Interventions, Outcome: Depression at end of treatment. </p> </div> </div> </div> </section> <section id="CD009501-sec-0078"> <h5 class="title">Substance use</h5> <p>See: <a href="./references#CD009501-fig-0015" title="">Analysis 2.3</a>; <a href="./references#CD009501-fig-0016" title="">Analysis 2.4</a>. </p> <p>Although both studies used the Timeline Follow‐Back (TLFB) (<a href="./references#CD009501-bbs2-0195" title="SobellLC , SobellMB . Timeline followback: a technique for assessing self‐reported ethanol consumption. In: JAllen , RZLitten editor(s). Measuring Alcohol Consumption: Psychosocial and Biological Methods. Totowa (NJ): Humana Press, 1992:41‐72. ">Sobell 1992</a><b>;</b> <a href="./references#CD009501-bbs2-0194" title="SobellMB , MaistoSA , SobellLC , CooperAM , CooperT , SandersB . Developing a prototype for evaluating alcohol treatment effectiveness. In: SobellLC , SobellMB , WardE editor(s). Evaluating Alcohol and Drug Abuse Treatment Effectiveness: Recent Advances. New York: Pergamon Press, 1980:129‐50. ">Sobell 1980</a>), the method of reporting this substance use outcome differed between studies, with one study examining percentage of days abstinent in the month prior to the end of treatment (<a href="./references#CD009501-bbs2-0006" title="MarkowitzJC , KocsusJH , ChristosP , BleibergK , CarlinA . Pilot study of interpersonal psychotherapy versus supportive psychotherapy for dysthymic patients with secondary alcohol abuse or dependence. Journal of Nervous and Mental Disease2008;196(6):468‐74. [PUBMED: 18552624] ">Markowitz 2008</a>), and the other examining relapse at three months post‐treatment (defined as heavy drinking (4+ drinks) or drug use on at least 10% of non‐incarcerated days or positive urine test). Due to this heterogeneity, substance use outcomes were examined separately for each study. There was no significant difference in the percentage of days abstinent in the month prior to the end of treatment when comparing IPT‐D to Brief Supportive Psychotherapy (MD ‐2.70, 95% CI ‐28.74 to 23.34; 26 participants), and no significant difference in relapse at three months post‐treatment when comparing IPT‐D to Psychoeducation (RR 0.67, 95% CI 0.30 to 1.50;38 participants). </p> </section> <section id="CD009501-sec-0079"> <h5 class="title">Treatment retention</h5> <p>See: <a href="./references#CD009501-fig-0017" title="">Analysis 2.5</a>. </p> <p>For the meta‐analysis comparing IPT‐D with other treatment (Brief supportive psychotherapy/psychoeducation), there was no significant difference between the groups in treatment retention (RR 1.00, 95% CI 0.81 to 1.23; I<sup>2</sup> = 0%; 2 studies 64 participants). </p> </section> </section> <section id="CD009501-sec-0080"> <h4 class="title">3. Integrated Functional Family Therapy (FFT) andCoping With Depression (CWD) versus sequenced FFT‐CWD; Integrated FFT and CWD versus sequenced CWD‐FFT </h4> <p>One study with 170 adolescents compared integrated FFT and CWD to sequential FFT followed by CWD, or CWD followed by FFT (<a href="./references#CD009501-bbs2-0007" title="RohdeP , WaldronHB , TurnerCW , BrodyJ , JorgensenJ . Sequenced versus coordinated treatment for adolescents with comorbid depressive and substance use disorders. Journal of Consulting and Clinical Psychology2014;82(2):342‐8. [PUBMED: 24491069] ">Rohde 2014</a>). Adolescents were aged 13 to 18 years, were predominately white (61%) males (88%) experiencing a depressive disorder (54% major depression) and comorbid substance use disorder, which was predominately a cannabis use disorder (94%), comorbid with alcohol use disorder (65%). For ease of comparison the combined treatment was compared with the sequential treatment on primary outcomes. The first row in each analysis compares integrated FFT and CWD versus sequenced FFT‐CWD; and the second row compares integrated FFT and CWD versus sequenced CWD‐FFT. Assessments were completed at post‐treatment (20 weeks) and six and 12 months later. </p> <section id="CD009501-sec-0081"> <h5 class="title">Depression</h5> <p>See: <a href="./references#CD009501-fig-0018" title="">Analysis 3.1</a>; <a href="./references#CD009501-fig-0019" title="">Analysis 3.2</a>. </p> <p>The Children’s Depression Rating Scale‐Revised (CDRS‐R), a clinician‐rated depression tool for adolescents, adapted from the HDRS, was used for all comparisons (<a href="./references#CD009501-bbs2-0189" title="PoznanskiEO , HartmutBM . Children's Depression Rating Scale, Revised (CDRS‐R). Los Angeles: Western Psychological Services, 1995. ">Poznanski 1995</a>). The analyses reported in the article were separated based on whether or not an adolescent experienced Major Depressive Disorder. The authors were contacted, and scores were obtained and are reported for the total sample. There was no difference in depression scores between the integrated treatment and either of the sequential treatments (CWD‐FFT or FFT‐CWD) immediately post‐treatment (MD ‐3.60, 95% CI ‐8.76 to 1.56; MD ‐3.49, 95% CI ‐8.08 to 1.10) or at 12‐month follow‐up (MD ‐1.44, 95% CI ‐7.98 to 5.10; MD 0.13, 95% CI ‐6.72 to 6.98). </p> </section> <section id="CD009501-sec-0082"> <h5 class="title">Substance use</h5> <p>See: <a href="./references#CD009501-fig-0020" title="">Analysis 3.3</a>; <a href="./references#CD009501-fig-0021" title="">Analysis 3.4</a>. </p> <p>The TLFB interview was used (<a href="./references#CD009501-bbs2-0181" title="MillerWR , DelBocaFK . Measurement of drinking behavior using the Form 90 family of instruments. Journal of Studies on Alcohol. Supplement1994;12:112‐8. [PUBMED: 7722987] ">Miller 1994</a>), with the square root of the percentage of past 90‐day daily use reported at all assessment points. The integrated group had higher daily substance use at post‐treatment when compared with the FFT‐CWD (MD 1.30, 95% CI 0.01 to 2.59) but not the CWD‐FFT (MD 0.60, 95% CI ‐0.69 to 1.89). At 12‐month follow‐up the integrated treatment had higher daily substance use than both the FFT‐CWD (MD 1.32, 95% CI 0.00 to 2.64) and the CWD‐FFT (MD 1.32, 95% CI 0.02 to 2.62) sequential groups. </p> </section> <section id="CD009501-sec-0083"> <h5 class="title">Treatment retention</h5> <p>See: <a href="./references#CD009501-fig-0022" title="">Analysis 3.5</a>; <a href="./references#CD009501-fig-0023" title="">Analysis 3.6</a>. </p> <p>Treatment adherence was assessed through premature termination (attending &lt; 2 sessions) and mean total session attendance (maximum sessions 24). There was no difference between integrated or sequential treatment for treatment retention (RR 0.47, 95% CI 0.15 to 1.43; RR 0.66, 95% CI 0.20 to 2.12); however, integrated treatment had higher mean treatment attendance than CWD‐FFT (MD 4.10, 95% CI 0.98 to 7.22) but not FFT‐CWD (MD 1.40, 95% CI ‐1.58 to 4.38). </p> </section> </section> <section id="CD009501-sec-0084"> <h4 class="title">4. Behavioral Therapy for Depression in Drug Dependence (BTDD) versus Relaxation Intervention (REL) </h4> <p>One study with 38 participants on methadone maintenance therapy for opiate dependence, who met criteria for a DSM‐IV depressive disorder, compared BTDD with REL (<a href="./references#CD009501-bbs2-0003" title="CarpenterKM , SmithJL , AharonovichE , NunesEV . Developing therapies for depression in drug dependence: results of a stage 1 therapy study. American Journal of Drug and Alcohol Abuse2008;34(5):642‐52. [PUBMED: 18821458] ">Carpenter 2008</a>). Participants were predominately white (58%) males (82%) with a mean age of 40.1 years (SD = 10.7). Assessments were completed immediately post‐treatment (24 weeks). </p> <section id="CD009501-sec-0085"> <h5 class="title">Depression</h5> <p>See: <a href="./references#CD009501-fig-0024" title="">Analysis 4.1</a>; <a href="./references#CD009501-fig-0025" title="">Analysis 4.2</a>. </p> <p>The the HDRS clinician interview and Beck Depression Inventory (BDI‐II) self‐report measure (<a href="./references#CD009501-bbs2-0143" title="BeckAT , SteerRA , BrownGK . Beck Depression Inventory‐Second Edition Manual. San Antonio: The Psychological Corporation, 1996. ">Beck 1996</a>) were used to assess post‐treatment depression outcomes. Evidence suggested no difference in depression scores for participants receiving BTDD compared with REL, for either the clinician‐rated HDRS (MD 2.10, 95% CI ‐6.03 to 10.23; 24 participants) or the self‐reported BDI‐II (MD 6.60, 95% CI ‐4.94 to 18.14; 24 participants). </p> </section> <section id="CD009501-sec-0086"> <h5 class="title">Substance use</h5> <p>See: <a href="./references#CD009501-fig-0026" title="">Analysis 4.3</a>; <a href="./references#CD009501-fig-0027" title="">Analysis 4.4</a>; <a href="./references#CD009501-fig-0028" title="">Analysis 4.5</a>. </p> <p>The Substance Use Weekly Inventory (SUI), a modification of the TLFB (<a href="./references#CD009501-bbs2-0194" title="SobellMB , MaistoSA , SobellLC , CooperAM , CooperT , SandersB . Developing a prototype for evaluating alcohol treatment effectiveness. In: SobellLC , SobellMB , WardE editor(s). Evaluating Alcohol and Drug Abuse Treatment Effectiveness: Recent Advances. New York: Pergamon Press, 1980:129‐50. ">Sobell 1980</a>), was used at the beginning of each treatment session to assess the past week number of substance‐using days, with substance use confirmed through a urine test. In the study results, proportion of weeks substances were used was only reported for opiates, cocaine and benzodiazepines. There were no significant differences in the proportion of weeks opiates (MD 0.11, 95% CI ‐0.09 to 0.31; 24 participants), cocaine (MD 0.10, 95% CI ‐0.13 to 0.33; 24 participants), and benzodiazepines (MD 0.02, 95% CI ‐0.21 to 0.25; 24 participants) were used throughout treatment. </p> </section> <section id="CD009501-sec-0087"> <h5 class="title">Treatment retention</h5> <p>See: <a href="./references#CD009501-fig-0029" title="">Analysis 4.6</a> </p> <p>Treatment adherence was examined through the average total session attendance (maximum sessions 24), with no significant difference between the two groups in treatment attendance (MD ‐3.70, 95% CI ‐7.83 to 0.43; 38 participants). </p> </section> </section> <section id="CD009501-sec-0088"> <h4 class="title">5. Cognitive Therapy (CT) versus Narrative Therapy (NT) versus Prescriptive Therapy (PT) </h4> <p>One study with 40 patients experiencing comorbid DSM‐IV depression disorder and stimulant (cocaine or methamphetamine) dependence, compared CT, NT and PT (<a href="./references#CD009501-bbs2-0001" title="BeutlerLE , MoleiroC , MarlikM , HarwoodTM , RomanelliR , Gallagher‐ThompsonD , et al. A comparison of the dodo, EST, and ATI factors among comorbid stimulant‐dependent, depressed patients. Clinical Psychology &amp; Psychotherapy2003;10(2):69‐85. [DOI: 10.1002/cpp.354] ">Beutler 2003</a>). Participants were predominately white (75%) males (57%) with a mean age of 33.1 years (SD = 1.83). Assessments were completed immediately post‐treatment (20 weeks) and six months post‐treatment. Given the very small sample size, and the multiple comparisons that would be required to be conducted between treatment conditions, a narrative review of findings is presented below. </p> <section id="CD009501-sec-0089"> <h5 class="title">Depression</h5> <p>Depression scores were assessed through the Beck Depression Inventory (BDI; <a href="./references#CD009501-bbs2-0140" title="BeckAT , WardCH , MendelsonM , MockJ , ErbaughJ . An inventory for measuring depression. Archives of General Psychiatry1961;4:561‐9. [PUBMED: 13688369] ">Beck 1961</a>) and the HDRS. No differences between treatments were reported on either of these measures. </p> </section> <section id="CD009501-sec-0090"> <h5 class="title">Substance use</h5> <p>A modified TLFB (<a href="./references#CD009501-bbs2-0195" title="SobellLC , SobellMB . Timeline followback: a technique for assessing self‐reported ethanol consumption. In: JAllen , RZLitten editor(s). Measuring Alcohol Consumption: Psychosocial and Biological Methods. Totowa (NJ): Humana Press, 1992:41‐72. ">Sobell 1992</a>) was used to assess past 30‐day mean days per week of reported substance use, the Addiction Severity Index (ASI; <a href="./references#CD009501-bbs2-0179" title="McLellanAT , LuborskyL , WoodyGE , O’BrienCP . An improved diagnostic instrument for substance abuse patients: The Addiction Severity Index.. Journal of Nervous and Mental Disease1980;168:26‐33. ">McLellan 1980</a>) was used to create alcohol and drug index scores and urine samples were also conducted to determine abstinence of participants. There was no reported difference between treatment conditions for clean urine samples or reported abstinence, or on the TLFB or ASI. </p> </section> <section id="CD009501-sec-0091"> <h5 class="title">Treatment retention</h5> <p>Dropout was assessed as failure to attend three consecutive appointments. The study reported that the NT condition had lower dropout rates than with PT or CT, but no other information was provided. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD009501-sec-0092" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD009501-sec-0092"></div> <section id="CD009501-sec-0093"> <h3 class="title" id="CD009501-sec-0093">Summary of main results</h3> <p>This review assessed the efficacy of psychological interventions alone or in combination with pharmacotherapy for comorbid depression and substance use disorders. Seven RCTs with a total of 608 participants were included. All studies compared different types of psychological interventions; no studies combining psychological interventions with pharmacotherapy; or comparing psychological interventions with no treatment, treatment as usual or delayed treatment control conditions were found. </p> <p>Two studies compared Integrated Cognitive Behavioural Therapy (ICBT( with Twelve Step Facilitation (TSF), another two studies compared Interpersonal Psychotherapy for Depression (IPT‐D) with other treatment (Brief Supportive Therapy or Psychoeducation), a fifth study compared the integrated delivery of Functional Family Therapy (FFT) and Coping With Depression (CWD) with two sequenced methods (CWD then FFT; FFT then CWD), a sixth study compared Behavioral Therapy for Depression in Drug Dependence (BTDD) with a relaxation intervention, and the final study compared cognitive therapy (CT), narrative therapy (NT) and prescriptive therapy (PT). </p> <p>Due to heterogeneity in outcomes only two meta‐analyses were conducted. The first meta‐analysis focused on the two studies comparing ICBT versus TSF (see <a href="./full#CD009501-tbl-0001">summary of findings Table for the main comparison</a>). Very low‐quality evidence indicated there was no difference in depression symptoms, treatment attendance or retention outcomes at post‐treatment or follow‐up, but a significant improvement in substance use outcomes in favour of the ICBT was found at six‐ to 12‐month follow‐up. </p> <p>The second meta‐analysis, conducted with two studies, compared IPT‐D with other treatment (Brief Supportive Psychotherapy/Psychoeducation) (see <a href="./full#CD009501-tbl-0002">summary of findings Table 2</a>), and found very low‐quality evidence that IPT‐D resulted in lower depressive symptoms at post‐treatment than other treatment, but this effect was not maintained at three‐‐month follow‐up. No significant differences between the groups in treatment retention were found. Substance use was examined separately in each study due to heterogeneity in outcomes. No significant differences in these outcomes (percentage of days abstinent, risk of relapse) were found. </p> <p>The two other studies, which compared different cognitive behavioural therapy (CBT) interventions (BTDD; CT) with other psychological treatments (Relaxation; NT or PT) found no significant differences on depression, substance use or treatment retention outcomes. The seventh study found integrated FFT and CWD had higher treatment attendance rates than the sequenced treatments but worse substance use outcomes but than the CWD‐FFT group at post‐treatment and both the CWD‐FFT and FFT‐CWD groups at 12‐month follow‐up. </p> </section> <section id="CD009501-sec-0094"> <h3 class="title" id="CD009501-sec-0094">Overall completeness and applicability of evidence</h3> <p>The seven studies identified are insufficient to address the objectives of this review. All included studies were conducted in the USA, which limits their applicability to other contexts. Moreover, the studies that were included in the meta‐analyses were from quite specific populations (i.e. veterans, incarcerated females), with a lack of variation in country source (i.e. all from the USA) or participant demographics (i.e. predominately Caucasian), which also questions the wider application of the findings. </p> <p>It was difficult to compare the results of studies, as even though five studies compared CBT and two compared IPT‐D with other psychological interventions, there was wide variability in the type of CBT (e.g. cognitive therapy, behaviour therapy) and other psychological treatments compared, as well as the treatment target (depression, substance use, depression and substance use), content, intensity/length and mode of delivery (e.g. group, individual, family). There was also wide variability in the definitions and measures of depression, substance use outcomes use and treatment dropout/retention used across the seven studies. The treatment population also varied considerably ranging from veterans and female prisoners to community adults and adolescents potentially limiting the applicability of results to these particular populations. While requiring all study participants to have comorbid depression and substance use disorders strengthened the internal validity of the review, clinicians in real‐world settings treat only individuals with substance use and depression problems of varying severity, not only people with fully established disorders. Clinicians are also likely to treat individuals with other comorbid presentations (e.g. substance use, depression and anxiety problems). This limits the external validity of the review. </p> </section> <section id="CD009501-sec-0095"> <h3 class="title" id="CD009501-sec-0095">Quality of the evidence</h3> <p>All seven studies were at high risk of performance bias. Two of six studies were at high risk of selection bias due to inadequate random sequence generation (<a href="./references#CD009501-bbs2-0002" title="BrownSA , Glasner‐EdwardsSV , TateSR , McQuaidJR , ChalekianJ , GranholmE . Integrated cognitive behavioral therapy versus twelve‐step facilitation therapy for substance‐dependent adults with depressive disorders. Journal of Psychoactive Drugs2006;38(4):449‐60. [PUBMED: 17373561] ">Brown 2006</a>; <a href="./references#CD009501-bbs2-0005" title="LydeckerKP , TateSR , CumminsKM , McQuaidJ , GranholmE , BrownSA . Clinical outcomes of an integrated treatment for depression and substance use disorders. Psychology of Addictive Behaviors2010;24(3):453‐65. [PUBMED: 20853931] WorleyMJ , TateSR , McQuaidJR , GranholmEL , BrownSA . 12‐step affiliation and attendance following treatment for comorbid substance dependence and depression: a latent growth curve mediation model. Substance Abuse2013;34(1):43‐50. [PUBMED: 23327503] WorleyMJ , TrimRS , RoeschSC , Mrnak‐MeyerJ , TateSR , BrownSA . Comorbid depression and substance use disorder: longitudinal associations between symptoms in a controlled trial. Journal of Substance Abuse Treatment2012;43(3):291‐302. [PUBMED: 22406052] ">Lydecker 2010</a>). Two studies were at high risk for detection bias due to the use of non‐blinded interview raters (<a href="./references#CD009501-bbs2-0003" title="CarpenterKM , SmithJL , AharonovichE , NunesEV . Developing therapies for depression in drug dependence: results of a stage 1 therapy study. American Journal of Drug and Alcohol Abuse2008;34(5):642‐52. [PUBMED: 18821458] ">Carpenter 2008</a>; <a href="./references#CD009501-bbs2-0005" title="LydeckerKP , TateSR , CumminsKM , McQuaidJ , GranholmE , BrownSA . Clinical outcomes of an integrated treatment for depression and substance use disorders. Psychology of Addictive Behaviors2010;24(3):453‐65. [PUBMED: 20853931] WorleyMJ , TateSR , McQuaidJR , GranholmEL , BrownSA . 12‐step affiliation and attendance following treatment for comorbid substance dependence and depression: a latent growth curve mediation model. Substance Abuse2013;34(1):43‐50. [PUBMED: 23327503] WorleyMJ , TrimRS , RoeschSC , Mrnak‐MeyerJ , TateSR , BrownSA . Comorbid depression and substance use disorder: longitudinal associations between symptoms in a controlled trial. Journal of Substance Abuse Treatment2012;43(3):291‐302. [PUBMED: 22406052] ">Lydecker 2010</a>). All four studies that reported self‐report outcomes were at unclear risk of detection bias (<a href="./references#CD009501-bbs2-0001" title="BeutlerLE , MoleiroC , MarlikM , HarwoodTM , RomanelliR , Gallagher‐ThompsonD , et al. A comparison of the dodo, EST, and ATI factors among comorbid stimulant‐dependent, depressed patients. Clinical Psychology &amp; Psychotherapy2003;10(2):69‐85. [DOI: 10.1002/cpp.354] ">Beutler 2003</a>; <a href="./references#CD009501-bbs2-0003" title="CarpenterKM , SmithJL , AharonovichE , NunesEV . Developing therapies for depression in drug dependence: results of a stage 1 therapy study. American Journal of Drug and Alcohol Abuse2008;34(5):642‐52. [PUBMED: 18821458] ">Carpenter 2008</a>; <a href="./references#CD009501-bbs2-0006" title="MarkowitzJC , KocsusJH , ChristosP , BleibergK , CarlinA . Pilot study of interpersonal psychotherapy versus supportive psychotherapy for dysthymic patients with secondary alcohol abuse or dependence. Journal of Nervous and Mental Disease2008;196(6):468‐74. [PUBMED: 18552624] ">Markowitz 2008</a>; <a href="./references#CD009501-bbs2-0007" title="RohdeP , WaldronHB , TurnerCW , BrodyJ , JorgensenJ . Sequenced versus coordinated treatment for adolescents with comorbid depressive and substance use disorders. Journal of Consulting and Clinical Psychology2014;82(2):342‐8. [PUBMED: 24491069] ">Rohde 2014</a>) and four of the seven studies were at high risk of attrition bias (<a href="./references#CD009501-bbs2-0001" title="BeutlerLE , MoleiroC , MarlikM , HarwoodTM , RomanelliR , Gallagher‐ThompsonD , et al. A comparison of the dodo, EST, and ATI factors among comorbid stimulant‐dependent, depressed patients. Clinical Psychology &amp; Psychotherapy2003;10(2):69‐85. [DOI: 10.1002/cpp.354] ">Beutler 2003</a>; <a href="./references#CD009501-bbs2-0002" title="BrownSA , Glasner‐EdwardsSV , TateSR , McQuaidJR , ChalekianJ , GranholmE . Integrated cognitive behavioral therapy versus twelve‐step facilitation therapy for substance‐dependent adults with depressive disorders. Journal of Psychoactive Drugs2006;38(4):449‐60. [PUBMED: 17373561] ">Brown 2006</a>; <a href="./references#CD009501-bbs2-0003" title="CarpenterKM , SmithJL , AharonovichE , NunesEV . Developing therapies for depression in drug dependence: results of a stage 1 therapy study. American Journal of Drug and Alcohol Abuse2008;34(5):642‐52. [PUBMED: 18821458] ">Carpenter 2008</a>; <a href="./references#CD009501-bbs2-0006" title="MarkowitzJC , KocsusJH , ChristosP , BleibergK , CarlinA . Pilot study of interpersonal psychotherapy versus supportive psychotherapy for dysthymic patients with secondary alcohol abuse or dependence. Journal of Nervous and Mental Disease2008;196(6):468‐74. [PUBMED: 18552624] ">Markowitz 2008</a>). Risk of selective reporting was unclear in all seven studies, as none had published research protocols. Due to heterogeneity in outcomes only two meta‐analyses were performed, each comprised of two studies. </p> <p>The quality of evidence of the meta‐analysis comparing IPT‐D studies with other treatment (Brief Supportive Psychotherapy /Psychoeducation) was very low for assessing its impact on depression and for the substance use and treatment retention outcomes. The meta‐analysis comparing ICBT to TSF also provided very low‐quality evidence for all outcomes. Moreover, other methodological flaws in the seven studies included the use of small sample sizes (<a href="./references#CD009501-bbs2-0002" title="BrownSA , Glasner‐EdwardsSV , TateSR , McQuaidJR , ChalekianJ , GranholmE . Integrated cognitive behavioral therapy versus twelve‐step facilitation therapy for substance‐dependent adults with depressive disorders. Journal of Psychoactive Drugs2006;38(4):449‐60. [PUBMED: 17373561] ">Brown 2006</a>; <a href="./references#CD009501-bbs2-0003" title="CarpenterKM , SmithJL , AharonovichE , NunesEV . Developing therapies for depression in drug dependence: results of a stage 1 therapy study. American Journal of Drug and Alcohol Abuse2008;34(5):642‐52. [PUBMED: 18821458] ">Carpenter 2008</a>; <a href="./references#CD009501-bbs2-0004" title="JohnsonJE , ZlotnickC . Pilot study of treatment for major depression among women prisoners with substance use disorder. Journal of Psychiatric Research2012;46(9):1174‐83. [PUBMED: 22694906] ">Johnson 2012</a>; <a href="./references#CD009501-bbs2-0006" title="MarkowitzJC , KocsusJH , ChristosP , BleibergK , CarlinA . Pilot study of interpersonal psychotherapy versus supportive psychotherapy for dysthymic patients with secondary alcohol abuse or dependence. Journal of Nervous and Mental Disease2008;196(6):468‐74. [PUBMED: 18552624] ">Markowitz 2008</a>), the reporting of only post‐treatment outcomes (<a href="./references#CD009501-bbs2-0001" title="BeutlerLE , MoleiroC , MarlikM , HarwoodTM , RomanelliR , Gallagher‐ThompsonD , et al. A comparison of the dodo, EST, and ATI factors among comorbid stimulant‐dependent, depressed patients. Clinical Psychology &amp; Psychotherapy2003;10(2):69‐85. [DOI: 10.1002/cpp.354] ">Beutler 2003</a>; <a href="./references#CD009501-bbs2-0003" title="CarpenterKM , SmithJL , AharonovichE , NunesEV . Developing therapies for depression in drug dependence: results of a stage 1 therapy study. American Journal of Drug and Alcohol Abuse2008;34(5):642‐52. [PUBMED: 18821458] ">Carpenter 2008</a>; <a href="./references#CD009501-bbs2-0006" title="MarkowitzJC , KocsusJH , ChristosP , BleibergK , CarlinA . Pilot study of interpersonal psychotherapy versus supportive psychotherapy for dysthymic patients with secondary alcohol abuse or dependence. Journal of Nervous and Mental Disease2008;196(6):468‐74. [PUBMED: 18552624] ">Markowitz 2008</a>) or short‐term outcomes (<a href="./references#CD009501-bbs2-0004" title="JohnsonJE , ZlotnickC . Pilot study of treatment for major depression among women prisoners with substance use disorder. Journal of Psychiatric Research2012;46(9):1174‐83. [PUBMED: 22694906] ">Johnson 2012</a>), and the uneven group distribution of adjunctive treatment (both pharmacological and psychosocial). While all studies conducted treatment fidelity ratings, risk of bias was unclear in all but the two studies in which the fidelity ratings were performed by independent raters, and no studies tested for possible contamination effects in the control conditions. </p> </section> <section id="CD009501-sec-0096"> <h3 class="title" id="CD009501-sec-0096">Potential biases in the review process</h3> <p>There was low risk of publication bias, as a comprehensive search of published and unpublished studies without any language restrictions was conducted. Nevertheless, there is a chance some trials were missed during the search including unpublished studies, particularly those with negative results; as well as some studies in non‐English languages. A funnel plot to assess publication bias was not constructed due to the small number of studies. The authors of studies that did not report the data required to complete the review were contacted. All responded and provided the relevant data. </p> </section> <section id="CD009501-sec-0097"> <h3 class="title" id="CD009501-sec-0097">Agreements and disagreements with other studies or reviews</h3> <p>The findings of this review are consistent with other meta‐analyses and narrative systematic reviews of the literature, which have found insufficient empirical support to inform psychological treatments for comorbid substance use disorders and depression (<a href="./references#CD009501-bbs2-0136" title="BabowitchJD , AntshelKM . Adolescent treatment outcomes for comorbid depression and substance misuse: a systematic review and synthesis of the literature. Journal of Affective Disorders2016;201:25‐33. [PUBMED: 27156096] ">Babowitch 2016</a>; <a href="./references#CD009501-bbs2-0139" title="BakerAL , ThorntonLK , HilesS , HidesL , LubmanDI . Psychological interventions for alcohol misuse among people with co‐occurring depression or anxiety disorders: a systematic review. Journal of Affective Disorders2012;139(3):217‐29. [DOI: 10.1016/j.jad.2011.08.004] ">Baker 2012</a>; <a href="./references#CD009501-bbs2-0167" title="HesseM . Integrated psychological treatment for substance use and co‐morbid anxiety or depression vs. treatment for substance use alone. A systematic review of the published literature. BMC Psychiatry2009;9:6. [PUBMED: 19232121] ">Hesse 2009</a>; <a href="./references#CD009501-bbs2-0169" title="HobdenB , BryantJ , CareyM , BakerAL , Farrell M. OldmeadowC , et al. Finding the optimal treatment model: A systematic review of treatment for co‐occurring alcohol misuse and depression. Australian &amp; New Zealand Journal of Psychiatry2018;52(8):737‐50. [DOI: 10.1177/0004867418758922] ">Hobden 2018</a>; <a href="./references#CD009501-bbs2-0191" title="RiperH , AnderssonG , HunterSB , deWitJ , BerkingM , CuijpersP . Treatment of comorbid alcohol use disorders and depression with cognitive‐behavioural therapy and motivational interviewing: a meta‐analysis. Addiction (Abingdon, England)2014;109(3):394‐406. [PUBMED: 24304463] ">Riper 2014</a>). Previous reviews have focused on adolescent (<a href="./references#CD009501-bbs2-0136" title="BabowitchJD , AntshelKM . Adolescent treatment outcomes for comorbid depression and substance misuse: a systematic review and synthesis of the literature. Journal of Affective Disorders2016;201:25‐33. [PUBMED: 27156096] ">Babowitch 2016</a>) and adult (<a href="./references#CD009501-bbs2-0139" title="BakerAL , ThorntonLK , HilesS , HidesL , LubmanDI . Psychological interventions for alcohol misuse among people with co‐occurring depression or anxiety disorders: a systematic review. Journal of Affective Disorders2012;139(3):217‐29. [DOI: 10.1016/j.jad.2011.08.004] ">Baker 2012</a>; <a href="./references#CD009501-bbs2-0167" title="HesseM . Integrated psychological treatment for substance use and co‐morbid anxiety or depression vs. treatment for substance use alone. A systematic review of the published literature. BMC Psychiatry2009;9:6. [PUBMED: 19232121] ">Hesse 2009</a>; <a href="./references#CD009501-bbs2-0169" title="HobdenB , BryantJ , CareyM , BakerAL , Farrell M. OldmeadowC , et al. Finding the optimal treatment model: A systematic review of treatment for co‐occurring alcohol misuse and depression. Australian &amp; New Zealand Journal of Psychiatry2018;52(8):737‐50. [DOI: 10.1177/0004867418758922] ">Hobden 2018</a>) populations, and on a wide variety of psychological treatments including CBT, FFT, IPT‐D and TSF. Most of the previous reviews found CBT to be the most popular therapy investigated, and all four of the reviews included studies with integrated motivational interviewing/CBT treatments, with one study only investigating the efficacy of motivational interviewing/CBT in treating comorbid alcohol use disorders and depression (<a href="./references#CD009501-bbs2-0191" title="RiperH , AnderssonG , HunterSB , deWitJ , BerkingM , CuijpersP . Treatment of comorbid alcohol use disorders and depression with cognitive‐behavioural therapy and motivational interviewing: a meta‐analysis. Addiction (Abingdon, England)2014;109(3):394‐406. [PUBMED: 24304463] ">Riper 2014</a>). </p> <p>Previous reviews have highlighted the promise of integrated approaches (<a href="./references#CD009501-bbs2-0167" title="HesseM . Integrated psychological treatment for substance use and co‐morbid anxiety or depression vs. treatment for substance use alone. A systematic review of the published literature. BMC Psychiatry2009;9:6. [PUBMED: 19232121] ">Hesse 2009</a>), particularly those that integrate motivational interviewing and CBT (<a href="./references#CD009501-bbs2-0136" title="BabowitchJD , AntshelKM . Adolescent treatment outcomes for comorbid depression and substance misuse: a systematic review and synthesis of the literature. Journal of Affective Disorders2016;201:25‐33. [PUBMED: 27156096] ">Babowitch 2016</a>; <a href="./references#CD009501-bbs2-0139" title="BakerAL , ThorntonLK , HilesS , HidesL , LubmanDI . Psychological interventions for alcohol misuse among people with co‐occurring depression or anxiety disorders: a systematic review. Journal of Affective Disorders2012;139(3):217‐29. [DOI: 10.1016/j.jad.2011.08.004] ">Baker 2012</a>; <a href="./references#CD009501-bbs2-0169" title="HobdenB , BryantJ , CareyM , BakerAL , Farrell M. OldmeadowC , et al. Finding the optimal treatment model: A systematic review of treatment for co‐occurring alcohol misuse and depression. Australian &amp; New Zealand Journal of Psychiatry2018;52(8):737‐50. [DOI: 10.1177/0004867418758922] ">Hobden 2018</a>; <a href="./references#CD009501-bbs2-0191" title="RiperH , AnderssonG , HunterSB , deWitJ , BerkingM , CuijpersP . Treatment of comorbid alcohol use disorders and depression with cognitive‐behavioural therapy and motivational interviewing: a meta‐analysis. Addiction (Abingdon, England)2014;109(3):394‐406. [PUBMED: 24304463] ">Riper 2014</a>). Small but significant effect sizes have been found for integrated motivational interviewing/CBT in both adolescent (<a href="./references#CD009501-bbs2-0136" title="BabowitchJD , AntshelKM . Adolescent treatment outcomes for comorbid depression and substance misuse: a systematic review and synthesis of the literature. Journal of Affective Disorders2016;201:25‐33. [PUBMED: 27156096] ">Babowitch 2016</a>) and adult (<a href="./references#CD009501-bbs2-0139" title="BakerAL , ThorntonLK , HilesS , HidesL , LubmanDI . Psychological interventions for alcohol misuse among people with co‐occurring depression or anxiety disorders: a systematic review. Journal of Affective Disorders2012;139(3):217‐29. [DOI: 10.1016/j.jad.2011.08.004] ">Baker 2012</a>; <a href="./references#CD009501-bbs2-0191" title="RiperH , AnderssonG , HunterSB , deWitJ , BerkingM , CuijpersP . Treatment of comorbid alcohol use disorders and depression with cognitive‐behavioural therapy and motivational interviewing: a meta‐analysis. Addiction (Abingdon, England)2014;109(3):394‐406. [PUBMED: 24304463] ">Riper 2014</a>) populations, with longer interventions shown to have greater improvements in mood and alcohol use outcomes (<a href="./references#CD009501-bbs2-0139" title="BakerAL , ThorntonLK , HilesS , HidesL , LubmanDI . Psychological interventions for alcohol misuse among people with co‐occurring depression or anxiety disorders: a systematic review. Journal of Affective Disorders2012;139(3):217‐29. [DOI: 10.1016/j.jad.2011.08.004] ">Baker 2012</a>). Unfortunately, many of these studies only focused on alcohol misuse (<a href="./references#CD009501-bbs2-0136" title="BabowitchJD , AntshelKM . Adolescent treatment outcomes for comorbid depression and substance misuse: a systematic review and synthesis of the literature. Journal of Affective Disorders2016;201:25‐33. [PUBMED: 27156096] ">Babowitch 2016</a>; <a href="./references#CD009501-bbs2-0139" title="BakerAL , ThorntonLK , HilesS , HidesL , LubmanDI . Psychological interventions for alcohol misuse among people with co‐occurring depression or anxiety disorders: a systematic review. Journal of Affective Disorders2012;139(3):217‐29. [DOI: 10.1016/j.jad.2011.08.004] ">Baker 2012</a>), examined comorbid depression and/or anxiety (<a href="./references#CD009501-bbs2-0139" title="BakerAL , ThorntonLK , HilesS , HidesL , LubmanDI . Psychological interventions for alcohol misuse among people with co‐occurring depression or anxiety disorders: a systematic review. Journal of Affective Disorders2012;139(3):217‐29. [DOI: 10.1016/j.jad.2011.08.004] ">Baker 2012</a>; <a href="./references#CD009501-bbs2-0167" title="HesseM . Integrated psychological treatment for substance use and co‐morbid anxiety or depression vs. treatment for substance use alone. A systematic review of the published literature. BMC Psychiatry2009;9:6. [PUBMED: 19232121] ">Hesse 2009</a>), or included non‐randomised controlled trials (<a href="./references#CD009501-bbs2-0169" title="HobdenB , BryantJ , CareyM , BakerAL , Farrell M. OldmeadowC , et al. Finding the optimal treatment model: A systematic review of treatment for co‐occurring alcohol misuse and depression. Australian &amp; New Zealand Journal of Psychiatry2018;52(8):737‐50. [DOI: 10.1177/0004867418758922] ">Hobden 2018</a>; <a href="./references#CD009501-bbs2-0191" title="RiperH , AnderssonG , HunterSB , deWitJ , BerkingM , CuijpersP . Treatment of comorbid alcohol use disorders and depression with cognitive‐behavioural therapy and motivational interviewing: a meta‐analysis. Addiction (Abingdon, England)2014;109(3):394‐406. [PUBMED: 24304463] ">Riper 2014</a>). No integrated motivational interviewing/CBT studies that meet the strict inclusion criteria of this review (i.e. randomised controlled trial, with diagnostic interviews to confirm presence of a substance use and depression disorder at study entry). Therefore, comments on the efficacy of integrated motivational interviewing/CBT treatments for comorbid substance use and depression disorders could not be made in this review. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD009501-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/urn:x-wiley:14651858:media:CD009501:CD009501-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_t/tCD009501-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD009501-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/full#CD009501-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009501-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/urn:x-wiley:14651858:media:CD009501:CD009501-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_t/tCD009501-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD009501-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/full#CD009501-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009501-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/urn:x-wiley:14651858:media:CD009501:CD009501-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_t/tCD009501-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD009501-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/full#CD009501-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009501-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/urn:x-wiley:14651858:media:CD009501:CD009501-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_t/tCD009501-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Integrated CBT vs Twelve Step Facilitation, Outcome: Depression at 6‐12 months" data-id="CD009501-fig-0004" src="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Comparison 1 Integrated CBT vs Twelve Step Facilitation, Outcome: Depression at 6‐12 months </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/full#CD009501-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009501-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/urn:x-wiley:14651858:media:CD009501:CD009501-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_t/tCD009501-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Integrated CBT vs Twelve Step Facilitation, Outcome: Percentage of Days Abstinent at 6 to 12 months." data-id="CD009501-fig-0005" src="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Comparison 1 Integrated CBT vs Twelve Step Facilitation, Outcome: Percentage of Days Abstinent at 6 to 12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/full#CD009501-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009501-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/urn:x-wiley:14651858:media:CD009501:CD009501-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_t/tCD009501-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Interpersonal Psychotherapy for Depression (IPT‐D) vs Other Theraputic Interventions, Outcome: Depression at end of treatment." data-id="CD009501-fig-0006" src="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Comparison 2 Interpersonal Psychotherapy for Depression (IPT‐D) vs Other Theraputic Interventions, Outcome: Depression at end of treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/full#CD009501-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009501-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/urn:x-wiley:14651858:media:CD009501:CD009501-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_t/tCD009501-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Integrated CBT vs Twelve Step Facilitation ‐ Post Treatment, Outcome 1 Depression ‐ HDRS: end of treatment." data-id="CD009501-fig-0007" src="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Integrated CBT vs Twelve Step Facilitation ‐ Post Treatment, Outcome 1 Depression ‐ HDRS: end of treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/references#CD009501-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009501-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/urn:x-wiley:14651858:media:CD009501:CD009501-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_t/tCD009501-CMP-001-02.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Integrated CBT vs Twelve Step Facilitation ‐ Post Treatment, Outcome 2 Depression ‐ HDRS: 6‐ to 12‐month follow‐up." data-id="CD009501-fig-0008" src="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Integrated CBT vs Twelve Step Facilitation ‐ Post Treatment, Outcome 2 Depression ‐ HDRS: 6‐ to 12‐month follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/references#CD009501-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009501-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/urn:x-wiley:14651858:media:CD009501:CD009501-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_t/tCD009501-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Integrated CBT vs Twelve Step Facilitation ‐ Post Treatment, Outcome 3 Substance use ‐ PDA: end of treatment." data-id="CD009501-fig-0009" src="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Integrated CBT vs Twelve Step Facilitation ‐ Post Treatment, Outcome 3 Substance use ‐ PDA: end of treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/references#CD009501-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009501-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/urn:x-wiley:14651858:media:CD009501:CD009501-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_t/tCD009501-CMP-001-04.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Integrated CBT vs Twelve Step Facilitation ‐ Post Treatment, Outcome 4 Substance use ‐ PDA: 6‐ to 12‐month follow‐up." data-id="CD009501-fig-0010" src="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Integrated CBT vs Twelve Step Facilitation ‐ Post Treatment, Outcome 4 Substance use ‐ PDA: 6‐ to 12‐month follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/references#CD009501-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009501-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/urn:x-wiley:14651858:media:CD009501:CD009501-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_t/tCD009501-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Integrated CBT vs Twelve Step Facilitation ‐ Post Treatment, Outcome 5 Treatment retention." data-id="CD009501-fig-0011" src="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Integrated CBT vs Twelve Step Facilitation ‐ Post Treatment, Outcome 5 Treatment retention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/references#CD009501-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009501-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/urn:x-wiley:14651858:media:CD009501:CD009501-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_t/tCD009501-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Integrated CBT vs Twelve Step Facilitation ‐ Post Treatment, Outcome 6 Treatment attendance." data-id="CD009501-fig-0012" src="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Integrated CBT vs Twelve Step Facilitation ‐ Post Treatment, Outcome 6 Treatment attendance. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/references#CD009501-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009501-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/urn:x-wiley:14651858:media:CD009501:CD009501-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_t/tCD009501-CMP-002-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Interpersonal Psychotherapy for Depression (IPT‐D) vs Other Theraputic Interventions, Outcome 1 Depression ‐ HDRS: end of treatment." data-id="CD009501-fig-0013" src="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Interpersonal Psychotherapy for Depression (IPT‐D) vs Other Theraputic Interventions, Outcome 1 Depression ‐ HDRS: end of treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/references#CD009501-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009501-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/urn:x-wiley:14651858:media:CD009501:CD009501-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_t/tCD009501-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Interpersonal Psychotherapy for Depression (IPT‐D) vs Other Theraputic Interventions, Outcome 2 Depression ‐ HDRS ‐ 3‐month follow‐up (IPT‐D vs Psychoed)." data-id="CD009501-fig-0014" src="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Interpersonal Psychotherapy for Depression (IPT‐D) vs Other Theraputic Interventions, Outcome 2 Depression ‐ HDRS ‐ 3‐month follow‐up (IPT‐D vs Psychoed). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/references#CD009501-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009501-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/urn:x-wiley:14651858:media:CD009501:CD009501-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_t/tCD009501-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Interpersonal Psychotherapy for Depression (IPT‐D) vs Other Theraputic Interventions, Outcome 3 Substance use ‐ PDA: end of treatment (IPT vs BST)." data-id="CD009501-fig-0015" src="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Interpersonal Psychotherapy for Depression (IPT‐D) vs Other Theraputic Interventions, Outcome 3 Substance use ‐ PDA: end of treatment (IPT vs BST). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/references#CD009501-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009501-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/urn:x-wiley:14651858:media:CD009501:CD009501-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_t/tCD009501-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Interpersonal Psychotherapy for Depression (IPT‐D) vs Other Theraputic Interventions, Outcome 4 Substance use ‐ Relapse: 3‐month follow‐up (IPT vs Psychoed)." data-id="CD009501-fig-0016" src="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Interpersonal Psychotherapy for Depression (IPT‐D) vs Other Theraputic Interventions, Outcome 4 Substance use ‐ Relapse: 3‐month follow‐up (IPT vs Psychoed). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/references#CD009501-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009501-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/urn:x-wiley:14651858:media:CD009501:CD009501-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_t/tCD009501-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Interpersonal Psychotherapy for Depression (IPT‐D) vs Other Theraputic Interventions, Outcome 5 Treatment retention." data-id="CD009501-fig-0017" src="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Interpersonal Psychotherapy for Depression (IPT‐D) vs Other Theraputic Interventions, Outcome 5 Treatment retention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/references#CD009501-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009501-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/urn:x-wiley:14651858:media:CD009501:CD009501-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_t/tCD009501-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Combined FFT &amp; CWD vs sequential FFT‐CWD; Combined FFT &amp; CSD vs sequential CWD‐FFT, Outcome 1 Depression ‐ CDRS‐R: end of treatment." data-id="CD009501-fig-0018" src="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Combined FFT &amp; CWD vs sequential FFT‐CWD; Combined FFT &amp; CSD vs sequential CWD‐FFT, Outcome 1 Depression ‐ CDRS‐R: end of treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/references#CD009501-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009501-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/urn:x-wiley:14651858:media:CD009501:CD009501-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_t/tCD009501-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Combined FFT &amp; CWD vs sequential FFT‐CWD; Combined FFT &amp; CSD vs sequential CWD‐FFT, Outcome 2 Depression ‐ CDRS‐R: 12‐month follow‐up." data-id="CD009501-fig-0019" src="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Combined FFT &amp; CWD vs sequential FFT‐CWD; Combined FFT &amp; CSD vs sequential CWD‐FFT, Outcome 2 Depression ‐ CDRS‐R: 12‐month follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/references#CD009501-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009501-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/urn:x-wiley:14651858:media:CD009501:CD009501-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_t/tCD009501-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Combined FFT &amp; CWD vs sequential FFT‐CWD; Combined FFT &amp; CSD vs sequential CWD‐FFT, Outcome 3 Substance use ‐ square root % daily use: end of treatment." data-id="CD009501-fig-0020" src="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Combined FFT &amp; CWD vs sequential FFT‐CWD; Combined FFT &amp; CSD vs sequential CWD‐FFT, Outcome 3 Substance use ‐ square root % daily use: end of treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/references#CD009501-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009501-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/urn:x-wiley:14651858:media:CD009501:CD009501-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_t/tCD009501-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Combined FFT &amp; CWD vs sequential FFT‐CWD; Combined FFT &amp; CSD vs sequential CWD‐FFT, Outcome 4 Substance use ‐ square root % daily use: 12‐month follow‐up." data-id="CD009501-fig-0021" src="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Combined FFT &amp; CWD vs sequential FFT‐CWD; Combined FFT &amp; CSD vs sequential CWD‐FFT, Outcome 4 Substance use ‐ square root % daily use: 12‐month follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/references#CD009501-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009501-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/urn:x-wiley:14651858:media:CD009501:CD009501-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_t/tCD009501-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Combined FFT &amp; CWD vs sequential FFT‐CWD; Combined FFT &amp; CSD vs sequential CWD‐FFT, Outcome 5 Premature termination." data-id="CD009501-fig-0022" src="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 Combined FFT &amp; CWD vs sequential FFT‐CWD; Combined FFT &amp; CSD vs sequential CWD‐FFT, Outcome 5 Premature termination. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/references#CD009501-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009501-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/urn:x-wiley:14651858:media:CD009501:CD009501-CMP-003-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_t/tCD009501-CMP-003-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Combined FFT &amp; CWD vs sequential FFT‐CWD; Combined FFT &amp; CSD vs sequential CWD‐FFT, Outcome 6 Treatment attendance." data-id="CD009501-fig-0023" src="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-CMP-003-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3 Combined FFT &amp; CWD vs sequential FFT‐CWD; Combined FFT &amp; CSD vs sequential CWD‐FFT, Outcome 6 Treatment attendance. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/references#CD009501-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-CMP-003-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009501-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/urn:x-wiley:14651858:media:CD009501:CD009501-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_t/tCD009501-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Behavioral Therapy for Depression in Drug Dependence vs Relaxation intervention, Outcome 1 Depression ‐ HDRS: end of treatment." data-id="CD009501-fig-0024" src="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Behavioral Therapy for Depression in Drug Dependence vs Relaxation intervention, Outcome 1 Depression ‐ HDRS: end of treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/references#CD009501-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009501-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/urn:x-wiley:14651858:media:CD009501:CD009501-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_t/tCD009501-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Behavioral Therapy for Depression in Drug Dependence vs Relaxation intervention, Outcome 2 Depression ‐ BDI‐II: end of treatment." data-id="CD009501-fig-0025" src="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Behavioral Therapy for Depression in Drug Dependence vs Relaxation intervention, Outcome 2 Depression ‐ BDI‐II: end of treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/references#CD009501-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009501-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/urn:x-wiley:14651858:media:CD009501:CD009501-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_t/tCD009501-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Behavioral Therapy for Depression in Drug Dependence vs Relaxation intervention, Outcome 3 Substance use ‐ Opiates: end of treatment." data-id="CD009501-fig-0026" src="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Behavioral Therapy for Depression in Drug Dependence vs Relaxation intervention, Outcome 3 Substance use ‐ Opiates: end of treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/references#CD009501-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009501-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/urn:x-wiley:14651858:media:CD009501:CD009501-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_t/tCD009501-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Behavioral Therapy for Depression in Drug Dependence vs Relaxation intervention, Outcome 4 Substance use ‐ Cocaine: end of treatment." data-id="CD009501-fig-0027" src="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 Behavioral Therapy for Depression in Drug Dependence vs Relaxation intervention, Outcome 4 Substance use ‐ Cocaine: end of treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/references#CD009501-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009501-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/urn:x-wiley:14651858:media:CD009501:CD009501-CMP-004-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_t/tCD009501-CMP-004-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Behavioral Therapy for Depression in Drug Dependence vs Relaxation intervention, Outcome 5 Substance use ‐ Benzodiazepines: end of treatment." data-id="CD009501-fig-0028" src="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-CMP-004-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4 Behavioral Therapy for Depression in Drug Dependence vs Relaxation intervention, Outcome 5 Substance use ‐ Benzodiazepines: end of treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/references#CD009501-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-CMP-004-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009501-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/urn:x-wiley:14651858:media:CD009501:CD009501-CMP-004-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_t/tCD009501-CMP-004-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Behavioral Therapy for Depression in Drug Dependence vs Relaxation intervention, Outcome 6 Treatment attendance." data-id="CD009501-fig-0029" src="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-CMP-004-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.6</div> <div class="figure-caption"> <p>Comparison 4 Behavioral Therapy for Depression in Drug Dependence vs Relaxation intervention, Outcome 6 Treatment attendance. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/references#CD009501-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/media/CDSR/CD009501/image_n/nCD009501-CMP-004-06.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD009501-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Integrated CBT compared with Twelve Step Facilitation for co‐occurring depression and substance use disorders</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p><b>Integrated CBT compared with Twelve Step Facilitation for co‐occurring depression and substance use disorders</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="8" rowspan="1" valign="top"> <p><b>Patient or population:</b> co‐occurring depression and substance use disorders<br/> <b>Setting:</b> <br/> <b>Intervention:</b> Integrated CBT<br/> <b>Comparison:</b> Twelve Step Facilitation </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Twelve Step Facilitation</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Integrated CBT</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Depression score<br/> Assessed with: Hamilton Depression Rating Scale (HDRS) ‐ Structured clinical interview (21 items)<br/> Scale from: 0 to 54 (higher score worse)<br/> Follow‐up: end of treatment </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean depression score ranged from 21.0 to 23.2</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 4.05 higher<br/> (1.43 higher to 6.66 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>212<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Depression score<br/> Assessed with: Hamilton Depression Rating Scale (HDRS) ‐ Structured clinical interview (21 items)<br/> Scale from: 0 to 54 (higher score worse)<br/> Follow‐up: 6 months to 12 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean depression score ranged from 21.0 to 27.9</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 1.53 higher<br/> (1.73 lower to 4.79 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>181<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Percent of days abstinent<br/> Assessed with: The calendar‐assisted structured interview ‐ Time‐Line Follow‐Back (TLFB) for past 3‐month substance use<br/> Scale from: 0 to 100 (lower score better)<br/> Follow‐up: end of treatment </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean proportion of days abstinent ranged from 93 to 90</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 2.84 lower<br/> (8.04 lower to 2.35 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>220<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Percent of days abstinent<br/> Assessed with: TLFB for past 3‐month substance use<br/> Scale from: 0 to 100 (lower score better)<br/> Follow‐up: 6 months to 12 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean proportion of days abstinent ranged from 72 to 75</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 10.76 higher<br/> (3.10 higher to 18.42 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>189<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>2 3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Treatment retention<br/> Assessed with: dropped out of treatment after attending an average of 1.2 sessions </p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.95<br/> (0.72 to 1.25) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>296<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>785 per 1,000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>745 per 1,000<br/> (565 to 981) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of treatment sessions attended<br/> Scale from: 0 to 36 </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of Treatment Sessions Attended ranged from 19.4‐22.1</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 1.27 lower<br/> (6.10 lower to 3.56 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>270<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>2 3 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>MD:</b> mean difference; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="8" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate. The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited. The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate. The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p><sup>1</sup> Downgraded two levels due to very serious risk of bias: high levels of performance bias, attrition bias and uneven medication use between groups. One study also had high risk of selection bias and unclear risk for selective reporting. </p> <p><sup>2</sup> Downgraded one level due to Imprecision: small number of trials/participants </p> <p><sup>3</sup> Downgraded one level due to indirectness: population of predominately Caucasian male veterans </p> <p><sup>4</sup> Downgraded two levels due to very serious risk of bias: high levels of selection bias, performance bias, attrition bias, unclear risk for selective reporting and uneven attendance between groups at 12‐step Community Meetings </p> <p><sup>5</sup> Downgraded two levels due to very serious risk of bias: mean attendance was based on a reduced sample, not those originally randomised into the study. Also high risk of selection bias, performance bias and attrition bias </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Integrated CBT compared with Twelve Step Facilitation for co‐occurring depression and substance use disorders</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/full#CD009501-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD009501-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Interpersonal Psychotherapy for Depression (IPT‐D) compared with Other Psychological Interventions for co‐occurring depression and substance use disorders</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Interpersonal Psychotherapy for Depression (IPT‐D) compared with Other Psychological Interventions for co‐occurring depression and substance use disorders</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> Individuals experiencing co‐occurring depression and substance use disorders<br/> <b>Setting:</b> any setting<br/> <b>Intervention:</b> Interpersonal Psychotherapy for Depression (IPT‐D)<br/> <b>Comparison:</b> Other Psychological Interventions </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Other Theraputic Interventions</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Interpersonal Psychotherapy for Depression (IPT‐D)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Depression score<br/> Assessed with: Hamilton Depression Rating Scale (HDRS) ‐ Structured clinical interview (17 and 24 items)<br/> Scale from: 0 to 54 (higher score worse)<br/> Follow‐up: end of treatment </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>SMD 0.54 SD lower<br/> (1.04 lower to 0.04 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>64<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Depression score<br/> Assessed with: Hamilton Depression Rating Scale (HDRS) ‐ Structured clinical interview (17 items)<br/> Scale from: 0 to 54 (higher score worse)<br/> Follow‐up: 3 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean depression score was 15.8</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 3.80 higher<br/> (3.83 lower to 11.43 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>3 4 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Percentage of days abstinent<br/> Assessed with: the calendar‐assisted structured interview ‐ Time‐Line Follow‐Back (TLFB) for past month of alcohol use<br/> Scale from: 0 to 100 (better)<br/> Follow‐up: end of treatment </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean percentage of days abstinent was 49.7</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 2.70 lower<br/> (28.74 lower to 23.34 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>3 6 7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Substance use ‐ relapse<br/> Assessed with: self‐reported heavy drinking (4+ drinks) or drug use on at least 10% of non‐incarcerated days or positive urine test<br/> Follow‐up: 3‐months </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.67<br/> (0.30 to 1.50) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>38<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>3 4 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>316 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>212 per 1,000<br/> (95 to 474) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Treatment retention</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.00<br/> (0.81 to 1.23) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>64<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>774 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>744 per 1,000<br/> (627 to 952) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>MD:</b> mean difference; <b>RR:</b> Risk ratio; <b>SMD:</b> standardised mean difference </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate. The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited. The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate. The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded two levels due to serious risk of bias: high levels of performance bias due to difficulties with blinding participants and personnel, one of the studies also had high attrition bias and reported group differences in use of antidepressants and adjunctive mental health counselling </p> <p><sup>2</sup> Downgraded one level due to indirectness: one of the study was based on a female prison population, the other were recruited through a medical college, neither sample is likely to be representative of broader population of individuals experience comorbid substance use and depressive disorders </p> <p><sup>3</sup> Downgraded two levels due to very small sample size </p> <p><sup>4</sup> Downgraded two levels due to serious risk of bias: high levels of performance bias due to difficulties with blinding participants and personnel and reported group differences in use of antidepressants and adjunctive mental health counselling </p> <p><sup>5</sup> Downgraded one level due to indirectness: Female prison population unlikely to be representative of broader population of individuals experience comorbid substance use and depressive disorders </p> <p><sup>6</sup> Downgraded two levels due to serious risk of bias: high levels of performance bias due to difficulties with blinding participants and personnel </p> <p><sup>7</sup> Downgraded one level due to indirectness: sample recruited through a medical college, predominately White male, unlikely to be representative of broader population of individuals experience comorbid substance use and depressive disorders </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Interpersonal Psychotherapy for Depression (IPT‐D) compared with Other Psychological Interventions for co‐occurring depression and substance use disorders</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/full#CD009501-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009501-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Integrated CBT vs Twelve Step Facilitation ‐ Post Treatment</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Depression ‐ HDRS: end of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>212</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.05 [1.43, 6.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Depression ‐ HDRS: 6‐ to 12‐month follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>181</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.53 [‐1.73, 4.79]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Substance use ‐ PDA: end of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>220</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.84 [‐8.04, 2.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Substance use ‐ PDA: 6‐ to 12‐month follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>189</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>10.76 [3.10, 18.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Treatment retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>296</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.72, 1.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Treatment attendance <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>270</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.27 [‐6.10, 3.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Integrated CBT vs Twelve Step Facilitation ‐ Post Treatment</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/references#CD009501-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009501-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Interpersonal Psychotherapy for Depression (IPT‐D) vs Other Theraputic Interventions</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Depression ‐ HDRS: end of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.54 [‐1.04, ‐0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Depression ‐ HDRS ‐ 3‐month follow‐up (IPT‐D vs Psychoed) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Substance use ‐ PDA: end of treatment (IPT vs BST) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Substance use ‐ Relapse: 3‐month follow‐up (IPT vs Psychoed) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Treatment retention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.81, 1.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Interpersonal Psychotherapy for Depression (IPT‐D) vs Other Theraputic Interventions</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/references#CD009501-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009501-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Combined FFT &amp; CWD vs sequential FFT‐CWD; Combined FFT &amp; CSD vs sequential CWD‐FFT</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Depression ‐ CDRS‐R: end of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Depression ‐ CDRS‐R: 12‐month follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Substance use ‐ square root % daily use: end of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Substance use ‐ square root % daily use: 12‐month follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Premature termination <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Treatment attendance <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Combined FFT &amp; CWD vs sequential FFT‐CWD; Combined FFT &amp; CSD vs sequential CWD‐FFT</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/references#CD009501-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009501-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Behavioral Therapy for Depression in Drug Dependence vs Relaxation intervention</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Depression ‐ HDRS: end of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.10 [‐6.03, 10.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Depression ‐ BDI‐II: end of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.60 [‐4.94, 18.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Substance use ‐ Opiates: end of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [‐0.09, 0.31]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Substance use ‐ Cocaine: end of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.1 [‐0.13, 0.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Substance use ‐ Benzodiazepines: end of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.21, 0.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Treatment attendance <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.70 [‐7.83, 0.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Behavioral Therapy for Depression in Drug Dependence vs Relaxation intervention</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009501.pub2/references#CD009501-tbl-0006">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD009501.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD009501-note-0004">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD009501-note-0002">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD009501-note-0003">Français</a> </li> <li class="section-language"> <a class="" href="ja#CD009501-note-0012">日本語</a> </li> <li class="section-language"> <a class="" href="ko#CD009501-note-0010">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD009501-note-0001">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD009501-note-0011">Polski</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD009501-note-0009">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009501\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009501\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009501\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009501\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009501\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009501\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009501\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009501\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009501\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009501\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009501\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009501\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009501\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009501\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009501\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009501\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009501\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009501\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=77cjsSG8&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009501.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009501.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD009501.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD009501.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009501.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740718484769"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009501.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740718484773"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009501.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dd1794d22f401',t:'MTc0MDcxODQ4NS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 